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Abstract
High-risk Human Papillomavirus (HPV) types such as HPV-16 cause a spectrum 
of pre-cancerous neoplastic changes in epithelial sites including that of the cervix. 
HPV-induced cervical lesions that display low to moderate neoplastic changes are 
graded as low-grade squamous intraepithelial neoplasia (LSIL). HPV-induced 
lesions that display high levels of neoplasia are graded as high-grade squamous 
intraepithelial neoplasia (HSIL).
The previous analyses of cervical lesions of LSIL and HSIL grades have shown 
that the timing of early and late viral gene expression changes, as the lesion 
becomes more neoplastic. In HSIL lesions, the HPV-16 E7 surrogate marker 
MCM-7 persists throughout the epithelium, which coincides with a delay in late 
gene expression including L1 capsid expression. HSIL lesions often do not support 
a complete virus life cycle.
The work in this thesis has shown that the Normal Immortalized Human 
Keratinocyte (NIKS) organotypic raft culture system, which is commonly used to 
study the HPV-16 life cycle, surprisingly recapitulates the spectrum of gene 
expression patterns identified in both LSIL and HSIL lesions. In addition, this 
model also demonstrates pathological changes, which correlate with both LSIL 
and HSIL phenotypes. This has rendered this system a potential model of 
episomal HPV-16 induced neoplasia. This auspicious finding led us to make use of 
this system to explore viral characteristics that potentially underlie HSIL-like gene 
expression patterns and neoplastic changes. Monolayer LSIL-like and HSIL-like 
HPV-16 cell lines were subsequently used to evaluate viral copy number, early 
oncogene expression and growth potential.
In these experiments we have found that episomal HSIL-like HPV-16 cell lines 
bypass density-dependent growth arrest, which coincides with a rise in E6 and E7 
oncogene levels. Finally, we have found that high E6 and E7 expression levels 
and growth potential at cell-cell contact correlate with MCM-7 persistence in the 
HPV-16 raft epithelium.
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Chapter 1 - Introduction
1.0 Introduction
1.1 Classification of Papillomaviruses
Papillomaviruses (PVs) are non-enveloped double-stranded DNA viruses. PVs are 
a member of the family Papillomaviridae, which is comprised of 200-300 PV types. 
The Papillomaviridae are an extremely old family of viruses and it is estimated that 
the existence of PVs date back beyond the origin of Homo sapiens (Ho, Chan et 
al. 1993; Bernard, Chan et al. 1994). The mutation rate of PVs is estimated to be 
0.25% per 10-20,000 years. In relation to the evolutionary time-scale, this rate is 
thought to be similar to the mutation rate of the host germ line (Chan, Bernard et 
al. 1997).
It is not surprising that PVs have been part of a long evolutionary trail due to the 
enormous diversity of animal species that PV infect. Some of these species other 
than Homo sapiens include bovine and other ungulates such as goats and pigs, 
birds, reptiles and cetaceans, which include whales and dolphins (de Villiers, 
Fauquet et al. 2004).
To date there is no knowledge of interspecies transmission, which can be partially 
explained through a divergence in their PV nucleotide sequence identity. PVs are 
broadly organized into genera based on their highly conserved L1 capsid ORF 
where greater than a 60% difference in nucleotide sequence identity constitutes a 
new PV genus (Bernard, Chan et al. 1994). Most host species appear to be 
infected by PVs within their own genera. PV genera can be further broken down 
into PV species, which are based on a 40% difference in L1 nucleotide sequence
1
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identity and then to PV types where only a 10% difference in L1 nucleotide 
sequence identity distinguishes these types (Bernard, 1994)
Amongst a genetic divergence a common fundamental biological feature of all PV 
genera is demonstrated by their complex and unique requirement of infecting 
epithelial cells and utilizing the entire epithelium to complete their life cycle. It is 
widely established however that within the epithelium PV types also diverge to 
create a clinical spectrum of PV disease. These pathological differences have 
formed a large basis for the study of different HPV types.
1.2 Human Papillomaviruses
The first genital and laryngeal HPV isolates were discovered over thirty years ago 
(Gissmann, Pfister et al. 1977; zur Hausen 1977; Gissmann, Wolnik et al. 1983). 
To date over 100 different HPV types have been isolated from various tissues 
(Bernard 2005)
HPVs infect a range of tissues including the skin and mucous membranes of 
conjunctiva, oral cavity, larynx, tracheobronchial tree, esophagus and areas of the 
anogenital tract including the anus, vulva and cervix. HPVs are also tissue and site 
specific. HPV-1 infects stratified squamous epithelium of the sole and foot 
producing plantar warts. HPV-2 and 4 infect skin of fingers to produce common 
warts. HPV-6 and 11 almost exclusively infect mucosal surfaces of oral cavity and 
anogenital tract, (de Villiers, Fauquet et al. 2004)
HPVs can be divided into five genera including Alpha, Beta, Gamma Mu and Nu 
(reviewed in (Doorbar 2006) . Beta HPVs such as HPV 5 and 8 infect cutaneous
2
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tissue and are usually associated with mild skin lesions. The exception is for 
some individuals who suffer from the inherited disease epidermodysplasia 
verruciformis. This hereditary skin disorder predisposes these patients to non­
melanoma skin cancers (Harwood and Proby 2002; Pfister 2003). The Gamma, 
Mu and Nu such as HPV-65, 63 and 41 respectively mostly infect cutaneous sites 
and primarily cause benign cutaneous lesions such as verrucas (Pfister 1992).
The largest genera the Alpha Papillomaviruses infect cutaneous tissue such as the 
hands (e.g. HPV-2) and mucosal tissue, including the cervix (e.g. HPV-16, 18). As 
just mentioned, the Alpha Papillomaviruses in particular infect various sites of the 
anogenital tract such as the cervix and vulva.
Some of the Alpha Papillomaviruses have the ability to cause both pre-cancerous 
neoplastic changes and cancers in the tissues such as the cervix (de Villiers, 
Fauquet et al. 2004). These types are known as high-risk types, which comprise 
approximately 20 of the Alpha Papillomaviruses. The remaining 15 Alpha 
Papillomaviruses that infect areas of the anogenital tract are referred to as low-risk 
viruses as these types mostly lead to benign disease. Low-risk HPV types are 
more equally prevalent in infected tissues compared to high-risk HPV types. The 
high risk types HPV-16 and 18 appear to be the most prevalent, together causing 
60% of all cervical cancers (Munoz, Bosch et al. 2003). The ability of high-risk 
HPV types to cause both benign and malignant disease has rendered them as 
interesting candidates towards the understanding of HPV oncogenesis.
3
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1.3 HPV-16 related disease
High-risk HPV types such as HPV-16 can cause a clinical spectrum of disease in 
cutaneous and mucosal tissues. The most studied of these is HPV-16 disease of 
the cervix. HPV-16 is associated with both precancerous low-grade and pre- 
cancerous high-grade lesions, which develop in the ectocervix (Wright 2002). 
However a rare event, persistent HPV-16 infections also have the potential to 
develop into cancer. Within the cervix, precancerous HPV-16 lesions and HPV-16 
associated cancers commonly form in the transformation zone where cells 
undergo metaplastic changes (Wright 2002).
HPV has been established as the main causative agent of cervical cancer. 
Approximately 99.8% of cervical cancers are caused by infections with HPV and 
approximately 50% of these cancers are caused by HPV-16 (Walboomers, Jacobs 
et al. 1999; Munoz, Bosch et al. 2003). HPV-16 is also thought to be associated 
with cancers in other places of the anogenital tract including the anus, vulva and 
penis (Rubin, Kleter et al. 2001; Bosch and de Sanjose 2003). In 2006 2,873 
women in the UK were diagnosed with cervical cancer, which caused 941 deaths 
in 2007 (quoted from the Health Protection Agency, UK). HPV related cancers are 
more prominent in developing countries where HPV screening programs are less 
available (Cohen 2005).
1.4 Pathological grading system for HPV associated lesions
It is widely established that HPV-16 can cause a range of pre-cancerous 
neoplastic changes in the cervix in addition to its ability to cause cancer. As these 
neoplastic changes precede cancer formation, their diagnosis is crucial for the 
prevention of cancer.
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Pathologists use a diagnostic grading scale to quantify non-invasive cervical 
squamous epithelial abnormalities associated with HPV infection. In 1988 the 
Bethesda system of pathological grading was created and is now used in many 
countries to treat HPV disease. The Bethesda system specifically divides the 
severity of pre-cancerous neoplastic changes in the cervix into two categories 
(Diane Solomon 2004) HPV lesions that display mild dysplasia in the first third of 
the epithelium are categorized as a low-grade squamous intraepithelial lesion 
(LSIL). HPV lesions that display moderate to severe dysplasia through the middle 
and final third of the epithelium are categorized as a high-grade intraepithelial 
squamous lesion (HSIL). An alternative grading scale has also been used which 
divides the grading scale into three categories. HPV lesions that display mild 
dysplasia in the first third of the epithelium are categorized as cervical 
intraepithelial neoplasia 1 (CIN-1) (Ivan Damjanov 2007). The grade of CIN-1 and 
LSIL are recognized as being equivalent. HPV lesions that display moderate to 
severe dysplasia in the middle and final third of the epithelium are categorized as 
CIN-2 and CIN-3, respectively. Both CIN-2 and CIN-3 fall under the Bethesda 
grade, HSIL(lvan Damjanov 2007).
1.5 Pathology of high-risk HPV types in cervical lesions
The diagnosis of LSIL and HSIL is based on a set of uniform criteria, which is used 
to identify the severity of pathological changes in the epithelium. Figure 1.1 
contains an example of an H&E stained cervical epithelium with no pathological 
changes, a cervical lesion graded with LSIL/CIN-1, and two cervical lesions grades 
with HSIL (CIN-2 and CIN-3, respectively). In cervical tissue that exhibits no 
pathological changes, the basal cells are small and uniform in size. The cells in the
5
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basal layer are aligned and maintain their normal polarity. Normal stratification or 
squamous maturation occurs above the basal layer.
In cervical lesions graded with LSIL, hyperplasia is evident in the lower third of the 
epithelium (Figure 1.1). The nuclei starting in the basal layer are pleomorphic, 
meaning that they vary in size and shape. The lower third of the epithelium is 
more disorganized and the cells lack polarity. The lesion also exhibits mild 
dysplasia or lack of squamous maturation, which persist until the middle-third of 
the epithelium. Another feature of HPV induced LSIL is the presence of koilocytes, 
which can be seen in the upper two thirds of the epithelium. This perinuclear 
clearing is a cytopathic effect from the virus. Pathologists can distinguish 
koilocytes from the vacuolar glyocogenation seen in normal cervical tissue above 
(Wright 2002; Ivan Damjanov 2007).
In lesions with HSIL/CIN-2 nuclear pleomorphisms extend throughout the bottom 
and middle-third of the epithelium (Figure 1.1). The nuclei appear more crowded 
within this region and most of the cells also exhibit a loss in polarity. There is a 
further delay in squamous maturation where the cells remain dysplastic until the 
final-third of the epithelium. In the lesion with HSIL/CIN-3 the cells remain 
dysplastic throughout the entire epithelium. The nuclei are highly pleomorphic 
throughout and cellular polarity is not maintained in the majority of the cells. 
Koilocytes are usually not present in HSIL lesions (Wright 2002; Ivan Damjanov 
2007).
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The equivalent lesions of LSIL and HSIL grades can be found in other sites of the 
anogential tract including the vulva and more rarely the penis. (Demeter, Stoler et 
al. 1993; Hillemanns and Wang 2006)
HSIL is thought to be a prerequisite for cancer development. However, the 
majority of LSIL and HSIL lesions regress back to asymptomatic phenotypes with 
the aid of the host immune system (Stanley 2008). The stages of HPV induced 
neoplasia (i.e. LSIL to HSIL) are also thought to be a progressive disease as a 
consequence of viral persistence, however recent statistics suggest that HSIL 
might develop more acutely (Koutsky, Holmes et al. 1992; Woodman, Collins et al. 
2001).
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Figure 1.1 Pathological changes in cervical lesions with LSIL and HSIL
In the normal cervix basal cells are small and uniform in size. Squamous maturation begins two to 
three layers above the basal layer. The noticeable vacuolation in the mature squamous cells is 
caused by the presence of glycogen. In the lesion graded with LSIL, dysplastic cells persist until 
the middle of the epithelium. The nuclei in the first third of the epithelium are pleomorphic and the 
cells exhibit a loss of polarity. Squamous maturation is not evident until the middle-and final-third of 
the epithelium. Koilocytes, recognized as a cytopathic affect of the virus, persist in the middle and 
final third of the epithelium. In the lesion with HSIL (CIN-2) dysplastic cells are evident until the 
final third of the epithelium. The nuclei are pleomorphic and most of these cells have lost their 
normal polarity. Squamous maturation does not occur until the last several layers. In the lesion 
with HSIL (CIN-3) the cells remain dysplastic throughout the entire epithelium. All of the nuclei are 
pleomorphic and a loss in cellular polarity is detected throughout the epithelium
DC
Normal Cervix
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1.6 Terminal differentiation of the epithelium
As stated earlier a common biological feature of PVs is their ability to infect 
keratinocytes of the basal epithelium and use the entire differentiating epithelium 
to carry out their life cycles. It is therefore important to recognize that the virus will 
encounter three to four very distinct host cell environments as it completes its life 
cycle in the differentiating epithelium.
Keratinocytes are named from their high levels of keratin filaments, which 
compose up to 90% of the total epithelial mass (Candi, Schmidt et al. 2005). 
Keratins or keratin intermediate filaments (KIFS) form the cytoskeleton of all 
keratinocytes, which also supply a structure to the epithelium.
The epithelium of cutaneous and mucosal tissues has primarily evolved to protect 
the underlying tissue by supplying a structural and physical barrier. Keratinocytes 
create this barrier through the process of terminal differentiation where in this 
process cells are pushed up to the surface to create several layers of stratified 
squamous cells. Mucosal and cutaneous epithelia follow a similar program of 
terminal differentiation first beginning with the basal layer, which is composed of 
pre-differentiated cells. Directly in contact with the basal lamina or dermis the first 
layer of cells called the basal layer contain the only cells that have the capacity for 
DNA synthesis and mitosis. Basal cells are also distinguished by their 
composition of two distinct keratins, K5 and K14 (Nelson and Sun 1983) (Figure 
1.2). During basal cell division, transit-amplifying cells are pushed to the layer 
above and it is at this point that cells commit to the terminal differentiation 
program. The process of terminal differentiation can be broken down into early 
and late stages.
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The differentiating cells immediately above the basal layer begin the early phase 
of terminal differentiation. In these cells a new set of keratins are expressed. One 
of the most abundant keratins expressed during early differentiation is K10, in 
cutaneous epithelia and K13, in mucosal tissue. During early differentiation the 
keratins in this layer such as K10 aggregate into bundles to create spinous-like 
cells (Eichner, Sun et al. 1986). Several layers of these cells that express K10 
form the spinous layer in cutaneous epithelia, which is referred to as the 
intermediate layer in mucosal tissue. It has been previously suggested that the 
expression of K10 prevents cellular proliferation above the basal layer (Paramio, 
Casanova et al. 1999). Spinous cells that express K10 are post-mitotic but are still 
metabolically active (Fuchs 1990).
The second distinct layers of cells compose the granular layer, which marks the 
start of late terminal differentiation. The granular layer, which is more predominant 
in cutaneous epithelia than mucosal epithelia, is smaller than the spinous layer, 
however it involves more destructive and physical changes to the cells. Within this 
layer new keratins are no longer made and the structural breakdown of the cells 
begins. This is accompanied by the start of nuclear degeneration and the end of 
metabolic functions. The structural breakdown begins with the creation of pro- 
filaggrin, which is contained in keratohyalin bundles, thus giving this layer a 
granular appearance (Dale, Salonen et al. 1990; Manabe and O'Guin 1994). Pro- 
filaggrin is then is cleaved by several proteases such as calpain to create filaggrin 
(Presland, Kimball et al. 1997). Filaggrin plays an important role in the aggregation 
of keratins, which leads to the collapse of the entire keratin network. The collapse 
of the keratin network contributes to the formation of the cornified layer. Filaggrin 
itself has a very short half-life of 6 hours and is eventually broken down into single
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amino acids to form a component of the cornified envelope (Candi, Schmidt et al. 
2005).
The cornified layer in cutaneous epithelium, and the superficial layer in mucosal 
epithelium is the final end-point of terminal differentiation. This is a highly 
impermeable and protective layer that consists of “cellular skeletons” with cross- 
linked proteins and keratin filaments (Fuchs 1990).
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Figure 1.2 Cutaneous Epithelium
Viral life cycle begins in infected cells within the basal compartment. The virus will then encounter 
three distinct layers during the terminal differentiation process. In normal epithelium, basal cells 
are the only cells with the ability to proliferate. As these cells proliferate cells are pushed into the 
spinous layer. This layer consists of four to six layers of cells that have lost the ability to proliferate 
but still maintain metabolic activity. In the spinous layer, which marks the start of early terminal 
differentiation, differentiation specific keratins such as K10 are actively expressed. As the cells 
migrate up through the epithelium they undergo late terminal differentiation. The granular layer 
specifically marks the site of late terminal differentiation. In this layer pro-filaggrin is contained in 
keratohyalin bundles, which demonstrate a granular appearance. In this layer pro-filaggrin is also 
processed into filaggrin. The specific role of filaggrin is to aggregate the keratin network, which will 
form the cornified layer above. In the granular layer active keratin expression also ends and 
nuclear degeneration begins. Terminal differentiation ends in the cornifed layer, which is an 
impermeable and insoluble layer. The cornifed layer is mainly filled with cellular skeletons with 
collapsed keratin filaments.
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1.7 The HPV-16 genome
HPV-16 contains eight functional genes within its 8kb double stranded circular 
genome (Figure 1.3). As with all PVs, the HPV-16 genome can be divided into 
three major regions. These regions are separated by two polyadenylation poly (A) 
sites, which are designated as early poly (A) and late poly (A). The third region 
contains the long control region (LCR) or upstream regulation region (URR), which 
lies upstream of both the early poly (A) and late poly (A) regions. The early poly 
(A) region encodes the majority of the HPV-16 ORFs including that of E1, E2, E4, 
E5, E6 and E7. E4 and E2 are encoded within the same ORF. The late poly (A) 
region encodes the ORF for the capsid proteins L1 and L2.
Two main promoters control viral gene expression in the epithelium. The early p97 
promoter, which only controls early gene expression (e.g. E1, E2, E4, E5, E6 and 
E7) is contained within the LCR, whereas the differentiation dependent late 
promoter, p670, is contained downstream within the E7 ORF (Smotkin and 
Wettstein 1986; Grassmann, Rapp et al. 1996). Due to its location in the genome 
several early genes (e.g. E1, E2, E4 and E5) as well as the late L1/L2 capsid 
genes can be expressed from the late promoter. Transcription from the late 
promoter must bypass the early poly (A) site to allow gene expression from the 
late region (Zheng and Baker 2006).
The regulatory region of the virus or the LCR lies just upstream of the E6 ORF. As 
just mentioned this region houses the early p97 promoter and also contains cis- 
acting regulatory sequences upstream of the p97 promoter, which are necessary 
for both replication and viral transcription. The binding sites for several cellular
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transcription factors have been identified in this region. Some of these cellular 
transcription factors that bind to designated sites within the LCR include: Sp-1, 
AP-1, Oct-1 and YY1. Transcription factors have been shown to both positively 
and negatively regulate transcription (Morris, Dent et al. 1993; Lace, Yamakawa et 
al. 2009). Amongst the transcription factor binding sites the LCR also contain 
gluccocorticoid responsive elements (GRE). The binding of gluccocorticoid to 
GREs results in an increase in replication (Piccini, Storey et al. 1997).
The LCR also contains four HPV-16 E2 binding sites (E2BS (1-4)) that are situated 
close to cellular transcription factor sites (Androphy, Lowy et al. 1987). The binding 
of E2 can consequently make these regions in the LCR inaccessible to cellular 
transcription factors. It has been further shown that when E2 binds to specifically 
E2BS-2 and -4, viral transcription from the p97 promoter is repressed (Sousa, 
Dostatni et al. 1990; Tan, Leong et al. 1994).The E2 protein has therefore been 
established as regulator of early transcription. In addition, E2BS-3 within the LCR 
is also located next to the viral origin of replication. E2 binds to this site as it 
recruits the HPV-16 E1 helicase to the origin of replication to begin the viral 
replication process (Desaintes and Demeret 1996). It has been shown that both 
E1 and E2 are necessary to carry out viral replication (Berg and Stenlund 1997).
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Figure 1.3 HPV-16 8kb double-stranded circular genome
The HPV-16 genome consists of six early genes (E1, E2, E4, E5, E6 and E7) and two late genes 
(L1 and L2) which are situated upstream of the early poly(A) and late poly (A) sites respectively. 
Early genes are expressed from the early p97 promoter whereas a subset of early as well as the 
late genes are expressed from the differentiation dependent late promoter, p670. The LCR is 
situated upstream of the early region and contains cis-acting regulatory regions which are 
necessary for both viral replication and transcription.
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1.8 HPV-16 transcription
The mapping of HPV-16 RNA transcripts and the identification of post- 
transcriptionally modified early and late mRNA products have been mostly carried 
out in HPV-16 W12 cells (Doorbar, Parton et al. 1990; Milligan, Veerapraditsin et 
al. 2007). HPV-16 W12 cells were previously isolated from a patient with low- 
grade cervical neoplasia and it has been shown that these cells contain the 
episomal form of the HPV-16 genome (Stanley, Browne et al. 1989). All of the 
HPV-16 genes are transcribed as polycistronic messages from either the early p97 
or late p640 promoters. Several other putative promoters have also been identified 
within the LCR and within the E4 ORF (Doorbar, Parton et al. 1990; Milligan, 
Veerapraditsin et al. 2007).
Polycistronic messages undergo extensive post-transcriptional alternate splicing 
from the early poly(A) and late poly(A) sites, to create early and late viral mRNAs. 
mRNA products of the early p97 promoter have been indentified in mixed pools of 
undifferentiated and differentiated cells, which suggest that these gene products 
are contained in both the basal layer and in the differentiating suprabasal layers. 
Early mRNA splice products include different combinations of E1, E2, E4 E5, E6 
and E7 polycistronic or bicistronic messages. (Doorbar, Parton et al. 1990) (Figure
1.4). The E4 protein is also referred to as E1AE4 as it is translated from a spliced 
mRNA, with the first five amino acids being encoded from the E1 ORF. 
Interestingly three distinct splice products of the E6 gene have also been identified 
which include E6-full length, and two truncated species, E6*l and E6*ll. E6*l has 
been found to be the most abundant E6 transcript product in cervical cancer cell 
lines (Cornelissen, Smits et al. 1990). Previous studies have also identified E6*l as
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a translated product and it also thought to have functional components in the HPV- 
16 life cycle (Pim, Tomaic et al. 2009).
mRNA products from the differentiation dependent late promoter, p640, have been 
mostly identified in differentiated cells. These mRNA products include different 
combinations of E1, E2, E5 E1AE4, L1 and L2 (Doorbar, Parton et al. 1990) 
(Milligan, Veerapraditsin et al. 2007). The bicistronic E1AE4 and L1 transcript has 
been identified as one of the main late transcript products. The E1AE4 and L1 
capsid protein have been subsequently identified in the differentiating cells of the 
suprabasal layers (Doorbar, Foo et al. 1997; Middleton, Peh et al. 2003; Peh and 
Doorbar 2005).
More recently L1 transcript products have also been found in undifferentiated cells, 
however these L1 transcripts did not contain a poly (A) site. L1 transcripts, 
including a poly (A) site, were subsequently detected in differentiated cells 
(Milligan, Veerapraditsin et al. 2007). It is therefore thought that late genes can 
also be transcribed early on in the life cycle, however the post-transcriptional 
regulation of late genes are carried out in the differentiating layers above.
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Figure 1.4 HPV-16 transcription map
HPV 16 ORFs are designated in the boxes at the top of the figure. Nucleotide boundaries of each 
ORF are indicated above each box. The positions of the early p97 promoter and the p640 promoter 
are indicated below the boxed ORFs. The early poly (A) site and late poly (A) site are identified at 
nucleotides 4215 and 7321 respectively. The different early and late mRNA species are indicated 
in rows A-T. The heavy lines indicate all exons, and the thin lines indicate introns. Early transcript 
products mapped to the p97 promoter are indicated in rows (A-N, #266). Late transcript products 
mapped to the differentiation-dependent late promoter, p640, are indicated in rows (O-T)
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1.9 The HPV-16 life cycle in the epithelium
1.9.1 Early events in the HPV-16 life cycle
It is thought that initial infection of HPV occurs in basal cells, which are the only 
mitotically active cells in the epithelium. More recently it has been shown that in 
order for viral transcription to commence, the virus must establish itself in cells that 
can undergo mitosis (Pyeon, Pearce et al. 2009). Following viral capsid uncoating 
the virus establishes itself as a stable episome in the host nucleus. Here the virus 
maintains itself at a low copy number which is estimated to be between 10-200 
copies (De Geest, Turyk et al. 1993). The low level replication of the virus in basal 
cells is facilitated by two viral early genes E1 and E2, which are expressed from 
the early p97 promoter. E1 serves as the viral helicase, which is transported to 
the origin of replication by the E2 protein (Hughes and Romanos 1993; Masterson, 
Stanley et al. 1998). In order to maintain viral genomes during cell division E2 
also anchors the viral episomes to mitotic chromosomes, which leads to correct 
viral genome segregation (You, Croyle et al. 2004).
During basal cell division cells that contain the HPV genome are pushed up to the 
suprabasal layer immediately above (Figure 1.5). In uninfected epithelium these 
cells would normally exit the cell cycle however doing so would likely prevent 
further replication of the virus, due to the absence of host replication machinery. 
To overcome the process of cell cycle exit the virus expresses its two viral 
oncogenes E6 and E7 from the early p97 promoter, which result in an extended S- 
phase compartment in the epithelium (Cheng, Schmidt-Grimminger et al. 1995) 
(Middleton, Peh et al. 2003). The most well established function of E7 is its ability 
to bind and degrade hypophosphorylated forms of Rb, which allows the E2F 
transcription factor to remain in a free state (Dyson, Howley et al. 1989; Boyer,
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Wazer et al. 1996). The active form of E2F transactivates several genes that are 
required for S-phase which include MCM-7 and PCNA (Black and Azizkhan- 
Clifford 1999). The E6 oncogene circumvents G1 cell cycle checkpoints by down 
regulating the tumor suppressor gene p53, which prevents apoptosis of the cell 
(Scheffner, Huibregtse et al. 1993) In addition E6 expression is thought to be 
necessary for viral episomal maintenance through it’s binding of several cellular 
PDZ domain proteins (Lee and Laimins 2004).
Viral episomes are maintained in an extended S-phase compartment above the 
basal layer, however these cells coincidently enter into the terminal differentiation 
program (Cheng, Schmidt-Grimminger et al. 1995). Terminal differentiation is 
required for the upregulation of the differentiation dependent late promoter, p640, 
and late viral gene expression (Grassmann, Rapp et al. 1996) (Figure 1.5).
1.9.2 Late events in the HPV-16 life cycle
As the cells migrate up the differentiating epithelium viral genes which include E1, 
E2 E5 E1AE4 and L1 and L2, are expressed from the differentiation dependent 
promoter. This promoter is also referred to as the late promoter, which is why the 
E1AE4 protein is sometimes referred to as a late gene. There is still uncertainty as 
to where in the differentiating layers the different dependent promoter is 
upregulated. The E1AE4 and L1 proteins which are translated from a highly 
abundant late bicistronic transcript have been detected in the spinous and granular 
layers of the epithelium (Doorbar, Foo et al. 1997; Middleton, Peh et al. 2003; Peh 
and Doorbar 2005). The identification of these late proteins might therefore be 
coincidental with late promoter upregulation.
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It is estimated that the E1AE4 protein accounts for 90% of the total viral protein 
mass in the upper layers of the epithelium. E1AE4 is typically first detected in the 
last layer of the extended E7/S-phase compartment (Peh, Middleton et al. 2002; 
Middleton, Peh et al. 2003; Peh and Doorbar 2005) (Figure 1.5). The overlap of 
E1AE4 and E7 is thought to mark the switch from early gene expression to late 
gene expression. The cells that contain both E7 and E1AE4 are also thought to 
contain the first amplified viral genomes (Doorbar, Foo et al. 1997; Middleton, Peh 
et al. 2003; Peh and Doorbar 2005). Past work has shown that in addition to the 
E1 and E2 viral replication proteins, E7 and E1AE4 expression is necessary for 
viral DNA amplification to occur. It is thought that E7 aids in viral DNA amplification 
by extending host replication machinery above in the suprabasal layers (Flores, 
Allen-Hoffmann et al. 2000). It has also been shown that in the absence of full- 
length E1AE4 proteins, viral amplification is reduced in the upper layers of the 
epithelium (Nakahara, Peh et al. 2005). The specific mechanism that E1AE4 
carries out to aid in viral DNA amplification is currently not known. One possible 
way that E1AE4 aids in amplification is through its ability to arrest cells in the G2 
phase of the cell cycle (Davy, Jackson et al. 2002). Arresting cells in G2 would 
potentially prevent the cell from proceeding through mitosis and would therefore 
allow viruses to amplify their genomes, following normal cellular replication
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1.9.2.1 Viral DNA amplification
During viral amplification the genome is amplified up to 1000 fold in order to create 
new genomes for packaging (Bedell, Hudson et al. 1991). There is also 
speculation that viral amplification itself is required for further expression of late 
E1AE4, L1 and L2 genes in the upper layers (Chow, Duffy et al. 2009).
Amplified genomes are then carried throughout the remaining upper layers of the 
epithelium for virus packaging (Figure 1.5). Interestingly it is has also been shown 
that the virus changes to a different mode of replication in the upper layers which 
differs from the mode of replication used during low-level replication, in the early 
part of the life cycle. During low-level replication such as in the basal layer it has 
been show that the virus replicates it genome through theta structures, which 
requires that the viral E1 helicase, are recruited to the origin of replication by E2, 
with every round of replication (Flores and Lambert 1997). In addition, host cell 
replication machinery, such as DNA polymerases, are also needed for every round 
of replication. It was further shown that when the virus amplifies its genome in the 
upper layers, the virus switches to rolling circle replication (Flores and Lambert 
1997). Rolling circle replication requires only one initiation event that subsequently 
leads to abundant levels of replicated DNA. This mode of replication might be 
more efficient for the virus when cellular replication machinery is not available 
beyond the E1AE4/E7 overlapping region.
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1.9.2.2 HPV-16 virus assembly and release
The final productive stage of the HPV-16 life cycle involves encapsidation of 
amplified viral genomes and the subsequent release of new viruses from the 
epithelium. HPV capsids are composed of the major L1 capsid and the minor L2 
capsid. The L1 protein and L2 protein are organized into a 72-capsomere 
icosohedral capsid shell (Chen, Garcea et al. 2000; Modis, Trus et al. 2002). It has 
been suggested that the L1 and L2 cased proteins accumulate at nuclear 
structures known as PML bodies to facilitate virus packaging (Day, Baker et al. 
2004).
L1 and L2 proteins are expressed as late proteins and are typically detected in 
E1AE4 positive cells of the cornified and superficial layers of the epithelium (Figure
1.5) (Peh, Middleton et al. 2002; Middleton, Peh et al. 2003). A temporal gap 
between the onset of the first detection E1AE4 and the first detection of L1/L2 
proteins occur in the upper layers of HPV-16 induced lesions.
Mature virus particles are not released until reaching the uppermost layer of the 
epithelium. As PVs are non-lytic viruses, it is thought that virus progeny are 
released from the epithelium within cornified squames that are shed from the top 
layer. It has been suggested similar to the case of HPV-11, the HPV-16 E1AE4 
protein might increase cellular fragility in the cornfield layer to facilitate virus 
release (Bryan and Brown 2000).
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virus entry
Figure 1.5 HPV-16 expression patterns in the differentiating epithelium Image taken from 
(Doorbar 2006)
Viruses enter the epithelium likely through a micro-wound. HPV-16 infects S-phase competent cells 
within the basal layer (BL). In these cells viral episomes are maintained at low levels. As these 
HPV infected cells divide they are pushed up into the suprabasal layers where the terminal 
differentiation program begins. At this point the HPV-16 p97 early promoter is active which results 
in the expression of the E1 and E2 replication proteins as well as the E6 and E7 oncognes (red 
cells). The E7 oncogene is necessary for S-phase entry. In addition to E1 and E2, E6 and E7 are 
necessary for episomal replication. As the cells proceed through the differentiation program, the 
differentiation dependent (late) promoter p670 is upregulated. This leads to increased levels of E1, 
E2, E5 and E4 (green cells). The start of late gene expression also coincides with a brief overlap of 
early genes and late genes (these cells can be identified within the red square). Cells that contain 
both (early) E7 and (late) E4 are thought to be the site of viral DNA amplification. Above this 
overlap the early genes are no longer expressed and high levels of E4 are expressed from the late 
promoter. A large number of E4 positive cells also contain amplified genomes (blue and green 
cells) and later L1/L2 capsid proteins (green and orange cells). Mature capsids that contain 
amplified genomes are released as cells are shed from the top layers.
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1.10 The use of cellular and viral markers to detect HPV-16 gene expression 
patterns in cutaneous and cervical mucosal epithelium
Due to extensive mapping of HPV-16 transcripts from the early and late 
promoters, the boundaries of early and late gene expression have been 
identifiable in the HPV infected epithelium through the use of three specific 
antibodies. In the early part of the life cycle the E6 and E7 oncogenes are 
expressed from the early promoter. Due to the lack of good antibodies it has been 
difficult to detect E6 and E7 proteins in paraffin embedded tissues. More recently, 
MCM-7 has been used to detect the presence of E7 and has been further 
established as a surrogate marker for E7 (Williams, Romanowski et al. 1998; 
Middleton, Peh et al. 2003).
MCM (2-7) complexes are highly expressed throughout the cell cycle and 
specifically perform the function of a DNA helicase during cellular S-phase 
(Maiorano, Lutzmann et al. 2006). During the early stages of infection HPV E7 can 
induce cellular S-phase through its binding to the hypo-phosphorylated form of Rb 
and additionally Rb family pocket proteins (e.g. p107 and p130) (Munger, Werness 
et al. 1989; Boyer, Wazer et al. 1996). The binding of E7 to Rb family proteins, 
which lead to their degradation, allows the E2F transcription factor to remain in an 
active state. In its active state E2F transactivates several cellular genes such as 
MCM-7, which are necessary to proceed through S-phase.
In cervical lesions MCM-7 protein expression overlaps with several other E2F 
activated genes such as PCNA and Cyclin B, and Cyclin D. However MCM-7 is a 
more reliable surrogate marker of E7 S-phase induction, as it appears to be more
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highly expressed in cervical lesions, when compared to other E2F activated genes 
(Williams, Romanowski et al. 1998; Freeman, Morris et al. 1999; Peh, Middleton et 
al. 2002). To date there are no sufficient antibodies to detect the E6 protein, 
however it is assumed that E6 and E7 are expressed in the same cells as they are 
both translated from the same bicistronic message.
The expression of HPV genes from the differentiation dependent late promoter has 
been easier to analyze in paraffin embedded tissues. This is due the availability of 
good antibodies targeted to the E4 gene and L1 capsid protein. DNA irt-situ 
methods are also available for the detection of viral DNA amplification.
1.11 HPV-16 gene expression patterns in low- and high-grade cervical 
lesions
As mentioned earlier HPV-16 infections can cause both low-and high-grade 
neoplasias, which are pathologically diagnosed as LSIL and HSIL respectively. 
The diagnosis of LSIL and HSIL has been primarily based on cellular pathology. 
Recent studies have also shown that HPV-16 gene expression patterns change in 
the epithelium, as the lesions become more neoplastic (Middleton, Peh et al.
2003) (Figure 1.6).
HPV-16 lesions of LSIL grade mostly contain gene expression patterns of a 
complete HPV life cycle. In lesions of LSIL grade MCM-7 expression is confined 
to the lower third of the epithelium, where late E4 expression is typically detected 
in the last layer of MCM-7 positive cells. E4 is also abundantly expressed 
throughout the upper layers of the epithelium. Late L1 capsid protein is also
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detected in E4 positive cells in the upper layers (Peh, Middleton et al. 2002; 
Middleton, Peh et al. 2003). By comparison in lesions with HSIL, MCM-7 positive 
cells persist throughout the middle third and final third of the epithelium (Figure
1.6). The high persistence of MCM-7, correlates with a delay in late E4 and L1 
capsid expression. In many cases L1 capsid proteins are not detected in lesions 
with HSIL, which demonstrates that the epithelium is unable to support a complete 
life cycle (Middleton, Peh et al. 2003). These analyses have shown that the order 
of HPV gene expression is conserved in low and high-grade lesions, however, 
early gene expression persists higher up in the epithelium as the lesion becomes 
more neoplastic. The level of MCM-7 persistence seems to also identify when late 
viral gene expression begins. This has emphasized important aspects of early and 
late gene regulation. Furthermore it has been proposed that MCM-7 and E4 could 
be potential biomarkers for neoplastic progression (Middleton, Peh et al. 2003).
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Figure 1.6 HPV-16 gene expression patterns during neoplastic progression
During neoplastic progression the order of early and late viral gene expression is conserved in the 
epithelium, however early genes persist in the upper layers in lesions with high-level neoplasia (i.e. 
HSIL) Early oncogene persistence coincides with a delay in late events (e.g. viral amplification) and 
late gene expression (e.g. E4 and L1). Lesions of HSIL grade typically do not support a complete 
life cycle.
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1.12 HPV-16 Viral oncogene regulation
Viral gene expression patterns of low and high-grade neoplastic lesions also 
highlight important aspects of HPV gene regulation. Early viral gene regulation 
associated with neoplasia and cervical cancer is not completely understood. Past 
studies have correlated HSIL and cancer with E6 and E7 integration. (Klaes, 
Woerner et al. 1999; Fujii, Masumoto et al. 2005). Viral Integration typically 
involves the insertion of E6 and E7 into host chromosomes, which over time can 
lead to genomic instability and the accumulation of cellular genetic mutations 
(McLaughlin-Drubin and Munger 2009). The integration of E6 and E7 has been 
shown to coincide with the loss of several other viral transcriptional regulatory 
genes such E2 (Baker, Phelps et al. 1987). When E2 is present at high levels as 
with expression from viral episomes it has been show to act as a transcriptional 
repressor of E6 and E7 (Steger and Corbach 1997). Past work has shown that E6 
and E7 integration coincides with an increase in E6 and E7 mRNA stability and an 
increase in E7 oncogene levels (Jeon and Lambert 1995; Alazawi, Pett et al. 
2002) These cells also maintain a selective growth advantage over cell lines that 
maintain episomal forms of the virus (Jeon and Lambert 1995). The actual 
integration of the genome can occur near fragile sites in the host genome sites 
however integration is not linked to any common regions in the host chromosome 
(Thorland, Myers et al. 2003; Ziegert, Wentzensen et al. 2003).
More recently it has been suggested that integration is not however important for 
precancerous stages of HPV induced neoplasia (i.e. LSIL and HSIL). In a recent 
study the authors found that E7 was only expressed from episomal forms of the 
virus, in 85% of lesions of HSIL grade (Klaes, Woerner et al. 1999). By 
comparison E7 was expressed from integrated forms of the genome in the majority
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of carcinomas in-situ. These results suggest that Integration of the genome occurs 
later in the disease process and that integration is more likely important for the 
final stages of HPV associated cancer rather than LSIL and HSIL.
It is therefore possible that the deregulation of E6 and E7 expression during 
neoplasia, leading to S-phase persistence, could therefore be due to differences in 
the episomal replication or transcription capacities.
1.13 The molecular basis of neoplastic progression and cancer with respect 
to the E6 and E7 oncogenes.
E6 and E7 expression is necessary to carry out a complete HPV life cycle however 
the persistent expression of the HPV oncogenes can lead to abnormal 
proliferation, cell survival and cellular genomic instability. E6 and E7 are both 
potent inducers of keratinocyte immortality. However, the viral molecular basis of 
HPV carcinogenesis and the exact mechanisms of E6 and E7 required to bring 
about pre-cancerous and cancerous stages of HPV disease, still form a large 
basis of research. Presented below are several mechanisms that are thought to 
be important for neoplastic progression and cancer development.
1.13.1 E7 and the cell cycle
The E7 oncogene is a small protein with a predicted molecular weight of 11kDA. 
Following infection with high risk HPVs E7 binds to over 20 cellular proteins. Most 
of these interactions take place in the cell nucleus and consequently allow the cell 
to progress from G1 to S phase of the cell cycle. It has also been shown that E7
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can induce S-phase in differentiated cells that have already exited the cell cycle 
(Banerjee, Genovese et al. 2006).
The most established cellular interaction partner of E7 is the Rb protein (Dyson, 
Howley et al. 1989). In quiescent HPV negative cells hypophosphorylated forms of 
Rb prevent progression through cellular G1 through its binding to the cellular 
transcription factor E2F. To begin G1 cell cycle progression Rb is phosphorylated 
by Cyclin D/Cyclin dependent kinase (CDK4) which allows for its dissociation from 
E2F (Buchkovich, Duffy et al. 1989). Active or unbound E2F can then transactivate 
several cellular proteins that allow the cells to proceed through S-phase and 
proliferation. Several of these proteins that are necessary for S-phase include 
MCM (2-7) complexes, PCNA and Cyclin E.
A similar mechanism involved in the release of E2F from Rb is established through 
the binding of E7 to Rb, which also leads to Rb degradation (munger 2001,Band 
1996). Similar to its hyperphosphorylated form, degraded Rb leads to E2F 
transactivation of S-phase proteins, which then allows for cell cycle progression. 
E2F activation is necessary for life cycle maintenance however, persistent 
inactivation of Rb leads to genomic instability, hyperplasia and disruption of the 
terminal differentiation program. (Balsitis, Sage et al. 2003). Mutations in the Rb 
gene are frequently detected in many types of cancers such as prostate and 
bladder cancers. (Gallie 1994; Kubota, Fujinami et al. 1995; Miyamoto, Shuin et al. 
1995).
It has also been shown in mouse models that the absence of Rb without the 
presence of E7 was not sufficient for tumors to form. It is therefore likely that
30
Chapter 1 - Introduction
additional cellular protein interactions of E7 are important for cancer progression 
(Balsitis, Dick et al. 2006).
E7 also binds to and degrades a similar set of proteins within the Rb family, which 
are the pocket proteins, p130 and p107 (Munger, Werness et al. 1989). These 
proteins have a similar role in the cell cycle where the phosphorylation of p130 and 
p107 leads to the transactivation of E2F transcription factors. The binding of E7 to 
the pocket proteins have been shown to be important for the productive life cycle 
and likely serves a similar function in the life cycle as Rb degradation (Collins, 
Nakahara et al. 2005). It has also been suggested that Rb degradation is confined 
to the basal layer where E7 interacts with and degrades p130 and p107 more-so in 
the suprabasal layers (Collins, Nakahara et al. 2005).
E7 also binds to histone deacetylases (HDACs) (Brehm, Nielsen et al. 1999). 
HDACs normally lead to the formation of compact and repressive chromatin. 
HDACs therefore function as transcriptional co-repressor and can also associate 
with hypophosphorylated forms of Rb. The binding of E7 to HDACs is however 
independent of its interactions with Rb but can also lead to increased transcription 
of E2F transactivated genes (Longworth, Wilson et al. 2005).
E7 has also developed mechanism to prevent the inhibition of cell cycle 
progression. E7 has been shown to bind to CDK inhibitors p21 and p27 (Zerfass- 
Thome, Zwerschke et al. 1996; Funk, Waga et al. 1997). The CDK 2/ CDK 4 
inhibitor, p21 is usually upregualted during times of cellular stress and also serves 
as part of the p53 mediated G1 checkpoint pathway. The binding of E7 to p21 thus 
prevents the inhibition of G1 cell cycle progression. It has been previously shown
31
Chapter 1 - Introduction
that the inactivation of both Rb and p21 is necessary to inhibit G1 cell cycle arrest. 
(Helt, Funk et al. 2002)
1.13.2 E6 and E7 related genomic instability
As stated previously it has been shown that E7 expression is sufficient to 
immortalize cells but expression on its own is not sufficient to cause cancer (Brake 
and Lambert 2005). It is widely established that additional host mutations or 
chromosomal abnormalities are needed for cancer development. It has been 
shown that both E6 and E7 can lead to the accumulation of chromosomal 
abnormalities in the host cell (Plug-Demaggio and McDougall 2002; McLaughlin- 
Drubin and Munger 2009). E6 and E7 associated chromosomal abnormalities 
have been identified in pre-cancerous stages of HPV neoplasia as well as in 
cancers (Duensing, Duensing et al. 2001). Cellular aneuploidy is a common 
chromosomal abnormality identified in HPV associated disease. Aneuploidy is 
specially the gain or loss of chromosomes in the cell and is subsequently caused 
by abnormal centrosomal duplications.
Centrosomal duplication is normally linked to the cell cycle and is controlled by 
hyper-phosphorylated forms of Rb. Correct centrosomal duplication ensures that 
equal segregation of the chromosomes occurs. It was originally thought that Rb 
degradation by E7 uncouples centrosomal duplication form the cell cycle, which 
would increase the centrosome number, thus leading to leading to aneuploidy and 
multipolar mitoses. However more recent evidence suggests that the abrogation of 
centrosome replication by E7 is independent of Rb degradation.(Duensing and 
Munger 2003)
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Recent work has also suggested that centrosomal abnormalities caused by E7 are 
more likely to occur in the presence of integrated vs. episomal forms of the virus. 
As stated earlier, during E6 and E7 integration, E2 is typically lost from the 
genome. When E2 is present, as during episomal maintenance, it has been shown 
to interact with E7 and consequently sequester E7 to an insoluble compartment in 
the cell (Gammoh, Grm et al. 2006). This interaction has shown to inhibit E7 
related Rb degradation and also centrosomal abnormalities (Gammoh, Isaacson et 
al. 2009). By comparison centrosomal abnormalities were not inhibited in the 
absence of E2, which would be in the case of viral integration. In addition 
centrosomal abnormalities were not inhibited when both E2 and E6 were 
expressed together (Gammoh, Isaacson et al. 2009). It is therefore thought that E6 
rather than E7 is likely to cause centrosomal abnormities when viral episomes are 
maintained. However following the integration of E6 and E7, it is likely that the 
expression of both oncogenes lead to centrosomal abnormalities.
1.13.3 E6 and cell survival
The E6 proteins are approximately 150aa in size and contain four conserved Cys- 
X-X-Cys motifs that give rise to two zinc fingers. Unlike the E7 gene that directly 
activates cellular proliferation, the mechanisms of E6 enhance cell survival and 
prevent density dependent growth arrest, that both contribute to malignancy. The 
induction of abnormal cellular and viral DNA replication by E7 leads to a host 
defense response termed as the trophic sentinel response (Eichten, Rud et al.
2004). The expression of E7 alone has been correlated with elevated levels of p53 
and cellular apoptosis (Demers, Halbert et al. 1994). In response to heightened
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levels of p53 by E7, the E6 proteins partly eliminate the trophic sentinel response 
by through inactivating p53. E6 inactivates p53, through its interaction with the 
cellular ubiquitin ligase E6AP (E6-associated protein) (Scheffner, Huibregtse et al. 
1993). This interaction subsequently leads to the proteosome-mediated de­
gradation of p53.
Expression of high-risk E6 also enhances cell survival by inducing human 
telomerase reverse transcriptase (hTERT) (Klingelhutz, Foster et al. 1996). 
Expression of hTERT leads to the prevention of telomere shortening. hTERT is 
normally present in cell types such as stem cells that undergo high numbers of cell 
division. Somatic cells however do not normally express hTERT, which is a 
strategy to restrict their proliferation capacity. HPV-16 E6 however contributes to 
cellular immortalization through inducing hTERT expression in these cells.
1.13.4 E6 and E7 interaction with adherin junction proteins
E6 and E7 can also induce transformation through interactions with adherin 
junction (AJ) related proteins. AJs are linked to the cytoskeleton network and 
serve as the main epithelial adhesive junctions. AJs contain receptors for several 
proteins that are important for cell-cell contact signaling pathways, which regulate 
proliferation, differentiation and cell polarity.
E-cadherin, one of the most studied AJ proteins is regarded as a tumor suppressor 
gene. When cell-cell contact is established, E-cadherin sequesters Beta-catenin 
from the nucleus to the cell membrane (Baida and Matter 2003). When Beta- 
catenin is active in the nucleus it forms a complex with LEF/TCF transcription
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factors. This complex transactivates proteins such as Cyclin D and C-myc that 
activate the cell cycle (Huelsken and Behrens 2002). It is therefore thought that E- 
cadherin can by one way, regulate the cell cycle by sequestering Beta-catenin 
away from the nucleus to sites of cell-cell adhesion.
Recent work has shown that E-cadherin is delocalized away from the cell 
membrane in the presence of E6 and E7, thus potentially removing it’s ability to 
sequester Beta-catenin to the membrane (Wilding, Vousden et al. 1996). 
Additional work has also shown that E7 suppresses cadherin mediated cell 
adhesion (Yuan, Ito et al. 2009). A reduction in E-cadherin expression has been 
correlated with increasing grades of neoplasia (Vessey, Wilding et al. 1995). 
Furthermore, increased nuclear Beta-catenin has been associated with many 
types of cancers including cervical cancer (Morin 1999).
The HPV-16 E6 protein has also been shown to interact with, degrade or 
delocalize AJ-related proteins, which include several cellular PDZ domain proteins. 
Cellular PDZ domains proteins are thought to be critical for maintaining cell 
polarity and regulating the cell cycle. PDZ proteins consist of different cellular 
pools however they mostly interact with specific transmembrane domains at the 
cellular basolateral wall. PDZ proteins are also highly expressed at cell 
membranes when cell-cell contact is established (Thomas, Narayan et al. 2008).
Human Dig (hDLG) and human Scribble (hScrib) protein are two specific PDZ 
domain proteins that are degraded by HPV-16 E6 (Thomas, Narayan et al. 2008). 
In the absence of E6 hScrib and hDIg are recruited to cell junctions and likely 
transduce extracellular signals towards the cytoplasm, which prevent G1 to S-
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phase progression. hDIg and hScrib are also thought to interact with the tumor 
suppressor gene, adenomatosis polyposis coli (APC) (Matsumine, Ogai et al. 
1996; Takizawa, Nagasaka et al. 2006). APC is a primary regulator protein in the 
Wnt pathway, which controls Beta-catenin activity. APC interacts with cytoplasmic 
Beta-catenin, which leads to the ubiquitination and degradation of Beta-catenin 
(Huelsken and Behrens 2002). It is thought that hScrib and hDIg facilitate the 
interaction between APC and Beta-catenin, which then prevents cell cycle entry 
(Nagasaka, Nakagawa et al. 2006). High or persistent E6 expression would 
therefore abolish this interaction.
It has also been shown that hScrib expression is reduced in neoplastic epithelium. 
(Nakagawa, Yano et al. 2004). The degradation of PDZ cellular proteins by E6 is 
also thought to lead to an increase in tumor size and enhance malignant 
progression (Shai, Brake et al. 2007).
1.14 The organotypic raft culture system: A laboratory system for HPV life 
cycle studies
Studying the HPV life cycle is somewhat arduous, as the virus requires a fully 
differentiated epithelium to complete its life cycle. In the past ten years organotypic 
raft cultures have provided a laboratory model to study the HPV life cycle 
(Lambert, Ozbun et al. 2005; Nakahara, Peh et al. 2005; Wilson and Laimins
2005). Organotypic raft cultures consist of a three-dimensional epidermis, which 
can successfully support a complete HPV virus life cycle. To create organotypic 
raft cultures keratinocyte cell lines that carry viral episomes, are first seeded on to 
dermal equivalents. The dermis in normal epithelium consists of collagen, which 
gives structural support to the skin and fibroblasts that secrete collagen and other
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growth factors to the skin. In addition the dermis contains blood vessels and lymph 
nodes that allow for the infiltration of lymphocytes and other cells involved in 
cellular immunity. “Dermal equivalents” in raft cultures primarily consist of collagen 
and human fibroblasts. More recently it has also been possible to integrate 
lymphocytes, dendritic cells and various cytokines into raft culture experiments.
To begin the differentiation process episomal cell lines are fed with high calcium 
media to induce desmosomal formation and differentiation. After several days the 
dermal equivalents are lifted on several cotton pads and are exposed to the air. 
Exposure to the air allows for cornification to begin and is necessary to conserve 
the epithelial architecture of the raft culture. Following a 14-day differentiation 
regimen several layers of stratified epithelium, that contain the virus are fixed and 
paraffin imbedded in wax. Similar to cervical biopsy tissue, raft cultures can be 
subsequently sectioned on to slides to carry out immunohistochemical analysis. 
Through this method viral gene expression patterns can be detected throughout 
the raft epithelial layers.
Additional uses of raft culture include: the harvesting of mature virions form raft 
culture epithelia for use in viral infectivity assays; biomarker development and 
immunotherapeutic approaches for neoplastic disease (Delvenne, Hubert et al. 
2001; Meyers, Bromberg-White et al. 2002).
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1.15 Aims of the Thesis
The organotypic raft culture system has been previously established as a reliable 
model to study the HPV life cycle. In our studies, the immunohistochemical 
analysis of HPV-16 raft cultures led to the discovery that this system could also 
recapitulate gene expression patterns that were previously identified in both low- 
and high-grade HPV induced lesions. This auspiciously led to the characterization 
of a newly established HPV-16 raft culture model of HPV induced neoplasia.
1) To establish NIKS HPV-31 and HPV-16 episomal cell lines for organotypic 
raft culture experiments.
NIKS HPV16 episomal cell lines were established in collaboration with several 
colleagues.
2) To establish a NIKS HPV-16 organotypic raft culture model that supports a 
complete HPV-16 life cycle.
HPV-16 cell lines were propagated in organotypic raft cell culture to allow epithelial 
cell differentiation Immunohistochemically stained NIKS organotypic raft cultures 
were compared alongside previously stained HPV-16 cervical lesions. The aim 
was to show that early gene expression and the productive phase of the life cycle, 
including genome amplification and virus cased expression, was conserved in the 
NIKS HPV-16 raft model system.
38
Chapter 1 - Introduction
3) To present a NIKS organotypic model of episomal HPV-16 induced 
neoplasia.
Immunohistochemically stained NIKS organotypic raft cultures were compared 
alongside low and high-grade HPV-16 cervical lesions. The aim was to show that 
HPV-16 episomal cell lines recapitulate the spectrum of viral gene expression 
patterns previously identified in low- and high-grade cervical lesions.
4) To characterize NIKS HPV-16 monolayer episomal cell lines in order to 
understand the molecular basis of HPV induced neoplasia.
The molecular basis leading to HSIL phenotypes is not completely understood. 
The current theory rests on that high-grade gene expression patterns are due to a 
deregulation of viral E6/E7 gene expression. Using monolayer HPV-16 cell lines 
we sought to determine if cellular growth potential, E6 and E7 expression level and 
viral copy number were important factors for a HSIL phenotype.
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C h a p te r  2: M a te r ia ls  a n d  M e th o d s
2.1 Commonly used buffers and reagents
All chemicals unless otherwise stated were purchased from Sigma-Aldrich 
Company Ltd. (UK), BDH Laboratory Supplies (UK), Fisher Scientific (UK) and 
VWR (UK).
2.1.1 Buffers and reagents prepared by the NIMR cell culture facility:
Commonly used buffers were prepared according to Table 2.1.
Table 2.1 Buffers and Reagents
Name Components
Luria-Bertani (LB) 
medium
1 % tryptone, 0.5 % yeast extract, 1 % NaCI
LB Agar LB medium plus 2 % Bacto agar
50x Tris acetate 
EDTA (TAE)
242 g Tris base, 57.1 mL glacial acetic acid, 18.6 g EDTA
Trypsin-versene 0.8 % NaCI, 0.02 % KCI, 0.12 % Na2HP04,
0.02 % KH2P 04, 0.01% EDTA, 0.13 % trypsin, 0.001% 
phenol red.
1x Phosphate 
buffered saline 
(PBS)
1 % NaCI, 0.025 % KCI, 0.14 % Na2HPO, 
0.025 % KH2 PO4
SDS
electrophoresis
buffer
25 mM Tris base, 192 mM glycine, 0.1 % sodium dodecyl 
sulfate (SDS)
Transfer buffer 30 mM Tris base, 192 mM glycine, 20 % methanol
Penicillin/ 
Streptomycin 
(cell culture)
0.6 % (v/v) penicillin, 1 % (v/v) streptomycin
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2.2 Keratinocyte and fibroblast monolayer cell culture
2.2.1 Cell lines
2.2.1.1 Normal Immortalized Human Keratinocytes (NIKS)
NIKS, a cutaneous foreskin keratinocyte cell line, were used as a host cell and as 
negative control with all HPV-16 experiments. NIKS were originally recovered as 
an HPV-negative spontaneously immortalized cell line after successive passages 
of their parental BCI-EP/SL cell line (Allen-Hoffmann, Schlosser et al. 2000).
2.2.1.2 NIKS wild-type (wt, #53)-HPV-16 (W12) and HPV-31 cell lines
Ten clonal wt-HPV-16 cell lines were established from two separate transfections 
(courtesy of Kenneth Raj; NIMR, London, UK and Qian Wang; NIMR, London UK). 
All wt-HPV-16 (W12) cell lines were established following cotransfections with 
recircularized replication competent W12-HPV-16 genomes and a pCDNA6 vector 
that contained a Blasticidin resistance gene. All wt-HPV-31 cell lines were 
established following co-transfections with recircularized replication competent 
HPV-31 genomes and a pCDNA6 vector that contained a Blasticidin resistant 
gene. HPV-31 and HPV-16 clonal cell lines were recovered after several days of 
Blasticidin drug (6 pg/mL) selection and were individually expanded into 6-well 
plates after the individual colonies became visible.
2.2.1.3 J2-3T3 mouse fibroblast cells
J2-3T3 cells, an immortalized fibroblast cell line, were originally isolated from 
Swiss albino mouse embryos (Todaro and Green 1963). The J2 clone has been
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widely used as a feeder layer to support the growth of human keratinocyte cell 
lines.
2.2.1.4 EF-IF human foreskin fibroblast cells
EF-IF fibroblasts were originally isolated from human foreskin tissues and have 
been maintained as a primary fibroblast cell line. EF-IF cells have been previously 
used for the creation of dermal equivalents.
2.2.2 Media supplements and recipes
2.2.2.1 Supplements
The following media supplements were prepared and filter sterilized, using a 2 pm 
membrane filter unit. All supplements were stored as 5 ml_ aliquots at -20°C.
100x Flvdrocortisone- 25 mg of hydrocortisone (Calbiochem) was dissolved into 
5mL of cold ethanol to make a 5 mg/mL solution. 0.8 mL of this solution was 
added to 100mL HBES and 5 % (v/v) Fetal Bovine Serum (FBS) (Hyclone; UK). 
100x Cholera Toxin- 1 mg of cholera toxin (Sigma; UK) was dissolved into 1.2 mL 
of sterile water to make a 10 pM solution. 50 pi of this working stock was added to 
50mL FIBES that contained 0.1 % (w/v) bovine serum albumin (BSA).
100x Insulin- 12.5 mg of insulin (Sigma; UK) was dissolved into 25 mL of 0.005 M 
HCL (247.5 pi concentrated HCL in 500 mL water). 2 mL of FBS was passed 
through the 2 pm syringe filter prior to adding the insulin stock.
100x Adenine- 121 mg of adenine (Sigma; UK) was dissolved into 50 mL of 0.05M 
HCL (24.7 mL concentrated HCL into 476 mL water)
42
Chapter 2 -  Materials and Methods
2.2.2.2 Cell culture media
The following medias in Table 2.2 were used to grow and maintain monolayer 
cultures of keratinocytes and fibroblasts.
Table 2.2 Monolayer cell culture media
Cell type Media name Media components
J2-3T3 3T3 media 500 mL DMEM (Sigma), 10 % (v/v/) FBS and 
5 mL pen/strep
NIKS and 
wt-HPV-16 
cell lines
F-Media
Incomplete
(FI)
375 mL F12-Hams (Gibco; UK), 125 mL high 
glucose DMEM (Gibco; UK). Supplements: 5 
mL (100x stocks) of adenine, cholera toxin, 
hydrocortisone, insulin and pen/strep, 5 % 
(v/v) FBS
NIKS and 
wt-HPV-16 
cell lines
F-Media
Complete
(FC)
500 mL FI media with 500 pi 1000x EGF
EF-IF Human
Fibroblast
Media
500 mL F12-Hams, 5 mL pen/strep and 10 % 
(v/v) FBS
J2-3T3 and NIKS Freeze Media 45 mL FBS and 10 % (v/v) DMSO
EF-IF Freeze Media 22.5 mL FI media, 22.5 mL FBS, 10 % (v/v) 
DMSO
2.2.3 Maintenance of monolayer cells
2.2.3.1 J2-3T3
J2-3T3 fibroblasts were cultured in 10 mL of 3T3 media in 75 cm flasks (Corning; 
UK) at 37°C and 5 % C 02. The fibroblasts were grown until they were 80 % 
confluent and were then split 1:20-1:50 to another 75 cm flask. To harvest the 
fibroblasts, the cells were washed with 5-10 mL PBS followed by the addition of 
1mL trypsin versene. The fibroblasts, along with the trypsin, were incubated at 
37°C for 1 minute followed by the addition of 9 mL of 3T3 media. An aliquot of the 
suspended cells was then added to a new flask for culturing. Cultures of J2-3T3
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were not used for experimental purposes above passage 20, where early passage 
stocks were frozen down (-70°C overnight then into liquid nitrogen indefinitely) in 1 
mL of 3T3 freeze media to maintain the line.
2.2.3.2 NIKS and wt HPV-16 cell lines
NIKS and HPV-16 cell lines were cultured on a bed of d-irradiated J2-3T3 cells in 
75 cm flasks at 37°C, 5 % CO2 . Prior to culturing the NIKS, J2-3T3 cells were 
irradiated at a dosage of 60Gy. Approximately 2x106 of these irradiated fibroblasts 
were seeded into the flask and were allowed to attach for 2 hours at 37°C. 
Following their attachment, a minimum of 5x106 NIKS or HPV-16 clones were 
added to the flask along with 10 mL of FI media. After 24 hours the media was 
changed and 10 mL of FC media was added every other day thereafter. All 
keratinocyte cell lines were cultured until they were 80-90 % confluent. To harvest 
the cells the media was removed and 10 mL of PBS was added and removed to 
wash the cells. To follow, 1mL of trypsin versene was added to the flask and the 
cells were incubated at 37°C for 1 minute. The flask was tapped several times to 
completely dislodge the feeder layer from the keratinocytes, which were then 
aspirated away. 2 mL of fresh trypsin versene was added to the remaining 
keratinocytes and the cells were incubated at 37°C for up to 15 minutes. After the 
cells were completely dislodged, 8 mL of FI media was added to the trypsin and a 
counted resuspension of the cells was added to a fresh flask of irradiated feeders 
or were frozen down in 1 mL freeze media for later use. All keratinocyte cell lines 
were never left in culture for more than 2-3 passages.
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2.2.3.4 Cell counts of NIKS and HPV-16 cell lines
For all experiments and the culturing of NIKS and HPV-16 cell lines, all cells were 
counted using a Beckman Z1 coulter particle counter. In order to get an accurate 
count, the coulter counter carried out an initial sizing of the keratinocytes, which 
consisted of increasing 2 pm increments. To do this, 1 mL of an 80 % confluent 
flask was resuspended in 9 mL of isotone solution (Beckman; UK) (1:10 dilution) 
and 1 mL of this suspension was then counted. To establish a more precise range 
of cell size for accurate counting the readout was plotted out on a graph as the 
total number cells/mL vs. cell size in pm. The majority of the cells fell within a peak 
range of 11-20 pm. In order to account for cells that were slightly larger due to 
differentiation, the coulter counter parameters were set to count all cells above the 
lower limit tL= 11 pm.
2.2.3.5 EF-IF human foreskin fibroblasts
Fresh stocks of early passage (passage 5-10) EF-IF fibroblasts were grown in T- 
25 flasks (NUNC; UK) in 5-6 mL of human fibroblast media until they were 90% 
confluent. To harvest the cells 5 mL of PBS was added and removed to wash the 
cells and the cells were then incubated at 37°C, 5 % C 02 with 1 mL of trypsin, in 
order to dislodge the cells. Following this incubation 4 mL of human fibroblast 
media was added to the cells and the entire suspension was transferred to a 75 
cm flask for expansion. The cells were harvested when they were 90 % confluent 
and were passaged at 1:4 to an additional 75 cm flask. EF-IF fibroblasts were not 
cultured beyond 2-3 passages before being used for experimental purposes. The 
maximum passage used for experimental purposes did not exceed passage 12.
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2.3 Organotypic raft cultures of NIKS and HPV-16 wild-type cell lines
Note: The entirety of these raft culture experiments, up until the time of sectioning, 
were carried out in a level 2 containment cell culture hood.
2.3.1 Media and reagents for raft cultures
Table 2.3 includes the media components and supplements required for the 
growth of organotypic raft cultures.
Table 2.3 Organotypic raft culture media and supplements
Media name Components
Human Fibroblast Media See Table 2.2
Keratinocyte Plating Media 500 mL FI media with 0.5 % (v/v) FBS 
and 610 pi CaCL (Ca2+ final 
concentration 1.88mM)
Cornification Media 1 500mL FI media with 5% (v/v) FBS 
and 610 pi CaCb (Ca2+ final 
concentration 1.88mM). Add fresh N 
1,2-dioctanoyl-sn-glycerol (C8:0) 
(Sigma; UK) to a final concentration of 
10 pM
2.3.2 Preparation of dermal equivalents
To prepare dermal equivalents for growing raft cultures 20 mL of collagen (approx. 
3.5mg/mL) (BD Scientific; UK) was resuspended on ice with 2.5 mL 10x F12 
media (Sigma), 6 pi 10N NaOH, 250 pi 100x Pen/Strep and 2.5mLFBS. 1 mL of 
this suspension was plated into individual 24mm transwell inserts (Costar; UK) that 
had been previously placed in a deep 6-well plate (BD Biosciences; UK). The 
deep well plate containing the collagen suspension was left in the cell culture hood 
for 5 minutes to allow the collagen mixture to harden. 600 pi of a 7.5 x 106 cells/ 
mL suspension of EF-IF fibroblasts was added to the remaining collagen mixture 
and an additional 2.6 mL of this mixture was plated out into the individual transwell 
inserts. The deep well plate was left to incubate for 30 minutes at 37°C, 5% CO2
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until the dermal equivalents had completely solidified. 20 mL of human fibroblast 
media was added to each transwell and the plate was left to incubate at 37°C, 5 % 
CO2 for 5-7 days.
2.3.3 Seeding and differentiation of keratinocytes
NIKS or wt-HPV-16 cell lines that were 90 % confluent were trypsinised, counted 
and resuspended in FI medium at a concentration of 4.2x106 cells/mL. The 
human fibroblast medium was removed from the transwell inserts and 100 pi of 
either NIKS or HPV-16 cell line suspensions were added drop-wise into individual 
transwell inserts. A gentle rocking of the dish was necessary to allow for the entire 
volume to cover the insert. The inserts were left to incubate at 37°C 5 % CO2 for 2 
hours to allow for the complete attachment of cells to the dermal equivalents. 
Following this incubation, 20mL of keratinocyte plating medium was added to each 
insert and the plate was left at 37°C 5 % C 02 for 4 days. During this interval, the 
keratinocytes and dermal equivalents were fed every other day with 20 mL of 
keratinocyte plating medium. On the fourth day the medium was removed and 
three sterile cotton pads (2.5 cm x 2.5 cm) (Schleicher and Schwell; Germany) 
were placed under the transwell inserts in order to lift them towards the air. The 
raft cultures were fed from underneath with 12.5 mL of cornification media and 
then 9.5 mL of cornification medium every other day thereafter until the time of 
harvest. Raft cultures were left to differentiate for a total of 10 days post lifting.
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2.3.4 Harvesting and fixation of raft cultures
After 10 days of differentiation, the dermal equivalents and their intact keratinocyte 
layers were removed from the transwell inserts for fixation. Prior to harvesting the 
raft cultures a fresh 2 % Bacto Agar, 1 % formalin solution was prepared as a 
fixation solution. To prepare the fixation solution 2 g of Bacto Agar was added to 
90 mL of sterile dH20 and the entire volume was boiled in the microwave on a low 
setting for 3 minutes. The dissolved agar was left to cool with constant stirring and 
was not allowed to cool below 55° C. After the agar cooled to 55°C 10 mL of 10 % 
formalin was added to it in the fume hood. The fixation solution was then placed in 
a 50°C water bath during the entire harvesting process to ensure that the agar did 
not solidify. To fix the raft cultures 3-4 mL per raft culture of the fixation solution 
was applied to glass plates in a slow circular motion where the surface area was 
roughly double the circumference of the raft culture. The fixation solution was left 
to solidify on the glass plates in the cell culture hood (approx. 2 minutes). 
Following the removal of the cornification media, the raft cultures were removed 
from the transwell inserts with sterile forceps and were each placed on the 
solidified layers of fixation solution. An additional 2-3 mL of fixation solution was 
placed on each raft culture at roughly the same surface area. Each glass plate 
was wrapped in aluminum foil and was placed at 4°C overnight. The following 
day, any excess solidified fixation solution around the perimeter of the raft cultures 
was removed with a sterile blade. The circular raft cultures sandwiched between 
two layers of fixation solution were cut into two equal halves with sterile scissors 
and were placed side by side in a tissue-tek cassette. The cassettes were then 
submerged in a 4 % formalin solution overnight at 4°C. The following day, the 4 %
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formalin solution was replaced with 70% ethanol. The cassettes remained in 70 % 
ethanol at 4° C until the time of sectioning.
2.3.5 Sectioning of raft cultures
All of the raft cultures were paraffin embedded in wax and sectioned by an NIMR 
histologist. The raft cultures were paraffin embedded and were transversely 
sectioned (5 pm thick sections) on to Superfrost plus slides. The slides were 
placed at 37° C overnight prior to immunostaining.
2.4 Immunocytology and Immunohistochemistry
2.4.1 Immunocytology of monolayer NIKS and wt-HPV-16 clones
In order to view monolayer cells for immunocytology purposes, round glass 
coverslips were added into 60 mm 6-well plates. Irradiated fibroblasts and 
keratinocytes were seeded on top of the coverslips as described in section 2.6.1.
2.4.1.1 Fixation of coverslips
Unless otherwise stated, all coverslips were fixed with 5 % paraformaldehyde for 5 
minutes at RT. To do this the coverslips were washed with 1x PBS and the 
coverslips were submerged in the 5 % parafomaldehyde. After this incubation the 
paraformaldehyde was removed and the coverslips were washed again with PBS.
2.4.1.2 Haematoxylin and Eosin (H&E) staining of monolayer cells
Coverslips were fixed and stained with H&E in order to look at the cytological and 
nuclear morphologies of the keratinocytes. A regressive Haematoxylin method 
was used for every experiment. To stain the coverslips, Harris’s Haematoxylin 
(Sigma; UK) was applied to the coverslips for 5 minutes at (rt). The Haematoxylin 
was removed with running tap water and the coverslips were quickly (approx. 10
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seconds) differentiated in 1 % acid alcohol (1 % (v/v) concentrated HCL, 95 % 
(v/v) 100 % ethanol). The acid alcohol was quickly removed with tap water and the 
coverslips were returned to a more alkaline environment by the addition of Scott’s 
tap water (40 g sodium bicarbonate, 7 g magnesium sulfate per 2 L of dH20). The 
blue stained cells were then washed again in tap water and an eosin solution was 
applied to the coverslips for 30 seconds. After this incubation the eosin was 
removed with tap water and then were dehydrated in 70 % ethanol. Prior to 
mounting the coverslips were cleared with the xylene substitute, Histoclear 
(National Diagnostics; USA).
2.4.2 Immunohistochemistry of raft culture section
2.4.2.1 Antibodies and chemical reagents
Table 2.4 Primary Antibodies
Target Species Clone Dilution Incubation Supplier
K14 Mouse CKB1 1:100 1 hr. RT Sigma
K10 Mouse DE-K10 1:200 1 hr. RT Neomarkers
Filaggrin Mouse N/A 1:50 1 hr. RT Novacastra
MCM-7* Mouse 47DC141 1:200 o/n 4°C Neomarkers
HPV-16 E4 Phage
display
B11 1:100 o/n 4°C In house
HPV-16 L1 Mouse K1H8 1:50 o/n 4°C DAKO
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Table 2.5 Secondary Antibodies
Target Species
raised
Conjugate Dilution Incubation Supplier
Mouse IgG goat Alexa 594 1:150 1 hr. Invitrogen
Mouse IgG goat Biotinylated 1:100 1 hr. Vector Labs
Goat IgG donkey Alexa 594 1:150 1 hr. Invitrogen
Table 2.6 Chemical Reagents
Reagent Dilution/Diluent Incubation Supplier
DAPI 1:1000/5% NGS 1 hr.
Strep A/B 
(avidin/biotin) 
(peroxidase) 
complex
1:400
50mM Tris/HCL 
pH 7.6
30 min. Vector Labs
Tyramide
(rhodamine)
1:100
Amplification
diluent
8 min. NEN Life Science
2.4.2.2 De-paraffinization and epitope exposure of raft sections
In order to conduct immunohistochemical analysis on raft culture sections, the 
paraffin embedded sections underwent, a dewaxing and rehydration process, 
followed by epitope exposure. To dewax the sections, each slide was submerged 
into two separate containers of xylene; the first for 10 minutes and the second for 
5 minutes. After the wax had been removed the sections were rehydrated in 
graded alcohols (2 x in 100 % ethanol for 2 minutes and then 1 x 80 %, 50 % and 
30 % ethanol, each for 2 minutes). The sections were then submerged in dh^O 
for a minimum of 5 minutes. Finally, in order to unmask targeted antigens, the 
next step included a microwave based epitope exposure. To do this the slides
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were placed in a plastic beaker with 500 mL of 0.01 M citric acid buffer, pH 6.0 
(10N NaOH was used drop-wise to increase the pH of the buffer). The slides were 
first allowed to equilibrate in the buffer for 10 minutes before they underwent two 
successive rounds of boiling in the microwave. The microwave method included a 
boiling step of 7 minutes on high setting, followed by a resting period of 2 minutes 
at (rt), and finally a second boiling step for 5 minutes on high setting. The sections 
were allowed to cool at (rt) for 20 minutes before blocking and applying antibodies 
to the sections.
2.4.2.3 Applying primary and secondary antibodies to raft sections
Directly following the epitope exposure of raft sections, the sections were 
equilibrated in PBS for 5 minutes. During this time a working stock of 10 % normal 
goat serum (NGS) (v/v) in PBS was prepared as a blocking solution. All sections 
were blocked with 10 % NGS in a human chamber at RT for at least one hour. 
After blocking, primary antibodies were diluted in 5 % NGS and were applied to 
the sections according to Table 2.4. All primary antibodies were removed by 
washing each section in PBS/Tween-0.05 % for 3x5 min at (rt). Secondary 
antibodies were diluted in 5 % NGS and were applied to each section according to 
Table 2.5. At this time the DAPI nuclear stain was also applied to the sections, 
according to Table 2.6. Secondary antibodies were removed using the identical 
wash program. In cases where Alexa conjugated secondary antibodies were 
applied to the sections, the raft cultures were immediately ready for visualization.
2.4.2.4 Primary antibody signal amplification
In cases where an amplified signal of the primary antibody was needed, secondary 
biotinylated antibodies were applied to the raft sections, according to Table 2.5. 
Approximately 30 minutes through this incubation, Strep A/B (avidin/biotin)
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complexes were assembled using the ABC (peroxidase) kit according to Table 2.6 
and the manufacturer’s instructions. The complexes were removed using the same 
PBS-Tween 0.05 % wash regimen. In order to quench endogenous human 
peroxidases, 3 % hydrogen peroxide/PBS (v/v) was applied to the section for 15 
min. at RT, following the removal of ABC complexes. The hydrogen peroxide was 
removed by rinsing the sections several times in PBS. To complete the 
amplification process, the fluorochrome labeled Tyramide (rhodamine) was applied 
to the sections according to Table 2.6 and the manufacturer’s instructions. The 
rhodamine was removed using the same PBS-Tween 0.05 % wash regimen.
2.4.2.5 H&E staining of raft cultures
In order to examine the cellular pathology of NIKS and wt-HPV-16 raft cultures, 
raft culture sections were stained with H&E reagents. Prior to this staining, the 
sections were de-waxed and rehydrated using the identical procedure as 
described in Section 2.3.4. A regressive H&E staining procedure was then carried 
out using the same protocol as described in Section 2.4.1.2.
2.4.2.6 Mounting raft culture coverslips for microscopy
Prior to viewing and capturing images of raft culture sections, coverslips were 
mounted on to the sections using the appropriate mounting reagents. For 
fluorescently stained raft cultures 10-20 pi of citifluor reagent (Citifluor LTD; UK) 
was dropped on to the section and a coverslip was laid on top of the section. 
Slides that contained fluorescently stained raft cultures were kept in the dark at 
4°C. For raft culture sections that had been stained with H&E a drop of DPX 
mountant (Sigma; UK) was placed on to the section and a coverslip was applied
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on to the section. The slides were either left to dry at (rt) o/n or were dried using 
the microwave on a medium setting, for 2 minutes.
2.5 Microscopy and imaging software
All fluorescently stained cells were viewed on a Nikkon EFD-3 microscope 
equipped with fluorescent filters. Fluorescent images were captured using a 
SenSytem camera and images were viewed using IPLAB software. All H&E 
stained cells were viewed on a Zeiss A1 microscope. Color images were captured 
using a MRc camera and images were viewed using Axiovision software.
2.6 Monolayer growth assays of NIKS and HPV-16 clones
Growth assays were used to assess the level of proliferation for monolayer NIKS 
and HPV-16 clones. NIKS and all selected clones were counted in triplicate on 
specific days over a 7-day time period. Unless otherwise specified total cell 
numbers/mL for each triplicate were assessed on days 1, 3, 4, 5 and 7.
2.6.1 Seeding of fibroblasts and keratinocytes for growth assays
Approximately 1x105 d irradiated fibroblasts were seeded into each required well, 
of a 60 mm 6-well plate. The cells were allowed to attach for 2 hours in 1-2 mL of 
FI media at 37°C, 5 % CO2 . 1x105 NIKS or HPV-16 clones were seeded on to the 
attached fibroblasts and were incubated in FI media overnight at 37°C, 5 % CO2 . 
Until the end of the experiment all remaining cells were fed with 4 mL FC media 
every other day thereafter.
2.6.2 Harvesting and counting NIKS and HPV-16 cell lines during growth 
assays
On each day of harvesting, each well was first washed with 1 mL PBS and then 
0.5 mL of trypsin was added to the fibroblast and keratinocyte layers. The cells 
were incubated at 37° C, 5 % CO2 for 1 minute followed by a light tapping of plate,
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in order to completely dislodge the fibroblasts. Any excess fibroblasts were 
washed away with PBS. To remove the keratinocytes 1 mL of trypsin was added 
to each well and the cells were left to incubate at 37°C, 5% CO2, for at least 15 
minutes or until the cells had completely dislodged from the plate. In order to 
create a single cell suspension, 1 mL of FI media was added to each well and the 
entire contents were put into individual 15 mL Falcon tubes. To count the cells 0.5 
mL Of each individual suspension was added to 9.5 mL isotone solution (1:20 
dilution) and were counted using a coulter counter as described in section 2.2.3.4. 
The results were plotted on an x vs.y axis graph (days vs. cell number) using 
standard deviation error bars. The remaining cells were used for various other 
experiments, which will be described later.
2.7 Molecular biology techniques
2.7.1 Bacterial transformation
Plasmid DNA was transformed into the XL-1 Blue Supercompetent strain 
(Stratagene; UK) using the manufacturers protocol. 50-100 pi of the transformed 
bacterial culture was plated out on to ampicillan (100 pg/mL) LB agar plates. All 
plates were left to incubate at 37°C overnight.
2.7.2 Extraction of bacterial plasmid DNA
Prior to the extraction of plasmid DNA from transformed bacterial colonies, each 
colony was picked with a sterile micropipette tip and was placed in 3-5 mL of LB 
broth with100 pg/mL ampicillin. Tubes were used to allow for optimal shaking. 
The bacterial cultures were shaken at approximately 300 rpm overnight at 37°C. 
To extract plasmid DNA, 1.5 mL of the expanded culture was used to perform a 
mini-prep DNA extraction using the QIAprep spin mini-prep kit (Qiagen; UK). The
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DNA was extracted and eluted using the buffers and protocol supplied by Qiagen. 
In order to grow up larger scale preps for DNA extraction, 250 pi of the remaining 
mini-prep culture was used in 250 mL (1:1000 dilution) of LB broth with 100 pg/mL 
ampicillin. The culture was shaken at approximately 300 rpm overnight at 37°C. 
The entire culture was used to perform a DNA extraction using the EndoFree 
plasmid maxi kit (Qiagen; UK). (It should be noted that if the mini-prep culture was 
more than 8 hours old, a fresh colony was picked for a small-scale overnight 
culture and 250 pi of this culture was then used for the large-scale maxi prep).
2.7.3 Extraction of total genomic DNA from NIKS and wt-HPV-16 cell lines
Prior to extracting the DNA, the cells were washed with PBS and pelleted at a low 
speed (3000rpm) in a microcentrifuge for 5 minutes. The cells were immediately 
put on ice and the pellets were prepared for the removal of RNA. In order to 
remove RNA from the cells, the pellet was resuspended in 140 pi of PBS and 40 pi 
of (10mg/mL) RNaseA (Invitrogen; UK). The cells were incubated in a 37°C water 
bath for 20 minutes and the DNA extraction protocol immediately followed. The 
extraction of total genomic DNA, including HPV genomic DNA, from NIKS or HPV- 
16 cell lines was performed using the QIAamp DNA Blood Mini kit (protocol for 
small volumes of blood) (Qiagen; UK). The complete set of buffers and reagents 
required to extract the DNA were contained in the Qiagen kit.
2.7.4 Quantification of plasmid and genomic DNA
Plasmid and genomic DNA was quantified using a Nano-drop 8000 
spectrophotometer.
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2.7.5 Agarose gel electrophoresis
The separation of plasmid and genomic DNA was carried out using 0.8%-1% 
agarose gels (depending on the size of the product). Agarose gels were prepared 
with 0.8 %-1 % (w/v) agarose in 1x TAE buffer with 5 pi (10 mg/mL) ethidium 
bromide per 100 mL of gel. The gels were cast into a BioRad electrophoresis gel 
tank and were run at a constant voltage of 100V.
2.7.6 Quantitative RT-PCR (QPCR)
Quantitative real-time (RT) polymerase chain reaction (PCR) was carried out on 
NIKS chromosomal and HPV genomic DNA to determine the HPV copy number 
per cell, within wt-HPV-16 cell lines. Forward and reverse primers (Table 2.7) 
were designed to detect a 150 bp HPV-16 E4 sequence and a 150bp human 
GAPDH sequence, which was used as an internal housekeeping gene. It should 
be noted that the region of GAPDH primer amplification was selected based on the 
fact that it contained the least amount of homology to that of the mouse GAPDH 
DNA sequence. This was to ensure that any contamination by mouse J2-3T3 
fibroblasts would not be reflected in the readout.
A Sybr Green ROX mix reagent that contained a Thermo Start DNA polymerase 
was used to amplify the DNA. The samples were run in triplicate wells (per primer 
set) in 96 well plates (Abgene; UK) using an ABI 7000 sequence detector system.
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2.7.6.1 QPCR primer design
Primer sets were designed using Primer Select software
Table 2.7 Primer Sequences
Target Sequence
HPV-16 
E4 (F)
5’ GACTATCCAGCGACCAAGATCAG 3’
HPV-16
E4(R)
5’ CTGAGTCTCTGTGCAACAACTTAGTG 3’
GAPDH
(F)
5’ CCTCCCGCTTCGCTCTCT 3’
GAPDH
(R)
5’ CTGGCGACGCAAAAGAAGA 3’
2.7.6.2 QPCR reagent cocktails
To amplify HPV-16 and NIKS genomic DNA a fresh cocktail of reagents was 
prepared for each primer set, (Table 2.8) immediately prior to the PCR analysis. 
The volume of cocktail was made according to the number of triplicates required 
for all DNA samples.
Table 2.8 QPCR cocktail
Cocktail 1 HPV-16 Cocktail 2 GAPDH
(pi) per reaction (well) (pi) per reaction (well)
*Primer Forward 1.75 pi 1.75 pi
*Primer Reverse 1.75 pi 1.75 pi
Syber Green 12.5 pi 12.5 pi
h 2o 8 pi 8 pi
x - number reactions 
needed
x number of reactions 
needed
* Primers were diluted to 1pM working stocks in sterile TE (Tris, EDTA) pH 8.0.
2.7.6.3 QPCR plating scheme and cycle parameters
To be statistically significant each sample was plated into triplicate wells, for both 
HPV-16 and GAPDH primer sets. 24 pi of the individual cocktail mixtures were
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pipetted into each well and 1 pi of 20-40ng/ pi DNA was then pipetted separately 
into each well. Table 2.9 contains the cycle parameters use to amplify the DNA 
products. Due to the fact that Sybr Green can bind to non-specific double stranded 
DNA products, a dissociation program immediately followed the amplification 
cycles. For each reaction, this determined if single or multiple PCR products had 
been amplified. Table 2.10 contains the parameters for the dissociation program.
Table 2.9 ABI 7000 PCR parameters
Step Number of 
cycles
Time per 
cycle
Temperature
1 1 2 minutes 50°C
2 1 15 minutes 95°C
3 40 15 seconds 95°C
4 1 1 minute 60°C
Table 2.10 Dissociation parameters
Step Number of 
cycles
Time per 
cycle
Temperature
1 1 15 seconds 95°C
2 1 20 seconds 60°C
3 1 95 seconds 95°C
2.7.6.4 Standard curves for primers
A standard curve and linear equation was generated for each primer set in order to 
determine their efficiency and sensitivity, within the selected PCR parameters.
To generate an HPV-16-E4 standard curve, a construct (pTZH16-W12) that 
contained the entire 8kb genome was used as the template. To establish a linear 
relationship, six 10-fold serial dilutions (10pg, 1 pg, 0.1pg, .01pg, 1fg and 0.1fg) of 
HPV-16 DNA were plated out in triplicate. To generate the standard equation that
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would determine the total number of HPV copies in each reaction, the 
concentrations of DNA were converted into their corresponding copy numbers 
(8.3x105, 8.3x104, 8.3x103, 8.3x102, 83 and 8.3 copies respectively). To generate
GAPDH standard curves a pDrive construct that contained the 300 bp of the
GAPDH ORF was used as the template. To establish a linear relationship six 10- 
fold serial dilutions (1 pg, 0.1 pg, .01pg, 1fg, 0.1fg and .01fg) were plated out in 
triplicate. To generate the standard equation that would determine the total 
number of GAPDH copies in each reaction the concentrations of DNA were 
converted into their corresponding copy numbers (2.5x105, 2.5x104, 2.5x103, 
2.5x102, 25 and 2.5 copies respectively). For both HPV-16 and GAPDH, the 
standard curves were only generated once as the same primer stocks were used 
for every QPCR experiment.The following are the standard curve equations for 
HPV-16 and GAPDH primer pairs:
Standard curve equation: HPV-16 y=-3.33x + 35.78 
Standard curve equation: GAPDH y=-3.39x + 40.61
2.7.6.5 Standard curve equations and calculations for copy number 
determination
The HPV-16 and GAPDH standard curve equations generated in the form of 
y=mx+b, contained two important parameters. The slope (m) referred to the linear 
relationship or efficiency of the primer pairs where a slope of -3.33 showed a 
perfect linear relationship between DNA copy number and cycle threshold (ct) 
value. The y-intercept or (y) determined the primer sensitivity where y= the 
number of cycles needed to amplify one copy of DNA. In this case, the y
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intercepts suggested that there were differences in sensitivity between primer sets, 
however both fell within the programmed parameter of 40 cycles (Table 2.9).
To use the standard equations to calculate the total number of HPV-16 copies per 
cell in wt-HPV-16 clones, each set of triplicate (ct) values were averaged. To 
account for pipetting errors the software also generated a standard deviation for 
every triplicate where standard deviations over 0.300 indicated excessive variation 
within the triplicate. Reactions were repeated if standard deviations exceeded 
0.300.
Acceptable (ct) averages were used in the standard equations as follows:
If y=mx+b where (m)=slope, (b)=y intercept and (y)=ct value, then solving for In'1 
x generated the total copies of HPV-16 or GAPDH in each reaction. In order to 
establish the total number of cells in each reaction, the GAPDH copy numbers 
were divided by four. This was due to the fact that initial work with these GAPDH 
primers had identified two additional GAPDH pseudogene sequences within the 
NIKS genome. To finally complete the HPV copy number/cell calculation for each 
cell line, the total number of HPV copies were divided by the total number of cells.
2.7.6.6 Copy number evaluations from growth curve assays
HPV copy numbers/cell of HPV-16 clones were assessed on day four of the 
monolayer growth assays. On day four of the monolayer growth assays (section 
2.6) the triplicate wells of each clone were harvested and counted as described in 
section 2.6.2 The entire remains of each well within a triplicate were washed with 
PBS and pelleted separately in micorcentrifuge tubes. Total genomic DNA was 
extracted as described in section 2.7.3. For each HPV-16 clone, a total of three 
triplicates or nine samples were harvested on day four, however each triplicate
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was harvested on a different day in order to test for the biological reproducibility of 
episomal maintenance. To quantify the HPV copy numbers/cell for each clone, all 
nine samples were plated as a single experiment on one 96-well plate. HPV copy 
numbers were quantified as described in 2.7.6.5.
2.7.6.6.1 Statistical evaluation of HPV copy numbers from growth assays
HPV copy numbers from the 9 samples were averaged and normalized against 
one DNA sample that had been carried through to each experiment. This sample 
was used to control for day-to-day variation caused by the PCR machine. 
Normalized averages of each clone were put through a two-tailed unpaired T test 
statistical significance was shown at p<0.05.
2.7.7 Southern blot analysis
A Southern blot analysis was conducted on each monolayer clone in order to show 
the physical state of the HPV genome. An entire 75cm flask of monolayer cells 
were harvested and pelleted. Total genomic DNA was extracted from the pellet as 
described in 2.7.3.
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2.7.7.1 Restriction enzyme digests for Southern blot analysis
5|jg of genomic DNA from NIKS and wt-HPV-16 cell lines were digested 
separately with Bam HI (Roche; UK) and Hind III (Roche; UK). The DNA samples 
were digested as follows:
Restriction digest
5pg DNA X pL
10x Restriction buffer 5pL
100x BSA 0.5pL
(10mg/mL) Rnase A 0.5pL
(10U/pl) Restriction enzyme 5pL
dH20 Final
Vol.
50pL
The digests were incubated o/n at 37°C
2.7.7.2 The separation of genomic DNA for southern blot analysis
Digested DNA samples were separated on a 0.8% agarose gel that contained 40 
pi (10 mg/mL) ethidium bromide. The samples were run for 10 minutes at 100V, 
then at 20V for 16 hours.
2.7.7.2 Southern blot transfer
Prior to transferring Southern blot gels, the gels were first soaked in denaturing 
buffer (0.5M NaOH ,1.5M NaCI) for 45 minutes, washed briefly with dH20 and then 
soaked in a neutralization buffer (0.5M Tris pH 7.4, 1.5M NaCI) for 45 minutes. 
The gels were briefly washed again with dH20 and then were set up for an
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overnight transfer. To transfer the gels each gel was placed face up in a clean 
transfer apparatus basin. A single hybond N+ (Amersham; UK) membrane cut to 
fit the exact dimensions of the gel, was pre-wet in dH20 and then placed on top of 
the gel. All air bubbles were removed with a clean strippette. One sheet of 
Whatman filter paper pre-wet in dH20 was placed on top of the membrane, which 
was followed by 2 dry sheets of Whatman filer paper. A moderate stack of dry 
towels was placed on the top layer and a flat book that supported two 500 ml_ 
bottles was used on top as a weight. The gel was transferred o/n at RT. After the 
transfer was complete the membrane was UV cross-linked (30 seconds at 
12x104J/cm2) to the membrane. The membrane was left in the dark until the 
probe hybridization.
2.7.7 A  Probe preparation and probe labeling for southern blot analysis
The entire 8kb HPV genome was used as a probe to detect physical forms of the 
HPV-16 genome. To prepare the probe, the 8kb genome was digested out of the 
backbone vector and excised from a 0.8% agarose gel. The probe was purified 
form the gel slice using a Qiamp gel extraction kit (Qiagen; UK). Up to 50 ng of 
the probe was labeled with 5ul alpha-32P-dCTP using the Ready to Go labeling 
system (GE ;UK) based on the manufacturer’s instructions. Prior to use in 
hybridization, radioactively labeled probes were cleaned using a G50 Sephadex 
column (GE; UK) according to the manufacturer’s instructions.
2.7.7.S Pre-hybridization, hybridization and washing of southern blot 
membranes
Prior to the hybridization of HPV-16 probes, the membrane underwent a pre­
hybridization regimen. Membranes were rolled and placed inside tubes and 50mL 
of pre-hybridization buffer (3X SSC, 0.1 % SDS, 100X Denhardts, 50% Dextran 
sulphate) was added along with 500 pi of denatured salmon sperm DNA
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(Invitrogen; UK). Prior to adding to the pre-hybridization buffer, the salmon sperm 
DNA was denatured for 5 minutes at 95° C and then was immediately cooled on 
ice for 5 minutes.) The membrane was incubated for at least one hour at 65° C 
prior to hybridization. During the pre-hybridization process the probes were 
labeled and purified as described above. Prior to probe hybridization the purified 
probes were denatured along with an additional 500 pi of salmon sperm DNA. 
The denatured DNA was then added directly to the pre-hybridization buffer and the 
membrane was incubated o/n at 65° C.
2.7.7.6 Exposure of southern blots
All membranes were exposed overnight in a Phosphorimager cassette. Southern 
blot analysis was conducted using a Storm 860 Phosphorimager scanner.
2.8 Amplification of Papillomavirus Oncogene Transcripts (APOT) analysis
2 x 106 sub-confluent HPV-16 cell lines were first harvested for total RNA 
extraction. Total RNA extraction was carried out using the Qiagen RNAeasy kit 
(Qiagen; UK) APOT analysis of HPV-16 extracted RNA was carried out using the 
exact primers and protocol as described in (Klaes, Woerner et al. 1999).
2.9 Protein Analysis
2.9.1 Cell lysis for western blot analysis
Monolayer HPV-16 cell lines were grown in 60cm dishes. Approximately 2x10 6 
NIKS or HPV-16 cell lines were harvested and pelleted for lysis. Pellets were 
washed with 1 X PBS and were then were resuspended in 100 pi lysis buffer (50 
mM Tris [pH 7.4], 150 ml NaCI, 1 mM EDTA + 4pl of 1x complete protease
inhibitor solution (Roche; UK)), The lysates were held on ice for 30 minutes and 
then were spun at 14000 rpm for 30 minutes. The soluble supernatant was
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removed and stored separately at -70°C until further analysis. The insoluble pellet 
was then resuspended in 100 pi 3x Laemelli buffer (New England Biolabs; UK) 
and was spun at 14000 rpm for 15 minutes at room temperature.
2.9.2 Protein quantification
The protein quantification of soluble lysates was carried out using the Bio-Rad 
RCDC kit (Bio-Rad; UK). Quantification was carried out according to the 
manufacturers instructions
2.9.3 SDS PAGE
2.9.3.1 Gel electrophoresis for E6 and E7 protein analysis
The separation of E6 and E7 proteins was carried out using 15 % Tris/ Glycine 
polyacrylamide gels. Table 2.7 contains the gel composition for both the stack and 
resolving gel. 7.5 ml_ of the resolving gel mixture was first poured and set at room 
temperature for 30 minutes. 2 ml_ of the stack gel was overlaid on top of the 
resolving gel and was left to polymerize for 30 minutes. 40 pg of soluble lysate 
was loaded into each well. Each gel was submerged in 500 mL of SDS running 
buffer (25mM Tris pH 8.3, 200mM glycine, 0.1% SDS) in Bio-Rad gel tanks. The 
separation of E6 and E7 proteins was carried out at 80 V for 30 minutes and then 
at 160 V for 1 hour.
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Table 2.7 15% Tris / Glycine polyacrylamide 
gel composition (resolving gel) 10 mL total
H20 3.3 mL
30 % Acrylamide 4.0 mL
1.5 M Tris (pH 8.8) 2.5 mL
10% SDS 0.1 mL
10% APS 0.1 mL
TEMED 0.004 mL
(stack gel) 2mL total 
H20 1.4 mL
30 % Acrylamide 0.33 mL
1.0 M Tris (pH 6.8) 0.25 mL
10% SDS 0.02 mL
10% APS 0.02 mL
TEMED 0.002 mL
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2.9.3.1 Gel electrophoresis for cellular proteins
The separation of various cellular proteins was carried out using 8 % or 10% Tris/ 
Glycine polyacrylamide gels. Proteins greater than 80 kDa were separated on a 
8% gel. Table 2.8 contains the gel composition for both the stack and resolving 
gel. 7.5 mL of the resolving gel mixture was first poured and set at room 
temperature for 30 minutes. 2 mL of the stack gel was overlaid on top of the 
resolving gel and was left to polymerize for 30 minutes. 20 pg of soluble lysate 
was loaded into each well. Each gel was submerged in 500 mL of SDS running 
buffer in Bio-Rad gel tanks. The separation of cellular proteins was carried out at 
80 V for 30 minutes and then at 160 V for 30 minutes to 1 hour depending on the 
protein size.
Table 2.8 (8% or 10%) Tris / Glycine 
polyacrylamide gel composition 
(resolving gel) 10 mL total
H20 4.6 mL or 4.0 mL
30 % Acrylamide 2.7 mL or 3.3 mL
1.5 M Tris (pH 8.8) 2.5 mL or 2.5 mL
10% SDS 0.1 mL
10% APS 0.1 mL
TEMED 0.006 mL or 0.004 mL
(stack gel) 2mL total
H20 1.4 mL
30 % Acrylamide 0.33 mL
1.0 M Tris (pH 6.8) 0.25 mL
10% SDS 0.02 mL
10% APS 0.02 mL
TEMED 0.002 mL
2.9.3.2 Membrane transfer for Western Blot
15 % polyacrylamide gels were transferred on to 0.22 pm nitrocellulose 
membranes. All other polyacrylamide gels were transferred on to 0.46 pm
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nitrocellulose membranes. Prior to transfer each membrane was submerged in 
methanol. All gels were transferred in 500 mL of transfer buffer ( 25 mM Tris-HCL 
pH8.3, 200mM glycine, 20 % methanol (v/v) ) in Bio-Rad gel tanks. All transfers 
were conducted overnight at 50V at 4 °C.
2.9.3.4 Blocking and Primary antibody incubation for Western blot
Following membrane transfer, each membrane was incubated in 5 % milk/PBS 
Tween-0.01 % (w/v) for 1-2 hours at room temperature or for 4-8 hours at 4 °C. 
Each membrane was then incubated with a specific primary antibody. Primary 
antibodies were diluted in 5% milk/PBS Tween-0.01 % (w/v). Table 2.9 contains 
all primary antibodies used for protein analysis and their respective dilutions. All 
membranes were incubated overnight with the respective primary antibodies at 4 
°C. Each membrane was then washed using the wash regimen stated in 2.9.3.5. 
Following one round of washing a mouse secondary antibody was incubated with 
the membrane at 1:4000 (diluted in 5% milk/PBS Tween-0.01 %). The identical 
wash regime described below was used following this incubation.
Table 2. Primary Antibodies for Western Blot
Antibody Clone Dilution Supplier
E7* ED17 and 8C9 1:300/1:300 Santa Cruz1
Invitrogen (Zymed)
E6 2E-3F8 1:1000 Euromedex
GAPDH MAB374 1:4000 Chemicon
Rb G3-245 1:1000 Pharmingen
P53 D0-1 1:1000 Santa Cruz
P16 G175-405 1:1000 Pharmingen
* Two E7 antibodies were used together as a cocktail
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2.9.3.5 Membrane washing for Western blot
Following the incubation with primary antibodies all membranes were washed in 
PBS/Tween 0.01 % at room temperature. Membranes for E6 and E7 analysis 
were washed 3 x short, 1 x 1 5  min. and 3 x 5  min. All other membranes were 
washed 3 x short and 3 x 5  min.
2.9.3.6 Western blotting detection
To detect E6 and E7 proteins the ECL plus kit (GE Healthcare; UK) was used 
according to the manufacturers instruction. All other proteins were detected using 
the standard ECL kit (GE Healthcare; UK) according to the manufacturers 
instructions
2.10 Beta-catenin activity assay
HPV-16 cell lines and HPV negative NIKS, were transfected with the TopFlash
Photinus plasmid, which contained the TCF/LEF Beta-catenin binding site. A
Renilla luciferase plasmid (pRL) was co-transfected with the TopFlash plasmid as
a transfection control. Prior to transfection, 4x105 cells of each cell line were
seeded on a bed of 1 x105 d-irradiated feeders. All HPV-16 cell lines were seeded
in duplicate in six-well plates. Each cell line was transfected with 0.4pg TopFlash
and .04pg of pRL. All transfections were carried out using the appropriate volume
of Effectene and media as indicated by Qiagen for the above DNA quantity and
plate size. 72-hours post-transfection the feeder cells were first discarded and
HPV-16 cell lines were lysed to assay the Photinus and Renialla activity. The
Promega Dual Reporter Luciferase Kit (Promega; UK) was used to lyse the cells
and assay the activities of Photinus and Renilla. The cells were lysed in 100 pi of
the supplied lysis buffer at room temperature for 30 minutes. The Photinus and
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Renilla activities were measured using the supplied regents and standard protocol, 
according to the manufacturers instructions. Photinus and Renilla measurements 
were carried out using a luminometer.
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3.0 The NIKS organotypic raft culture model of wild-type-HPV-16 
productive infection
3.1 Introduction
The regulation of the HPV life cycle has been broadly studied through the 
immunohistochemical analysis of various types of HPV-infected tissues. These 
tissues types can be distinguished as either cutaneous or mucosal epithelium. 
HPV-induced cutaneous and mucosal lesions have been isolated from common 
sites on the body that HPV can infect such as the hand (cutaneous) and the cervix 
(mucosal). Collectively, these studies have shown that a highly conserved order of 
HPV gene expression exists in both tissue types (Peh, Middleton et al. 2002; 
Middleton, Peh et al. 2003).
Although these lesions have been valuable for the analysis of viral life cycle 
regulation, biopsy material can often be hard to obtain. In addition, lesion size may 
limit the type of analysis. Due to these limitations many questions regarding the 
virus life cycle remain unanswered.
More recently it has been shown that organotypic raft cultures can support a 
complete HPV life cycle (Lambert, Ozbun et al. 2005; Wilson and Laimins 2005). 
In this system foreskin/cutaneous keratinocytes that carry the 8kb viral episome of 
high-risk HPV types (e.g. HPV-16, HPV-18 and HPV-31), are differentiated to 
produce stratified epithelial layers. Although this is still considered a quasi in-vivo 
model with regards to the absence of a functional immune system, the raft culture 
system is superior to current transgenic mouse models, which are only based on
the expression of one or two HPV genes (Brake and Lambert 2005). In contrast to
72
Chapter 3 -  Results
these models the organotypic raft culture system is able to support a productive 
viral life cycle, which is regulated from all eight HPV genes.
The analysis of this system can be broken down into two parts. The monolayer 
HPV episomal cell lines of high-risk HPV types mimic the proliferating basal 
compartment where the early stages of the virus life cycle begin. Early life cycle 
events such as viral DNA replication and early oncogene expression can be 
observed in these cells prior to their differentiation. To evaluate HPV gene 
regulation in the differentiated epithelium, monolayer cells are then differentiated 
to produce organotypic raft cultures. Immunohistochemical analysis of early and 
late gene expression can then be carried out on paraffin embedded HPV raft 
culture sections.
In order to dissect the early and late parts of the HPV-16 life cycle this thesis 
begins with the establishment of a NIKS (cutaneous) raft culture model of a 
productive HPV-16 infection. The NIKS HPV^16 raft system has been widely used 
to study the functions of specific viral genes in the HPV life cycle. However, the 
viral gene expression patterns in this NIKS (cutaneous) HPV-16 raft model have 
not been extensively compared to viral gene expression patterns in cervical 
(mucosal) biopsy material. Therefore, in order to use this model to answer 
questions about HPV life cycle in both cutaneous and cervical (mucosal) tissues it 
was first necessary to show that the order and timing of HPV-16 gene expression 
within the NIKS epithelium was similar to that of cervical epithelium.
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3.2 Results
3.2.1 The use of NIKS as a host keratinocyte cell line
First we aimed to establish NIKS clonal cell lines that maintain episomal forms of 
the HPV-16 and HPV-31 genomes. We chose specifically the high-risk types HPV- 
16 and HPV-31 with an interest in evaluating the biology of HPV types that have 
oncogenic potential. In addition HPV-16 and HPV-31 are genetically similar but 
interestingly have very different oncogenic potentials. HPV-16 alone has been 
shown to cause over 50% of total cervical cancers. This thesis will first present 
data on the generation of HPV-31 lines, however HPV-16 lines, which were 
generated in the same way were used in the remainder of the thesis.
The second aim of this chapter was to establish an organotypic raft culture model 
of a productive HPV-16 infection through the propagation of early passage NIKS 
HPV-16 episomal cell lines. By using immunohistochemical techniques we aimed 
to show that early and late HPV-16 gene expression patterns in our 
NIKS/cutaneous raft model system were similar to those of HPV-16 induced 
cervical/mucosal lesions.
We chose Normal Immortalized Human Keratinocytes (NIKS) as a host cell line for 
our model system due to their known ability to successfully maintain HPV viral 
episomes. It is also known that NIKS raft culture systems can successfully support 
the life cycle of several HPV types. NIKS, which are an immortalized cell line, were 
preferred over the use of primary foreskin keratinocytes, as they were expanded 
from a single colony (Allen-Hoffmann, Schlosser et al. 2000). By contrast, primary 
cell lines typically contain a mixture of stem cells and transit amplifying cells and
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therefore HPV cell lines could only be established from a heterogeneous 
population of cells.
Importantly, it was previously shown that NIKS are genetically stable and 
represent a uniform genetic background. This was crucial for our experiments, as 
we wanted to avoid genetic variation within our HPV cell lines. Only one 
abnormality was detected following the karyotyping of NIKS (Allen-Hoffmann, 
Schlosser et al. 2000). The respective authors found that over time all of the NIKS 
had acquired an additional copy of chromosome 8. This abnormality however has 
not affected their ability to produce a fully differentiated epithelium. The NIKS 
arose as spontaneously immortalized cell line, after 59 passages of their parental 
neonatal foreskin cell line, BC-1-EP. Despite the fact that foreskin keratinocytes 
are a natural host cell for HPV viruses, the authors confirmed there were no 
detectable levels of HPV DNA. In order to confirm that the NIKS maintained 
normal growth characteristics, they also measured the mRNA levels of autocrine 
growth factors and markers such as Transforming growth factor (TGF), TGF-G1 (a 
keratinocyte growth inhibitor), Epidermal growth factor (EGF), the oncogene c-myc 
and keratin K14. There were no differences in the expression levels of these 
growth factors and markers when compared to the parental cell line. NIKS have 
also been shown to be non-tumorigenic when injected into mice, which suggests 
that they are not a transformed line.
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3.2.2 The generation of NIKS wild-type HPV-16 and 31 episomal cell lines
In order to support a productive virus life cycle using the organotypic raft culture 
system, the NIKS would have to stably maintain an episomal form of the viral 
genome and avoid integration into the host chromosome. This has been previously 
achieved with several high-risk HPV types by the co-transfection of circular HPV 
genomes and a plasmid carrying a drug resistance gene as selection marker 
(Nakahara, Peh et al. 2005). To create the circular genomes for transfection, we 
excised full-length 8kb genomes from a plasmid. Then we religated the ends of the 
full-length genome to create a double-stranded circular form of the genome. These 
circular forms are then co-transfected into the keratinocytes together with a 
plasmid carrying a selection marker. Ideally, this plasmid integrates into a host 
chromosome whereas the circular genome is maintained in the nucleus but fails to 
integrate into a host chromosome.
To create HPV-31 cell lines for our system, we co-transfected NIKS cells with 
circularized wt-HPV-31 and a blasticidin resistance plasmid. The HPV-31 plasmid 
used for transfection carried a replication competent HPV-31 genome, which was 
previously cloned from the isolated cervical cell line, CIN 612 (Bedell, Hudson et 
al. 1991). The transfected cells underwent a positive selection with blasticidin for 
four days. Following drug selection, the colonies grew for an additional five to 
seven days. We then picked individual colonies and expanded them as individual 
cell lines. First we tested these cell lines for the presence of the HPV-31 genome. 
To do this we amplified a 1.1 kb fragment, contained within the E4 ORF, via 
conventional PCR methods. Figure 3.1 A shows the analysis of a subset of HPV- 
31 positive clones. Out of the 24 clones tested, 18 clones were positive for the E4 
ORF, which accounted for 75 % of the selected clones. This level of efficiency was
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Figure 3.1. Generation of HPV-31 episomal cell lines
Conventional PCR methods were used on total DNA extracts to detect the presence of the HPV-31 
genome in HPV-31 positive clonal NIKS cell lines. Primers specific for the E4 ORF amplified a 
1.1 kb fragment in HPV-31 positive clonal cell lines. (A) The agarose gel shows the presence or 
absence of the band representing the 1,1 kb PCR product (lanes 1-9). As size standard a 1 kb 
DNA marker (M) was used. A known positive HPV-31 cell line was used as a positive control (+) 
and HPV negative NIKS were used as a negative control (-).
(B) Two HPV-31 positive cell lines were differentiated in methylcellulose for 48 hours. To detect 
late viral protein expression the differentiated HPV-31 cell lines were stained with an E4 antibody 
(green, #248). DAPI was applied to the cells as a nuclear counterstain (blue).
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expected as the genomes of high-risk types are typically very easily maintained in 
keratinocyte cell lines like the NIKS cells we have used. Next, in order to 
determine if these clones could express viral proteins from the differentiation- 
dependent viral promoter, we differentiated two of the HPV-31 cell lines in 
methylcellulose for 48 hours. Methylcellulose can be specifically used as a semi­
solid media for single cell suspensions (Wilson and Laimins 2005). In this 
environment cell to cell contact is prevented which allows keratinocytes to default 
into their terminal differentiation program. This experiment was primarily carried 
out to pre-screen HPV-31 cell lines for their ability to produce late life cycle 
proteins such as the E4 protein. The HPV-31 cell lines that had this ability could 
then be used in lengthy raft culture experiments. Our analysis shows that roughly 
5-10 % of cells from each line had the ability to express E4 (Figure 3.1B). The 5- 
10% range of E4 positive cells was somewhat lower than expected, however 
typical percentages of E4 positive cells using this method of differentiation, do not 
usually exceed 10-20%. Nevertheless, this percentage was sufficient to proceed 
with raft culture experiments.
However, for the remainder of our life cycle studies we used NIKS HPV-16 
episomal cell lines, which had a similar percentage of E4 positive cells to the HPV- 
31 cell lines (data not shown). We have chosen HPV-16 cell lines for the 
remainder of the life cycle studies, as HPV-16 is more highly prevalent in HPV- 
induced cervical lesions. Two collaborators (Kenneth Raj, National Institute for 
Medical Research, London, UK; Qian Wang, National Institute for Medical 
Research, London, UK) established these HPV-16 episomal cells lines by using 
similar methods to the ones used for HPV-31. A plasmid that contained the 
replication competent W12 HPV1-16 genome was co-transfected into NIKS with a
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plasmid carrying a drug resistance gene to establish the HPV-16 cell lines. After 
drug selection we have chosen ten individual HPV-16 cell lines to carry out 
subsequent studies.
3.2.3 The terminal differentiation program is complete in HPV negative NIKS 
organotypic raft cultures
HPV-16 is highly prevalent in high-grade cervical lesions and we therefore wanted 
to show that our cutaneous system could also model a productive HPV infection in 
cervical/mucosal epithelium. Because the activation of the viral late promoter is 
linked to the terminal differentiation program it was important to show that our 
cutaneous NIKS model could follow a differentiation program that was similar to 
the one of cervical/mucosal epithelium. Although some architectural differences 
exist in cutaneous and mucosal epithelium, the overall process of terminal 
differentiation is a highly conserved process between these tissue types. We first 
wanted to show this in HPV-negative NIKS, which would represent a normal 
cutaneous epithelium
In order to create the NIKS epithelium we differentiated HPV negative NIKS on 
dermal equivalents for 14 days. To detect the process of terminal differentiation in 
NIKS/cutaneous raft sections we used antibodies targeted against proteins in early 
differentiation, Keratin K10, and late differentiation, filaggrin, respectively. We also 
used an MCM-7 antibody that identified S-phase competent cells, which are 
typically present in the mitotically active basal layer. This layer immediately 
precedes the layers of early terminal differentiation. A fellow lab member, Kate 
Middleton, previously carried out the Immunohistochemistry of cervical(mucosal) 
sections with stains against MCM-7, filaggrin and Keratin K13, which is the
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mucosal equivalent of the cutaneous keratin, K10. These sections were used for a 
direct comparison with our NIKS HPV-16 raft model.
In cutaneous NIKS raft cultures and cervical(mucosal) tissue, MCM-7 positive cells 
were sporadically detected within the first layer, which marked the “basal-like” 
layer (Figure 3.2A). However, cervical epithelium also contained MCM-7 positive 
transit amplifying cells above the basal layer. In both cutaneous and mucosal 
epithelial tissues stem cells give rise to daughter cells, which are transit-amplifying 
cells. These cells of the basal compartment go through subsequent rounds of 
proliferation and then commit to terminal differentiation in the layers above.
These observations demonstrated that HPV negative NIKS could maintain a 
proliferative compartment, but were unable to maintain the proliferation levels of a 
transit-amplifying layer.
In order to identify the start of terminal differentiation within the NIKS epithelium, 
we used keratin K10, which is the first keratin to be expressed at the start of 
terminal differentiation. In normal cutaneous tissue K10 is first detected in cells 
immediately above the basal layer (i.e. spinous layer). Although K10 is actively 
expressed only in the spinous layer, it can still be detected in its cross-linked forms 
throughout the granular and cornified layers. The same pattern is typically seen for 
keratin K13 in HPV-negative cervical (mucosal) epithelium.
In HPV-negative NIKS (cutaneus) raft sections and cervical (mucosal) epithelium 
both keratins K10 and K13 could be detected immediately above the basal layer 
and throughout the entire epithelium (Figure 3.2B). However, NIKS epithelium 
contained some K10 positive cells already within the basal compartment. This
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suggested an early onset of terminal differentiation, which was in line with the 
reduced level of proliferation in NIKS epithelium.
In order to identify the start of late differentiation filaggrin was used as a marker. 
As explained earlier pro-filaggrin is detected in keratohyalin granules, which 
constitutes the granular layer. Filaggrin, which represents the processed form of 
pro-filaggrin, can also be detected as a more filamentous pattern in normal 
cutaneous tissues. The role of filaggrin is to cross-link keratins to form the 
cornified layers, which are located immediately above the granular layer. Filaggrin 
is also more highly abundant in cutaneous versus mucosal tissues. This is due to 
the extensive cornification process in cutaneous tissue, which does not occur in 
mucosal tissue. Although extensive cornification is absent in mucosal tissues, 
keratins are still cross-linked to create the superficial layer in mucosal epithelium. 
After we stained cutaneous NIKS raft culture sections, a dense layer of pro- 
filaggrin and filaggrin could be detected in the upper layers (Figure 3.2C). By 
comparison only a small amount of pro-filaggrin/filaggrin could be seen in the 
cervical(mucosal) epithelium. In both NIKS(cutaneous) epithelium and 
cervical(mucosal) epithelium we also noticed a temporal gap between the onset of 
the respective keratin K10/K13 and filaggrin. These observations suggested that a 
normal step-wise process of terminal differentiation was occurring in our NIKS raft 
system. Although the onset of the terminal differentiation process as indicated by 
K10 was premature in some cells of our NIKS raft epithelium, we concluded that 
the virus would still encounter the same ordered process of differentiation like in 
the cervical(mucosal) epithelium and that the NIKS rafts would be a suitable 
environment for the full HPV life cycle.
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Figure 3.2. Proliferation and terminal differentiation in HPV-negative epithelium
HPV-negative NIKS were differentiated for 14 days to produce organotypic raft cultures. (A) To 
detect the proliferative compartment of HPV-negative tissues, NIKS raft sections were stained with 
an antibody against the S-phase marker MCM-7. HPV-negative cervical tissue previously stained 
with an MCM-7 antibody was used for direct comparison. (B) To detect the start of early 
differentiation, NIKS raft sections were stained with an antibody against (cutaneous) keratin K10. 
HPV-negative cervical tissue previously stained with an antibody against (mucosal) keratin K13 
was used for direct comparison. (C) To detect the start of late terminal differentiation, NIKS raft 
cultures were stained with filaggrin antibody. HPV-negative cervical tissue previously stained with 
filaggrin antibody was used for direct comparison. All sections were counterstained with DAPI 
(blue) and were photographed at x20 magnification. The broken line on NIKS raft cultures and in 
cervical tissues indicates the basal layer. The Immunohistochemistry of cervical (mucosal) sections 
was previously carried out by Kate Middleton (NIMR, London, UK) and used with permission.
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3.2.4 NIKS HPV-16 cell lines contain viral episomes and can produce L1 viral 
capsid upon differentiation
In order to validate our HPV-16 life cycle model we wanted to first establish that all 
ten HPV-16 cell lines contained characteristics necessary for a productive life 
cycle. First the cell lines had to maintain the HPV genome in a predominantly 
episomal and not an integrated state. The episomal form is the productive form of 
the viral genome. By comparison integration typically leads to the disruption of 
several viral genes such as the replication gene, E2 (Baker, Phelps et al. 1987). 
Therefore, integration typically renders the life cycle incomplete. The second 
criterion was that the differentiated HPV-16 cell lines had to express the late viral 
gene L1, which encodes the L1 protein, which forms viral capsids. This would 
demonstrate that we were analyzing the viral gene expression patterns of a 
complete HPV life cycle.
We first tested for the presence of episomal forms of the viral genome in our HPV- 
16 cell lines by Southern blot analysis. Only low passage cell lines (passage four 
to six) were used for rafting and this analysis, as integration events are more likely 
to occur after long-term culturing (Alazawi, Pett et al. 2002). In order to create a 
probe, which hybridizes with HPV-16 genomic DNA, a linearized 8 kb viral genome 
fragment was radioactively labeled with 32P. Then total DNA was first extracted 
from sub-confluent cultures of each cell line and digested separately with either 
Bam HI or Hind III. Bam H I, which cuts at the ends of the 8kb genome led to a 8kb 
linear form of the virus (Figure 3.3). This demonstrated that a full intact 
undisrupted HPV genome was maintained in all cell lines.
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Figure 3.3 Detection of HPV-16 episomes in monolayer cell lines
To test HPV-16 cell lines for their ability to maintain episomal forms of the viral genome, total DNA 
was extracted from HPV-negative NIKS and HPV-16-positive monolayer cell lines. Southern blot 
analysis of total DNA extracts digested with Bam HI or Hind III confirmed the presence of circular 
and linear forms following hybridization with a 32P radioactively-labelled full-length HPV-16 genome 
probe. Hind III, which does not cut within the genome, resulted in mostly supercoiled (SC) and 
some open circular (OC) and 8kb linear (L) forms. Bam HI, which cuts in the flanking region of the 
viral genome, resulted in a single 8kb linear band (L). To identify the 8kb linear genome, two 
dilutions of Bam Hl-linearized 8kb HPV-16 genomic DNA (HPV-16 DNA) were run alongside the 
DNA from the cell lines. HPV-negative NIKS were used as negative control (-). The asterix 
indicates bands, which run uncharacteristically in both the HPV-16 genomic DNA and total DNA 
from the HPV-16 cell lines
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Treatment with the second restriction enzyme, Hind III, which does not cut within 
the HPV-16 genome, retained several circular forms of the virus including the 
super coiled and open circular forms.
The supercoiled bands, which migrate faster than linear and open circular bands 
represent the unaltered form of the viral episome. Open circular bands are 
common as supercoiled structures can become relaxed during spontaneous DNA 
single-strand breakage. In addition a small amount of linear 8kb genome could be 
detected probably due to DNA double-strand breakage because of sheering. In 
addition following Hind III digestion, several minor bands were evident at the top of 
the gel, possibly representing integration events. However, digestion with Bam H I 
completely converts these high molecular bands to exclusively full-length 
undisrupted viral genome fragments. In contrast, integration events typically only 
appear as a series of multiple sized bands after Bam H I digestion as both the viral 
and cellular genome contain Bam H I. It is possible that the high molecular weight 
bands represented concatamerised circles of the virus. We therefore conclude that 
our HPV-16 cell lines predominantly carry episomal forms of the genome. We 
have conducted additional experiments, which will be presented in a later chapter, 
to show that viral genes are indeed expressed from episomal forms of the 
genome.
We next wanted to test if our NIKS HPV-16 cell lines could produce L1 capsid 
protein. To do so HPV-16 cell lines of identical early passage range were 
differentiated for 14 days to produce raft cultures. Raft sections of these HPV-16 
episomal cell lines were then stained with antibodies against the L1 capsid protein.
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We found L1 capsid within the cornified layers of seven out o ften cell lines (Figure 
3.4). The remaining three raft cultures that did not produce L1 capsid will be 
presented in Chapter 4. For our subsequent studies of the viral life cycle we chose 
to use the seven cell lines that contain predominantly episomal forms of the 
genome and that show the ability to produce L1 capsid protein.
1
2K 3K 4K
L1 capsid / DAPI
Figure 3.4 L1 capsid expression in HPV-16-positive raft cultures
To assess viral productivity HPV-16-positive monolayer cell lines were differentiated for 14 days to 
create organotypic raft cultures. Antibodies against L1 capsid protein (red) were applied to formalin 
fixed raft culture sections. DAPI was used as a nuclear counterstain (blue). The broken line on 
each raft culture indicates the basal layer. For clone 9Q a magnified section with L1-capsid positive 
cells is shown to the right.
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3.2.5 MCM-7 is a surrogate marker for E7 and S-phase induction in HPV-16 
raft cultures
After HPV infects cells in the basal compartment the HPV-16 E6 and E7 
oncogenes are expressed from the early p97 promoter (Smotkin and Wettstein 
1986). It is widely established that E7 maintains S-phase competent cells above 
the basal layer, via the E2F pathway, in order to maintain host replication 
machinery needed for viral DNA replication (Flores, Allen-Hoffmann et al. 2000). It 
is currently very difficult to detect E7 expression in the epithelium due to a lack of 
good antibodies. MCM-7, which is highly expressed during S-phase, has been 
established as a surrogate marker for E7 expression in the suprabasal cells 
(Freeman, Morris et al. 1999; Middleton, Peh et al. 2003). We therefore wanted to 
confirm that MCM-7 was indeed a surrogate marker of E7 in the NIKS raft system. 
To do this NIKS that expressed E6, E7 or E6/E7 from an integrated pLXSN 
retroviral plasmid were differentiated over 14 days to produce raft cultures. 
Western blot analysis of monolayer soluble extracts confirmed that each cell line 
expressed the transfected oncogenes (Figure 3.5a). After confirming this, an 
MCM-7 antibody was applied to each raft culture section. MCM-7 cells could be 
detected in every layer of E6/E7 and E7 raft cultures (Figure 3.5b). By comparison 
MCM-7 positive cells were only contained in the basal layer of E6 only raft 
cultures. This was identical to the MCM-7 pattern in HPV-negative NIKS raft 
cultures. This confirmed that the E7 oncogene alone is sufficient for the S-phase 
induction above the basal layer and we also demonstrated that MCM-7 could be 
used as an E7 surrogate marker in our NIKS raft system.
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Figure 3.5 MCM-7 as surrogate marker for E7 expression in NIKS organotypic raft cultures
(A) Western blot analysis of soluble protein extracts from untreated NIKS monolayer cells or NIKS 
previously transduced with a retroviral plasmid expressing either E6, E7 or E6/E7. Antibodies 
specific for E6 or E7 show the expression of these oncogenes in the respective cells. (B) Untreated 
NIKS cells and NIKS cells expressing E6, E7 or E6/E7 were differentiated for 14 days to produce 
raft cultures. An antibody against MCM-7 was applied to formalin fixed raft sections to detect the 
layers of S-phase competent cells. All sections were counterstained with DAPI (blue) and were 
photographed at x20 magnification. The broken line on each raft culture indicates the basal layer.
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3.2.6 S-phase is prolonged in wt-HPV-16 raft cultures
We next wanted to evaluate the extent of the S-phase compartment in raft culture 
sections of HPV-16 episomal cell lines. In these lines E7 should be expressed 
from the early p97 promoter of an intact 8 kb genome. To show that our HPV-16 
episomal cell lines could express E7, we analyzed soluble lysates of sub-confluent 
monolayer cultures of each cell line, by Western blots. We detected E7 expression 
in all seven clones. The Western blot in Figure 3.6a shows E7 expression from 
three of these cell lines (2K, 4K and 9Q). Western blots that show E7 expression 
from additional cell lines will be presented in Chapter 5.
Endogenous E7 expression levels are typically hard to detect by Western blot 
therefore a high concentration of protein was loaded on each gel, as indicated by 
the high levels of the GAPDH loading control. Due to overloading, at this point, we 
were unable to make claims about differences in E7 protein levels between each 
cell line.
To evaluate E7 oncogene expression within our model system, we applied a 
MCM-7 antibody to adjacent sections of all seven HPV-16 raft cultures. We 
compared this staining pattern to several high-risk HPV induced cervical lesions 
that were previously stained with MCM-7. Figure 3.6b shows two of these HPV-16 
raft culture sections alongside an HPV-16 induced cervical lesion. In both the 
HPV-16 raft epithelium and the high-risk HPV-16 induced cervical lesion we could 
detect MCM-7 expression in three to four layers of cells above the basal 
compartment. This MCM-7 pattern confirmed that E7 could prolong S-phase in our 
model system. It was also evident in both raft culture sections and the cervical
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lesion that MCM-7 could not be detected within the last 3-4 layers of the 
epithelium. This was indicative of early promoter regulation in the raft epithelium. 
In productive infections it is thought that the early promoter is switched off in order 
to allow for late gene expression to occur (Middleton, Peh et al. 2003). Activation 
of the differentiation dependent late promoter is necessary to carry out the 
productive phase of the virus life cycle.
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Figure 3.6 Expression of E7 and MCM-7 protein in HPV-16 raft cultures
(A) Western blot analysis of soluble protein extracts from three HPV-16 episomal cell lines and 
HPV-negative NIKS. Antibodies specific for the E7 protein show that E7 is expressed in all three 
HPV-16 cell lines. (B) HPV-negative NIKS and early passage (four to six) HPV-16 episomal cell 
lines were differentiated for 14 days to produce raft cultures. MCM-7 antibodies were applied to 
formalin fixed raft culture sections to assess the extent of S-phase competent cells. A section of 
HPV16-positive cervical tissue previously stained with MCM-7 was used for comparison (the 
cervical lesion was previously stained by Heather Griffin (NIMR, London, UK) and was used with 
permission). The broken line on each raft culture indicates the basal layer
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3.2.7 A brief overlap of early and late viral gene expression occurs in wt- 
HPV-16 raft cultures
In this HPV-16 raft culture model we could only detect MCM-7 expression in three- 
four layers of cells above the basal compartment. The last layer of the S-phase 
compartment is thought to mark the end of early promoter expression. In a 
productive HPV-16 life cycle the last layer of the S-phase compartment also 
typically coincides with the first detectable levels of E4 (Peh, Middleton et al. 2002; 
Middleton, Peh et al. 2003). At this point in the virus life cycle it is thought that 
high levels of E4 expression are the result of the activation of the differentiation 
dependent late promoter. E4 has been previously identified as a major late 
transcript product (Milligan, Veerapraditsin et al. 2007). The first set of E4 positive 
cells are usually found in cells that still express MCM-7. It is thought that viral 
amplification begins in these specific cells where E4 is expressed and host 
replication machinery is still available.
To determine if a switch from early to late gene expression occurred in our system, 
we applied MCM-7 and E4 antibodies to all seven HPV-16 raft culture sections. 
Figure 3.7 contain three raft culture sections from our model and one typical high- 
risk HPV induced cervical lesion that had been previously stained with MCM-7 and 
E4. In both raft cultures and cervical epithelium we detected E4 protein in MCM-7 
positive cells or just above an MCM-7 positive cell. MCM-7 was not detected in 
cells above the first E4 positive layer. The majority of the cells in this transient 
layer also contained both E4 and MCM-7, which likely marks the site of viral DNA 
amplification. We could therefore conclude that early and late promoter regulation 
was conserved in our HPV-16 raft culture model.
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Figure 3.7 Expression of late gene E4 and MCM-7 protein in HPV-16 raft cultures
In order to assess where early and late gene expression overlap in the HPV-16 life cycle, raft 
culture sections of HPV-16-positive episomal cell lines were stained with antibodies specific for the 
E7 surrogate marker MCM-7 and E4 protein, respectively. A section of HPV-16 positive cervical 
tissue previously stained with MCM-7 and E4 was used for comparison (the cervical lesion was 
previously stained by Kate Middleton (NIMR, London, UK) and was used with her permission). 
White arrows indicate cells that are positive for both MCM-7 and E4 protein. All sections were 
counter-stained with DAPI (blue) and were photographed at x20 magnification. The broken line on 
each raft culture indicates the basal layer.
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3.2.8 Viral DNA amplification and E4 expression commence in the same cells 
in HPV-16 raft cultures
The productive phase of the life cycle begins with amplification of the viral 
genome, which is thought to correlate with a thousand-fold increase in viral DNA 
(Bedell, Hudson et al. 1991). HPV amplified genomes first appear in the last layer 
of S-phase competent cells and also appear in the first cells that contain visible E4 
expression. It is thought that both expression of E7 and E4 are necessary to begin 
the viral amplification process. E7 ensures that host replication machinery is still 
available for the virus to amplify its genome. E4 has a known ability to arrest cells 
in G2, which would prevent the cells from entering mitosis (Davy, Jackson et al. 
2005). Preventing mitosis would give the virus a chance to replicate its own 
genome following cellular DNA replication.
To detect the amplified viral DNA in our system, HPV-16 raft culture sections were 
hybridized with a DIG labeled 8kb HPV-16 DNA probe. These sections were also 
stained with an E4 antibody. Amplified genomes were detected exclusively in E4 
positive cells, and in cells where E4 first appeared in the epithelium (Figure 3.8). 
Amplified viral DNA could also be detected in E4 positive cells throughout the 
cornified layers where viral packaging is likely to occur. These are thought to be 
previously amplified genomes that are carried up to the surface. An HPV-16 
cervical lesion also shows the typical staining pattern of E4 cells that contain 
amplified viral genomes. Here amplified genomes are also first detected in the first 
layer of E4 positive cells.
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We were unable to show a triple stain of MCM-7, E4 and DNA due incompatible 
protocols. However, due to the location of the first amplified genomes it is likely 
that these cells also contain MCM-7. In conclusion we were able to show that viral 
amplification in the NIKS (cutaneus) HPV-16 raft system commences in the first 
layer of E4 positive cells, which is similar to the onset of viral amplification in real- 
life productive HPV-16 cervical lesions.
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Figure 3.8 Detection of viral DNA amplification and E4 expression in HPV-16 raft cultures
To determine where viral DNA amplification starts relative to late life cycle events, raft cultures of 
HPV-16-positive episomal cell lines were hybridised with a DIG-labelled full length HPV-16 genome 
probe (HPV-16 DNA). Antibodies against HPV-16 protein E4 were applied to the same sections to 
detect late viral life cycle events. White arrows indicate cells that are positive for both HPV-16 DNA 
and E4 protein. A section of HPV-16-positive cervical tissue was stained the same way by Woei 
Peh (NIMR, London, UK) and used with permission for comparison. All sections were counter­
stained with DAPI (blue) and were photographed at x20 magnification. The broken line on each raft 
culture indicates the basal layer.
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3.2.9 The onset of early terminal differentiation commences normally in wt 
HPV-16 raft cultures and does not correlate with the appearance of late viral 
proteins.
The host cellular environment changes as the virus proceeds through the NIKS 
terminal differentiation program. It is widely established that the terminal 
differentiation program activates the late promoter, however the specific stage 
during terminal differentiation program has not been identified. We therefore 
wanted to establish whether late HPV gene expression in our system, correlated 
with any part of the NIKS terminal differentiation program. In addition we also 
wanted to evaluate if any alterations in the differentiation program occur as a result 
of the virus life cycle. Although this has not been extensively evaluated with HPV- 
16, previous work has shown that the expression of early keratins such as K10, 
are delayed in low-risk HPV-2 and HPV-63 induced cutaneous lesions. There was 
no such delay in low-risk HPV-11 induced cutaneous lesions. These studies also 
found no temporal relation between early terminal differentiation and late E4 
expression. As this could be type-specific, we wanted to evaluate K10 expression 
alongside E4 in our HPV-16 raft system.
To evaluate regions of early terminal differentiation and late viral gene expression 
we applied a K10 and an E4 antibody to sections of the HPV-16 raft cultures. An 
HPV16 cervical lesion, was used for comparison. In our system, all seven HPV-16 
raft culture sections showed little to no alterations in K10 expression compared to 
HPV negative NIKS rafts. In normal tissue K10 is expressed in the first layer above 
the basal compartment (Figure 3.9). By comparison K13 expression was slightly 
delayed above normal in the cervical/mucosal lesion. However, other HPV-
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induced cervical lesions have shown that K13 is also expressed abnormally in the 
basal layer (data not shown (Kate Middleton NIMR, London, UK)). At this point we 
could only conclude that HPV-16 did not affect the start of early differentiation in 
the NIKS HPV-16 raft system.
E4 expression showed no clear correlation between the start of early terminal 
differentiation and late life cycle events. This was evident in our system and in the 
cervical lesion. This was also in line with the previous studies of low-risk viruses. 
Secondly no distinct alterations of K10 expression could be seen in the first one or 
two layers of E4-positive cells where active expression of K10 is still likely to 
occur.
In conclusion we can confirm that late HPV gene expression does not coincide 
with early terminal differentiation as determined by in our system or in HPV- 
induced cervical lesions. This suggests that late promoter activation is likely to 
occur in cells undergoing late terminal differentiation. In addition no distinct 
alterations in the start of early differentiation program or K10 expression could be 
detected in our system.
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Figure 3.9 Expression of E4 protein and early terminal differentiation in HPV-16 raft cultures
To assess if E4 expression coincides with the onset of terminal differentiation, raft cultures sections 
of HPV-16-positive episomal cell lines were stained with the early differentiation marker K10 and 
an antibody against the HPV-16 protein E4. A section of HPV-16-positive cervical tissue previously 
stained with K13 and E4 antibody was used for comparison. All sections were counterstained with 
DAPI (blue) and were photographed at x20 magnification. The broken line on each raft culture 
indicates the basal layer. The Immunohistochemistry of the cervical tissue sections was previously 
carried out by Kate Middleton (NIMR, London, UK) and used with permission.
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3.2.10 Late HPV-16 gene expression coincides with late terminal 
differentiation
As we had just shown that late viral gene expression did not coincide with the 
early part of the terminal differentiation program, we wanted to investigate whether 
the epithelial regions of late terminal differentiation coincide with late viral 
expression. To identify regions of late differentiation and late viral gene expression 
we applied antibodies, to pro-filaggrin/filaggrin and E4, to sections of all seven 
HPV-16 raft cultures. As mentioned earlier pro-filaggrin and filaggrin are highly 
abundant within the granular layer, which immediately precedes cornification.
When comparing the granular layer in HPV infected tissues to HPV negative NIKS 
raft cultures, the virus did not appear to compromise the formation of this layer. In 
the HPV-16 raft culture system we detected a granular layer consisting of two to 
three layers of pro-filaggrin granules and processed filaggrin (Figure 3.10).
Most interestingly, E4 is first detected at the start of granular layer or within the 
granular layer. E4 positive cells could not be detected below the filaggrin layer. 
The same staining patterns could also be demonstrated in an HPV-16 induced 
cervical mucosal lesion. This overlap is typically not easily identified in cervical 
lesions, as filaggrin is not as abundantly expressed in mucosal epithelium, when 
compared to cutaneous epithelium.
In our system, filaggrin was not highly abundant in every E4 positive cell so we 
could not conclude that filaggrin itself was necessary for E4 expression or vice
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versa. It is however possible that the host cell environment during this stage of 
differentiation is necessary for late promoter activation and/or E4 accumulation.
These results highly suggest that E4 expression begins and/or E4 accumulates 
during late terminal differentiation, specifically in the granular layer. Secondly, it is 
possible that the formation of the granular layer is required for late viral events to 
occur.
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Figure 3.10 Expression of E4 protein and late terminal differentiation in HPV-16 raft cultures
To assess if late HPV-16 gene E4 expression correlates with late stages of cellular terminal 
differentiation, raft cultures sections of HPV-16-positive episomal cell lines were stained with 
antibodies against late terminal differentiation marker filaggrin and against E4 protein. A section of 
HPV-16-positive cervical tissue previously stained with filaggrin and E4 antibodies was used for 
comparison. All sections were counterstained with DAPI (blue) and were photographed at x20 
magnification. The broken line on each raft culture indicates the basal layer. The 
Immunohistochemistry of the cervical tissue sections was previously carried out by Kate Middleton 
(NIMR, London, UK) and used with permission.
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3.2.11 L1 capsid protein accumulates in the upper layers of E4 expressing 
cells
To complete a productive HPV life cycle L1 and L2 capsid proteins must be made 
and assembled into an intact capsid. Antibodies to L1 are primarily used to detect 
capsid protein in HPV induced lesions. L1 is a late transcript product, and is found 
in E4-positive cells of the cornified or superficial layers, of cutaneous or mucosal 
lesions respectively. L1 capsid protein has been also previously identified in first 
layer of E4 positive cells before the cornified layer. A temporal gap between the 
appearance of E4 and L1 is commonly detected in HPV lesions. It is possible that 
virus undergoes several rounds of genome amplification before L1 is expressed 
for virus packaging.
To assess where L1 capsid production occurred in our system, L1 and E4 
antibodies were applied to adjacent sections of HPV-16 raft cultures. A typical 
L1/E4 staining pattern is also shown in a HPV induced cervical lesion (Figure 
3.11). In our system L1 capsid was expressed in the upper layers of E4 cells 
(Figure 11). L1 was first detected in one or two E4 positive cells within the granular 
layer. However, most of the L1 capsid appeared to accumulate in E4 positive cells 
within the cornified or superficial layers.
There are still open questions regarding a possible role of E4 for L1 capsid 
assembly or infectivity. Current studies are evaluating if E4 enhances virions 
infectivity. (in personal communication with Pauline McIntosh, NIMR, London, UK). 
An alternative hypothesis is that E4 destabilizes cornified envelopes to allow for
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virus release.regions that carry these mature capsids. As HPV is not a lytic virus 
this would allow for their release from the epithelium.
In conclusion we have demonstrated that early and late HPV-16 gene expression 
patterns in our cutaneous raft culture system are highly similar to high-risk HPV 
gene expression in the cervix. For future life cycle studies we have established a 
model that represents the HPV-16 life cycle in cervical (mucosal) tissue.
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Figure 3.11 Expression of E4 protein and L1 capsid protein in HPV-16 raft cultures
To determine where L1 capsid protein accumulates within the virus life cycle, raft cultures sections 
of HPV-16-positive episomal cell lines were stained with antibodies against the L1 capsid protein 
and the E4 protein of HPV-16. A section of HPV-16 positive cervical tissue previously stained with 
antibodies against L1 capsid protein and E4 protein was used for comparison. All sections were 
counter-stained with DAPI (blue) and were photographed at x20 magnification. The broken line on 
each raft culture indicates the basal layer. The Immunohistochemistry of the cervical tissue section 
was previously carried out by Kate Middleton (NIMR, London, UK) and used with permission.
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3.3 Discussion
The NIKS organotypic raft model has been widely used to investigate the functions 
of various HPV genes within the HPV-16 life cycle. However the HPV-16 life cycle 
in this NIKS (cutaneous) raft system has not been directly compared to the HPV- 
16 life cycle in cervical (mucosal) epithelium. Recent work, which has extensively 
analyzed HPV-16 gene expression patterns in cervical lesions, has given the 
opportunity to compare the NIKS raft system to real-life cervical biopsy material 
(Peh, Middleton et al. 2002; Middleton, Peh et al. 2003). We have shown that the 
early and late viral gene expression patterns in HPV-16 induced cervical (mucosal) 
lesions are conserved in the NIKS (cutaneous) raft system.
To evaluate viral gene expression patterns in the NIKS raft system, we conducted 
a side-by side comparison with low-grade HPV induced cervical lesions. Cervical 
lesions had been previously stained with antibodies specific for the E7 surrogate 
marker MCM-7 and the late viral genes, E4 and L1. Prior to this comparison we 
were able to confirm that MCM-7 was indeed a surrogate marker of E7 in the NIKS 
HPV-16 raft system. Only HPV-16 cell lines that expressed the E7 gene could 
produce MCM-7 positive cells above the basal layer, in raft culture. Although we 
were confident that the MCM-7 expression was a consequence of E7 expression 
only, for future studies, it will be important to find a good antibody that will 
specifically identify E7 proteins in these cells.
In direct comparison to cervical lesions, we were also able to confirm that the 
MCM-7 compartment was extended above the basal layer in raft cultures of HPV- 
16 episomal cell lines. In both the cervical and raft culture epithelium the extended
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MCM-7 compartment was also maintained until a finite point in the epithelium, 
which likely identifies the end of early gene expression. It is currently not known as 
to where in the epithelium the early promoter is repressed, however one can 
speculate that the end of MCM-7 compartment marks the end of early gene 
expression in the epithelium. One possibility is that the early promoter is repressed 
by E2 in the upper layers. In addition to its role in viral DNA replication it has been 
shown that E2 also regulates transcription from the early p97 promoter (Tan, 
Leong et al. 1994). E2 is up-regulated by the differentiation dependent late 
promoter in the upper layers of the epithelium, in order to carry out viral 
amplification. It was also previously shown that high levels of E2 could specifically 
suppress E7 expression(Steger and Corbach 1997).
In both HPV induced cervical lesions and HPV-16 raft cultures we were able to 
show that the end of the MCM-7 compartment also coincided with the first 
identification of late E4 gene expression. In both cervical lesions and HPV-16 raft 
cultures the E4 protein was identified in the last layer of MCM-7/S-phase 
competent cells. As stated earlier It has been suggested that the overlap of S- 
phase competent cells and E4 is important for the start of viral amplification 
(Flores, Allen-Hoffmann et al. 2000; Peh, Middleton et al. 2002; Nakahara, Peh et 
al. 2005).
Similar to what was found in HPV-16 cervical lesions, amplified HPV-16 genomes 
were only detected in E4 positive cells and commenced in the first layer of E4 
positive cells. Although we could not perform a double-stain of MCM-7 it was 
highly plausible that MCM-7 were also expressed in the first layer of cells that 
contained E4 and amplified genomes. In both HPV-16 raft cultures and HPV-16
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cervical epithelium amplified genomes were also detected in E4 positive cells 
throughout the remainder of the upper layers.
Interestingly, late E4 expression also closely coincided with late terminal 
differentiation in the raft epithelium. The majority of E4 positive cells were localized 
in the granular layer in HPV-16 raft cultures. The granular layer was specifically 
marked by the presence of pro-filaggrin granules and cross-linked forms of 
filaggrin. One possibility is that the late promoter is upregualted specifically in this 
layer or cellular splice factors that generate late mRNAs (e.g. E4, L1) are more 
abundant in this layer.
Another possibility is that the granular layer is favorable for E4 accumulation. In 
the granular layer pro-filaggrin is processed into filaggrin by calpain cleavage 
(Presland, Kimball et al. 1997). E4 accumulates in cells following cleavage of its 
N-terminal domain. N-terminal cleavage of E4 is also carried out by calpain (in 
personal communication with Jameela Khan, NIMR, UK). It is possible that calpain 
is up-regulated in these cells during pro-filaggrin processing which is also 
favorable for the N-terminal cleavage of E4.
We were also able to identify several cervical lesions that expressed E4 only in 
filaggrin positive cells. Filaggrin is less abundant in cervical (mucosal) lesions, 
which has made this comparison more difficult. Additional analysis of cervical 
lesions will have to be completed before we can generally conclude that in both 
cervical (mucosal) and cutaneous lesions, E4 is expressed in cells that have 
entered late differentiation. It will perhaps be more beneficial to compare the NIKS
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rafts to a more keratinizing epithelium (e.g. vulval epithelium), which contains 
higher levels of filaggrin.
Finally, we had identified that the productive phase of the life cycle was near 
completion in the HPV-16 raft culture. In both HPV-16 raft cultures and cervical 
lesion L1 proteins were expressed in upper layers of E4 positive cells. In addition 
to the identification of capsid proteins it has also been shown that virus capsids 
can be harvested from raft cultures of several of these HPV-16 cell lines, (in 
personal communication with Kenneth Raj, NIMR, London, UK).
Table 3.1 contains a summary of HPV-16 raft culture characteristics.
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Table 3.1 HPV-16 raft culture characteristics
HPV-16 clone 2K 3K 4K 4Q 5K 9Q 13Q
Passage number 4-6 5 4-6 4-6 5 5 5
* MCM-7 above 
basal layer
Yes Yes Yes Yes Yes Yes Yes
* E4 protein Yes Yes Yes Yes Yes Yes Yes
* MCM-7/E4 
overlap
Yes Yes Yes Yes Yes Yes Yes
* Viral DNA 
amplification
Yes Yes NT NT NT NT NT
* L1 protein Yes Yes Yes Yes Yes Yes Yes
* Timing of K10 
expression
N N N N N N N
* Timing of 
filaggrin 
expression
N N N N N N N
Number of times 
rafted/observed
3 1 3 3 1 1 1
Key for Table 3.1
*= Viral or cellular protein expression/ viral DNA amplification in the HPV-16 NIKS raft 
epithelium is similar to HPV-16 positive cervical epithelium 
NT=Not tested
N=Normal when compared to H PV negative NIKS raft culture
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4.0 A raft based model of HPV-16 induced neoplasia
4.1 Introduction
In Chapter 3 we were able to show that the organization of early and late HPV 
gene expression in our cutaneous HPV-16 raft system is similar to a productive 
HPV-16 life cycle in HPV infected cervical (mucosal) tissue. Within the HPV 
disease spectrum these productive HPV-16 raft cultures also represent a 
pathologically low-grade HPV infection.
High-risk HPV types such as HPV-16 can cause a spectrum of precancerous 
dysplastic and neoplastic changes in the epithelium. Dysplasia refers to a 
decrease in cellular maturation like cytoplasmic maturation or cellular stratification 
and typically coincides with early stages of neoplasia. Neoplasia refers to the 
abnormal proliferation of cells, which can lead to tumor development and precedes 
cancer formation. Pathologists use a diagnostic grading scale to classify the extent 
of neoplastic changes in a lesion. Low-grade lesions that exhibit mild dysplasia in 
the bottom third of the epithelium are categorized as LSIL. High-grade lesions that 
exhibit moderate dysplasia to severe dysplasia throughout the middle third and 
upper third of the epithelium are categorized as HSIL (Diane Solomon 2004). Both 
LSIL and HSIL can be found in HPV-16-infected cutaneous and mucosal sites of 
the anogenital tract, which include the cervix, vulva, anus and penis. It is also not 
uncommon to find both LSIL and HSIL in the same lesion (in personal 
communication with Heather Griffin, NIMR, UK).
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Beyond a pathological diagnosis, recent studies have correlated an alteration in 
early and late HPV gene expression with increasing neoplastic grades (Freeman, 
Morris et al. 1999; Middleton, Peh et al. 2003). Collectively these studies have 
identified that the number of layers that contain MCM-7 positive cells increases 
with advanced neoplastic changes in the epithelium. In addition, the increase of 
the S-phase compartment also coincided with a delay in E4 expression and L1 
capsid within the upper layers (Middleton, Peh et al. 2003). Additionally, a high 
percentage of these high-grade lesions were associated with an incomplete HPV 
life cycle.
These studies led us to collectively evaluate the gene expression patterns and 
pathology of all ten of our NIKS HPV-16 raft cultures including the raft cultures that 
did not produce L1 capsid protein within the epithelium. This chapter will aim to 
show that the cutaneous NIKS HPV-16 episomal cell line model can represent a 
low-grade productive infection, but can also model the broader spectrum of HPV 
induced neoplasias. This is a presentation of the first known laboratory model of 
episomal HPV-16 induced neoplasia.
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4.2 Results
4.2.3 Raft cultures of HPV-16 cell lines demonstrate three distinct patterns of 
MCM-7 expression
It was evident from our earlier life cycle validation panel that three out of ten 
differentiated HPV-16 episomal cell lines either produced only minimal amounts of 
L1 capsid protein or that L1 capsid protein was completely absent. The other 
seven of the raft cultures sections however produced abundant L1 capsid protein.
Middleton et al. (2003) had previously shown that the loss of L1 capsid in high- 
grade cervical lesions correlated with the persistence of the E7 surrogate marker, 
MCM-7, throughout the epithelial layers. We therefore proceeded to evaluate if 
any alterations in early and late viral gene expression in our system correlated with 
the loss of L1 capsids. To evaluate viral gene expression patterns we applied a 
panel of MCM-7, HPV-16 E4 and HPV-16 L1 capsid antibodies to raft culture 
sections of all ten HPV-16 episomal cell lines. We first applied an MCM-7 antibody 
to evaluate the early part of the viral life cycle (Figure 4.1). Interestingly, we could 
distinguish three distinct MCM-7 staining patterns in the ten HPV-16 raft culture 
sections. Each differentiated HPV-16 cell line showed reproducibly only one of 
these patterns throughout the majority of the raft culture sections. The observed 
MCM-7 expression patterns can be divided into three categories that we refer to 
as A, B and C.
Pattern A was found in raft culture 4K (Figure 4.1). In this pattern only a few 
positive MCM-7 cells could be detected in the basal layer. MCM-7-positive cells 
were only sporadic in the first several layers above the basal compartment and
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clearly absent from the upper layers. Pattern B was detected in the majority of the 
raft cultures (2K, 3K, 4Q, 5K, 9Q and 13Q). In raft sections with this pattern, MCM- 
7 was detected in all cells within the basal compartment and in the majority of cells 
within the next two to three spinous layers. There was no sporadic distribution of 
MCM-7-positive cells as seen with pattern A, and the cells in the upper layers did 
not contain MCM-7. Interestingly, we recognized that the raft cultures with patterns 
A and B are the seven raft cultures from Chapter 3 that contained productive life 
cycles (Figure 3.4)
In raft cultures with pattern C, a greater number of layers contained MCM-7 
positive cells. MCM-7-positive cells persisted throughout the entire epithelium and 
only a few sporadic MCM-7-negative cells were detected in the top layer. 
Interestingly raft cultures with pattern C represent the remaining three raft cultures 
from the original panel (1K, 6K and 6Q) that did not produce L1 capsid protein.
This led us to conclude that upon differentiation, individual early passage HPV-16 
episomal cell lines could produce different phenotypes with respect to the degree 
of S-phase persistence in the epithelium. In addition, raft cultures with a less 
persistent S-phase compartment correlated with the presence of L1 capsid 
proteins whereas raft cultures with highly persistent S-phase compartments 
correlated with the loss of L1 capsid proteins.
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Figure 4.1 Three distinct patterns of MCM-7 expression in HPV-16 raft cultures
Sections of raft cultures from ten HPV-16 episomal cell lines were stained for MCM-7 protein (red) 
to identify the S-phase compartment and counterstained with DAPI (blue). The broken white line 
indicates the basal layer. Three distinct patterns of MCM-7 expression could be distinguished in 
these cell lines. Pattern A was identified in raft culture 4K and is characterized by the predominant 
absence of MCM-7 positive nuclei from the basal compartment and only sporadic presence in the 
second and third layers. Also, MCM-7 positive nuclei are absent from the upper layers. Pattern B 
was identified in raft cultures 2K, 3K, 4Q, 5K, 9Q and 13Q. In these raft cultures, MCM-7-positive 
cells are uniformly distributed but are only present in the first several layers of the epithelium and 
absent from the upper layers. Pattern C was found in raft cultures 1K, 6K and 6Q. In pattern C raft 
cultures, MCM-7-positive cells are contained in greater numbers and MCM-7 expression persists 
throughout the entire epithelium.
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4.2.4 The persistence of MCM-7 in the upper layers of HPV-16 raft cultures 
correlates with a delay in late gene expression and an incomplete life cycle
After we found that expression of late gene E7 surrogate marker MCM-7 could 
persist in several of the raft cultures, we were curious to see if the onset of late E4 
gene expression was also delayed. To evaluate this we applied an E4 antibody 
onto all ten raft culture sections that we had previously stained with MCM-7 
(Figure 4.2). We observed that in fact E4 expression was dramatically delayed in 
the three raft culture epithelia with a persistent S-phase compartment (pattern C). 
In addition, E4 protein was only sporadically detected in the last layer of MCM-7 
positive cells. In contrast, and as previously observed in Chapter 3, we detected 
an earlier onset of E4 expression in raft cultures with patterns A and B, which 
contained less persistent S-phase compartments. In these rafts E4 was also 
expressed at high levels throughout the remaining layers.
Next, we wanted to evaluate the timing of the expression of both late genes E4 
and L1. To assess this we applied an E4 antibody to all ten raft culture sections 
previously stained with an L1 capsid antibody (Figure 4.3). In the HPV-16 raft 
culture epithelium with pattern A, E4 and L1 were both first detected in the lower 
third of the epithelium. L1 capsid protein could be mostly found in E4-positive cells 
within the last several layers of the epithelium. In all raft cultures with pattern B the 
first appearance of E4 and L1 expression was delayed when compared to pattern 
A. However we detected L1 capsid in E4-positive cells within the final few layers. 
Finally in the raft cultures with pattern C, we detected an extreme delay in E4 
expression. L1 capsid was rarely detected or was completely absent.
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Figure 4.2 Onset of late E4 protein expression in HPV-16 raft cultures
Sections of raft cultures from ten HPV-16 episomal cell lines were stained for MCM-7 protein (red) 
and E4 (green, #248) to detect early and late HPV-16 gene expression in the epithelium. DAPI 
was applied as a nuclear counterstain (blue). The broken white line indicates the basal layer. An 
early onset of E4 expression is evident in raft culture 4K which contains a sporadic MCM-7 
compartment (pattern A) and E4 remains highly abundant throughout the upper layers. In raft 
cultures with a uniform yet less persistent MCM-7 compartment (pattern B), E4 expression is in 
some cases slightly delayed compared to pattern A, but E4 is highly abundant throughout the 
upper layers. In raft cultures with a highly persistent MCM-7 compartment (pattern C) E4 
expression is delayed until the last two cell layers and is only detected in sporadic MCM-7-positive 
cells.
117
Chapter 4 -  Results
As previously found in HPV-induced cervical lesions, the MCM-7, E4 and L1 gene 
expression patterns in the HPV16 raft cultures highly suggest that the level of S- 
phase persistence in the NIKS epithelium, has an impact on the timing of late gene 
expression in the upper layers. This also proposes that persistent early gene 
expression is less favorable for the virus to complete its life cycle and can 
consequently lead to high-grade neoplasia.
From these results we concluded that our HPV-16 raft culture model could 
possibly recapitulate the spectrum of viral gene expression patterns that are 
present in both low (LSIL) and high-grade (HSIL) HPV-induced neoplasia.
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Figure 4.3 Onset of late L1 capsid protein expression in HPV-16 raft cultures
Sections of raft cultures from ten HPV-16 episomal cell lines were stained for L1 capsid protein 
(red) and E4 (green, #248) to detect late gene expression in the epithelium. DAPI was applied as 
a nuclear counterstain (blue). The broken white line indicates the basal layer. In raft culture 4K 
(pattern A) L1 capsid protein is detected early in the epithelium (magnified section from lower layer) 
in E4-positive cells and is detected throughout the cornified layers. In pattern B raft cultures (2K, 
3K, 4Q, 5K, 9Q and 13Q), L1 capsid protein is also first detected in the first layer of E4 positive 
cells and remains highly abundant throughout the cornified layers. In pattern C raft cultures (1K, 6K 
and 6Q) E4 expression is delayed and L1 capsid protein can not be detected at all.
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4.2.5 Raft cultures of early passage HPV-16 episomal cell lines mimic HPV 
induced LSIL and HSIL
So far we have established that MCM-7, E4 and L1 staining patterns in the NIKS 
HPV-16 raft system were reminiscent of HPV cutaneous and mucosal lesions with 
pathologically diagnosed LSIL and HSIL. Therefore, we attempted a side-by-side 
comparison between HPV-16 raft culture sections and sections of biopsied 
cutaneous and cervical (mucosal) lesions with MCM-7, E4 and L1 capsid as 
markers.
Pattern A can not be found in low-grade HPV-16 cervical lesions however it is 
commonly found in low-grade mucosal lesions infected with low-risk HPV types, 
such as HPV-11. Figure 4.4 shows the similarities in MCM-7 and E4 patterns 
between a low-grade HPV-11 mucosal lesion and raft culture 4K. These 
similarities include a sporadic S-phase compartment starting within the basal layer 
and a high abundance of E4 throughout the upper layers of the epithelium.
Pattern B raft cultures resemble the MCM-7 and E4 staining patterns of a typical 
HPV-16 cervical lesion with LSIL. In these HPV-16 low-grade lesions, MCM-7- 
positive cells are uniformly distributed in the first third of the epithelium. E4 
expression is also highly abundant in the upper layers of the epithelium.
Pattern C raft cultures resemble the MCM-7/E4 staining pattern of a typical HPV- 
16 cervical lesion with HSIL. MCM-7-positive cells extend through the middle-third 
and final-third of the epithelium. Expression of E4 is delayed compared to the
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other patterns and is only present in a subset of MCM-7 positive cells in the 
uppermost layers.
In Figure 4.5, the equivalent grades of cutaneous or cervical lesions are also 
comparable with the respective E4 and L1 staining patterns of the observed raft 
culture patterns. Low-grade (LSIL) HPV-1 cutaneous lesion and pattern A raft 
culture 4K both contain high levels of L1 capsid protein. In addition L1 capsid is 
detected early in the first several layers of the epithelium, which coincides, with the 
early onset of E4 expression. LSIL HPV-16 cervical lesions and raft cultures with 
pattern B also contain L1 capsid. However, late gene expression is slightly 
delayed compared to that of pattern A, and E4 and L1 capsid are starting to 
appear in the second-third of the epithelium. In HSIL HPV-16 cervical lesions and 
raft cultures with pattern C, late gene expression is delayed until the final third of 
the epithelium. Just like in Figure 4.4 this appears to confine E4 expression to the 
uppermost layers, while L1 capsid protein is reduced in the cervical lesion and 
seems to be completely absent from the raft cultures 1K and 6K.
We conclude that the spectrum of viral gene expression patterns observed in our 
HPV-16 raft culture system, is similar to those found in HPV-induced cervical 
lesions of LSIL and HSIL pathological grades. We have also found low-grade 
phenotypes that are commonly found in cutaneous lesions infected with low-risk 
HPV types. It is quite possible that these phenotypes exist in HPV-16- infected 
cervical lesions however due to their less neoplastic pathology, they are not 
frequently biopsied for analysis. This emphasizes that this system could potentially 
present intermediate phenotypes of the virus that we would not normally find in 
available biopsy material.
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In order to continue with the evaluation of our model we have chosen three HPV- 
16 cell lines of both LSIL and HSIL phenotypes. In this thesis these cell lines are 
from now on grouped and named as LSIL phenotypes (cell lines 4K, 2K and 4Q) 
or HSIL phenotpyes (cell lines 1K, 6K, 6Q).
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Figure 4.4 Comparison of MCM-7 and E4 expression between HPV-16 raft cultures and HPV- 
induced lesions with LSIL and HSIL.
Raft cultures sections of HPV-16-positive episomal cell lines and HPV induced lesions were 
stained against MCM-7 (red) and E4 (green, #248). DAPI was applied as a nuclear counterstain 
(blue). The broken white line indicates the basal layer. Pattern A raft culture resembles a 
pathologically diagnosed low-grade (LSIL) mucosal lesion infected with HPV-11. In both epithelia 
MCM-7 expression is less prominent in the basal layer, which correlates with high levels of E4 
expression in the upper layers. Pattern B raft cultures resemble a pathologically diagnosed cervical 
lesion with LSIL. MCM-7 expression is more uniform and the S-phase compartment ends in the 
first to middle-third of the epithelium. This correlates with high levels of E4 expression in the upper 
layers. Pattern C raft cultures resemble high-grade cervical lesion (HSIL), where MCM-7 persists 
through the entire epithelium and E4 expression is delayed until the top layer.
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Figure 4.5 Comparison of L1 capsid protein and E4 expression between HPV-16 raft cultures 
and HPV-induced lesions with LSIL and HSIL.
Raft cultures sections of HPV-16-positive episomal cell lines and HPV-induced cervical lesions 
were stained against L1 capsid protein (red) and E4 (green, #248). DAPI was applied as a nuclear 
counterstain (blue). The broken white line indicates the basal layer. Pattern A resembles a low- 
grade (HSIL) cutaneous lesion infected with HPV-1. In this case L1 capsid protein is detected in 
E4- positive cells in the first third of the epithelium and in clusters throughout the upper layers. 
Pattern B raft cultures resemble a low-grade HPV-16 cervical lesion with LSIL. L1 capsid protein is 
detected in the middle to final third of the epithelium and is detected in clusters in the upper layers. 
In Pattern C raft cultures, E4 expression is delayed, which results in low levels of L1 capsid protein 
or it is completely absent from the epithelium
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4.2.7 LSIL-like and HSIL-like phenotypes are reproducible in HPV-16 raft 
cultures with respect to MCM-7, E4 and L1 capsid expression.
We next wanted to show that the early and late HPV gene expression patterns 
were reproducible in independent raft culture experiments. To show their 
reproducibility, all six LSIL and HSIL cell lines were differentiated for 14 days to 
create two replicate raft cultures each (raft culture 1 and 2). Each HPV-16 cell line 
was differentiated at a similar early passage (passage four-six) as the first set of 
raft cultures. To quantify and compare replicate raft cultures of each cell line, the 
same combinations of either MCM-7 and E4 or E4 and L1 antibodies were applied 
as before (Figure 4.6). Three typical regions of equal measured size from each 
independent raft culture, were selected for counting. In order to quantify the S- 
phase compartment we counted the total number of MCM-7-positive cells from the 
basal layer to the top layer.
The mean of MCM-7 positive cells from three sections for each replicate raft 
culture was calculated, and the bar chart shows the mean of the means of both 
replicate rafts (Figure 4.6B). The error bars represent +/- the standard deviation 
between the two replicate raft cultures (Figure 4.6). Although we found that there 
was more variation in the number of cells that contained MCM-7 above the basal 
layer in the HSIL-like replicates, they consistently contain approximately twice as 
many MCM-7 cells above the basal compartment than the LSIL-like raft cultures. It 
was also apparent that the timing of E4 expression in the epithelium coincided with 
the end of the S-phase compartment in all six raft cultures. We noted that the two 
extreme phenotypes with respect to MCM-7 persistence expression were that of 
4K (LSIL) with very low and 6K (HSIL) with very high persistence.
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Figure 4.6 Reproducibility of early and late gene expression in HPV-16 raft cultures with 
LSIL and HSIL phenotype.
(A) Each three HPV-16-positive episomal cell lines with either the LSIL or HSIL phenotype were 
differentiated for 14 days to produce two replicate raft cultures (raft 1 and 2), respectively. Raft 
culture sections were stained against HPV-16 E7 surrogate marker MCM-7 (red) and HPV-16 E4 
(green, #248) to observe early and late viral gene expression, respectively. DAPI was applied as a 
nuclear counterstain (blue). The broken white line indicates the basal layer. (B) In three separate 
sections from the raft cultures shown in (A) the number of MCM-7 positive cells above the basal 
layer was counted. The mean of MCM-7 positive cells for the three sections for each raft culture 
was calculated, and the bar chart shows the mean of the means of the replicate rafts. The error 
bars represent +/- the standard deviation between the two replicate raft cultures
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We also evaluated the reproducibility of L1 capsid protein abundance and virus 
productivity in replicate raft cultures (Figure 4.7). The mean of L1-positive cells of 
three sections for each raft culture was calculated, and the bar chart shows the 
mean of the means. The error bars represent +/- the standard deviation between 
the two replicate raft cultures (Figure 4.7B). The bar graph demonstrates that LSIL 
raft cultures on average contain much more L1 -positive cells compared to HSIL- 
like raft cultures. We detected great variation in the number of L1 -positive cells in 
raft culture 4Q. L1-positive cells are usually formed in the cornified layer and 
therefore we thought this inconsistency was potentially due to a variation in the 
degree of cornification at the top of the raft. We also detected L1-positive cells in 
HSIL raft culture 6Q but these were confined to sporadic pockets of E4-positive 
cells in the upper layers. It is worth mentioning that it is not untypical to find 
sporadic L1-positive cells in high-grade cervical lesions.
It was also interesting that we consistently identified raft cultures 4K (LSIL) and 6K 
(LSIL) as the two extremes with respect to both MCM-7 and L1 capsid abundance. 
This further suggests that the regulation of early oncogenes and/or the levels of 
early oncogenes in the epithelium can mark the region where late genes are 
expressed. From there we can conclude that the phenotypes presented in our 
HPV-16 episomal cell lines are reproducible with respect to their viral gene 
expression patterns. We are further able to consistently distinguish LSIL raft 
cultures from HSIL raft cultures based on observed differences in S-phase 
persistence and production of L1 capsid protein. This renders them valuable tools 
for future studies of HPV-induced neoplasia.
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Figure 4.7 Reproducibility of L1 capsid expression in HPV-16 raft cultures with LSIL and 
HSIL phenotype.
(A) Each three HPV-16-positive episomal cell lines with either the LSIL or HSIL phenotype were 
differentiated for 14 days to produce two replicate raft cultures (raft 1 and 2), respectively. Raft 
culture sections were stained against HPV-16 L1 capsid protein (red) and HPV-16 E4 (green, 
#248). DAPI was applied as a nuclear counterstain (blue). The broken white line indicates the 
basal layer.
(B) In three separate sections from the raft cultures shown in (A) the number of MCM-7 positive 
cells above the basal layer was counted. The mean of MCM-7 positive cells for the three sections 
for each raft culture was calculated, and the bar chart shows the mean of the means of the 
replicate rafts. The error bars represent +/- the standard deviation between the two replicate raft 
cultures.
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4.2.8 Early and late terminal differentiation is delayed in HSIL raft cultures
In HPV-16 raft cultures with detectable levels of L1 capsid protein expression 
(LSIL raft cultures) we have previously shown that early and late terminal 
differentiation followed a normal pattern of progression within the epithelium. We 
were also able to show that late E4 expression coincided with late terminal 
differentiation in the epithelium, specifically within the cells of the granular layer.
Previous studies have shown that the overexpression of the viral oncogenes E6 
and E7 can affect the early and late stages of the cellular differentiation program. 
A delay or reduction in keratin expression and granular layer formation has also 
been correlated with high-grade HPV lesions, which do not support a complete 
HPV life cycle. We therefore wanted to evaluate if a delay in the terminal 
differentiation program occurred in the HSIL raft cultures. Secondly we wanted to 
evaluate if the delay in E4 and L1 expression was due to alterations in the terminal 
differentiation program.
To evaluate the early and late stages of the differentiation program in the HPV-16 
raft cultures we applied keratin K10 and filaggrin antibodies to all six LSIL- or 
HSIL-raft cultures. In order to detect late viral gene expression, we stained for E4 
protein expression. When we looked first at early stages of differentiation we found 
that HSIL-like raft cultures showed marked differences in the timing of K10 
expression when compared to LSIL-like raft cultures. (Figure 4.8). In contrast to 
LSIL raft cultures where K10 expression commences just above the basal layer we 
detected a delayed K10 expression in HSIL raft cultures 1K and 6Q two to three 
cell layers above the basal compartment. In raft culture 6K we detected an even
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more dramatic delay in early terminal differentiation, where K10 was first detected 
in the middle-third of the epithelium.
The onset of late terminal differentiation was also delayed in all HSIL raft cultures 
when compared to LSIL raft cultures (Figure 4.9). In HSIL raft cultures 6K and 6Q 
we detected a dramatic delay in filaggrin expression and a reduction of the overall 
size of the granular layer indicated by the amount of filaggrin positive cells. 
Although the granular layer in HSIL raft culture 1K was more extensive than in the 
other two HSIL raft cultures 6K and 6Q, similarly filaggrin was not detected until 
the final third of the epithelium.
CO
4K  2K  4Q
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Figure 4.8. Early terminal differentiation in HPV-16 raft cultures with LSIL and HSIL 
phenotype.
To detect regions of early terminal differentiation in the epithelium sections of HPV-16 raft cultures 
with LSIL and HSIL phenotype, they were stained with an antibody against the early differentiation 
marker keratin K10. DAPI was applied as a nuclear counterstain (blue). The broken white line 
indicates the basal layer. K10 expression seemed to be overall delayed in raft cultures with HSIL 
phenotype compared to raft cultures with LSIL.
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Figure 4.9. E4 expression and late terminal differentiation in HPV-16 raft cultures with LSIL 
and HSIL phenotypes
To detect regions of late differentiation in the epithelium, sections of HPV-16 raft cultures with LSIL 
and HSIL phenotypes were stained with antibodies against filaggrin (red) and late HPV-16 gene E4 
(green, #248). DAPI was applied as a nuclear counterstain (blue). The broken white line indicates 
the basal layer. The white arrow in raft culture 1K identifies an E4 positive cell. The delay of late 
gene E4 expression in HSIL raft cultures seems to coincide with delayed filaggrin expression and 
late terminal differentiation
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A delay in the formation of the granular layer also coincided with a delay in late E4 
expression, as E4-positive cells were only first detected in this layer. We could 
however not correlate E4 abundance with the level of granular formation as HSIL 
raft culture 1K did not contain a higher level of E4-positive cells. This once again 
might suggest that the granular layer environment is favorable for E4 accumulation 
but it is unlikely that formation of the granular layer determines if the switch from 
the early to late gene expression will occur in this region.
We can conclude that in all HSIL raft cultures the terminal differentiation program 
is delayed compared to LSIL raft cultures that contain detectable numbers of L1- 
positive cells. We can also conclude that late viral gene expression is delayed and 
coincides with the onset of late cellular terminal differentiation in the epithelium. At 
this point however we cannot explain why the extent of the delay in terminal 
differentiation is different amongst the three HSIL like raft cultures. It is possible 
that alteration in the differentiation program are also linked to other viral induced 
pathological changes.
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4.2.9 LSIL-like and HSIL-like HPV-16 raft cultures also contain pathological 
features of LSIL and HSIL
So far the identified phenotypic similarities between our system and low and high- 
grade cervical lesions are based on the viral gene expression patterns. However, 
the identification of LSIL and HSIL in medical screening programs is based 
primarily on a pathological diagnosis.
In lesions with LSIL, pathological changes are confined to the first third of the 
epithelium, whereas in lesions with HSIL, pathological changes are extended to 
the middle and final-third of the epithelium. The pathological changes of LSIL and 
HSIL include varying degrees of a) cellular hyperplasia (i.e. abnormal 
proliferation), b) cellular dysplasia (i.e. lack of squamous maturation), c) the lack of 
cellular polarity and d) pleomorphic nuclei which vary in size and shape.
We wanted to identify if pathological changes that occur in low and high-grade 
cervical lesions also occur in a similar fashion in the epithelium of our HPV-16 
NIKS. To evaluate this, sections of HPV-16 raft cultures including the HPV- 
negative NIKS were stained with hematoxylin and eosin (H&E). This stain allowed 
us to visualize the described morphologies of the nucleus and cytoplasm within 
each epithelial layer.
It was first important to visualize the morphology of HPV-negative NIKS epithelium 
in order to show that pathological changes were not present in the absence of the 
virus. In raft cultures of HPV-negative NIKS, one or two layers of uniformly shaped 
nuclei could be seen in the basal compartment (Figure 4.10) and there was no
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evidence of dysplasia. Similar to what is known about normal cervical and 
cutaneous tissues, nuclear abnormalities were not present above the basal 
compartment and normal squamous maturation and stratification also occurred 
above the basal compartment. Squamous maturation was also accompanied by a 
process of nuclear degeneration, which eventually presented as small uniform 
pycnotic1 nuclei in the cornified layer. We therefore confirmed that no neoplastic 
changes were already evident in the HPV-negative NIKS epithelium.
In order to compare this to tissue with HPV-induced neoplasia, Figure 4.10 
contains a cervical lesion with typical features of LSIL. In this lesion hyperplasia is 
evident in the first several layers, where cells fail to mature and seem to extend 
the basal layer. Their nuclei are pleomorphic and enlarged, which results in a high 
nuclear to cytoplasmic ratio. The cells in this region are also disordered and 
display a lack of polarity. In the middle of the epithelium, squamous maturation 
occurs and the cells become less dysplastic. This is accompanied by the presence 
of koilocytes, which are cells that represent a cytopathic effect of HPV viruses. 
Koilocytes typically contain darkened hyperchromatic nuclei, which is 
accompanied by a clearing of the cytoplasm. In the uppermost layer of this lesion 
then small pycnotic nuclei appear indicating the degeneration of nuclei.
We compared this lesion to the LSIL raft 4K and found that in addition to its LSIL- 
like viral gene expression patterns it also displays pathological features of LSIL. 
Similar to the cervical lesions with LSIL we found atypical nuclei in LSIL raft 4K to 
be confined to the first third of the epithelium. The first several layers include 
enlarged pleomorphic nuclei and a loss of cellular polarity is also evident in these
1 The irreversible condensation of chromatin in the nucleus of a cell undergoing 
programmed cell death or necrosis
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layers. The cells become less dysplastic above these layers, which is evident by 
squamous maturation presented as elongated cells in the middle-third of the 
epithelium. Koilocytes were however not as easily detectable in the raft culture 
sections. Nuclei were also less pronounced in the upper layers of raft 4K and 
which presents as pycnotic nuclei within the cornified layers. It should be noted 
that the cornified layers, which are only contained in cutaneous tissues, were 
extensive in this raft culture. This level of cornification suggested that the 
differentiation process began early on in the rafting process. In real life cutaneous 
tissue this layer would normally slough off when it is replaced by new cells, 
whereas in raft cultures this layer accumulates throughout the differentiation 
process.
We can now compare this to the pathology of cervical lesions and raft lesions with 
HSIL. In the cervical lesion with HSIL, increased hyperplasia is represented in 
more tightly packed layers of cells, which persists throughout the second to final 
third of the epithelium. The nuclei in all of these layers are pleomorphic and 
display a high nuclear to cytoplasmic ratio. The cells remain dysplastic until the 
final third of the epithelium where squamous maturation develops. Koilocytes are 
confined to the final third of the epithelium.
Similar to the HSIL cervical lesions with, HSIL raft culture 6K presented with an 
increase in tightly packed layers of pleomorphic nuclei, which extend throughout 
the first and second third of the epithelium. An extensive loss in cellular polarity is 
also evident starting from the basal compartment and persists throughout the 
epithelium. Squamous maturation did not occur until the last third of the 
epithelium. The cornified layer was less extensive which suggests that late
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terminal differentiation was delayed and/or reduced in this epithelium relative to 
cell line 4K. We had previously identified that granular formation (late 
differentiation) in HSIL raft culture 6K is delayed and reduced in size when 
compared to LSIL raft culture 4K.
It is recognized that there are some variations between cutaneous and 
cervical/mucosal tissue and perhaps a more keratinizing tissue such as vaginal 
tissue could serve as a better comparison. However, we have shown that overall 
in this NIKS HPV-16 raft system we can correlate LSIL-like and HSIL-like viral 
gene expression patterns with their respective pathological grades.
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Figure 4.10. Pathology of HPV-16 raft cultures with LSIL and HSIL phenotypes
Hematoxylin and eosin (H&E) were applied to raft culture sections of HPV-negative NIKS, HPV-16 
raft culture 4K (LSIL) and HPV-16 raft culture 6K (HSIL)(For comparison H&E stained cervical 
sections of both LSIL and HSIL grades were taken from Branca, Ciotti et al. 2004.). HPV-negative 
NIKS display a normal pathology with small uniform sized nuclei in the basal compartment (MS). 
Normal stratification and cytoplasmic maturation occurs in the upper layers. This is accompanied 
by the degeneration of cellular nuclei, which are presented as small uniform pycnotic nuclei in the 
upper cornified layers (CL). Koilocytes are indicated by black arrows Both the LSIL cervical lesion 
and LSIL raft culture 4K displays a mild dysplasia (DC) in the first third of the epithelium. The nuclei 
are pleomorphic and a loss of cellular polarity is contained in this region. Normal stratification and 
cellular maturation occur in the middle and final-third of the epithelium. Small pycnotic nuclei are 
also present in the superficial and cornified layers (CL). The HSIL cervical lesion and HSIL raft 
culture 6K both display tightly packed basal-like cells, which extend through the final third of the 
epithelium. A loss in cellular polarity is evident throughout the first and middle-third of the 
epithelium. Cellular maturation is not evident until the upper two layers.
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4.2.10 p16 expression can be detected in cells in the upper layers of HSIL- 
like raft cultures but not in the upper layers of LSIL-like raft cultures
As mentioned before the identification of LSIL and HSIL phenotypes in cutaneous 
and cervical tissues relies heavily on a pathological diagnosis. However, the 
diagnoses are sometimes confounded by additional processes in the epithelium, 
such as inflammation. Due to these confounding factors many pathologists have 
adopted the use of a cellular marker in conjunction with the pathology, to diagnose 
the degree of neoplasia. The CDK4/CDK6 inhibitor, p16, has been shown to be a 
reliable diagnostic marker due to its accumulation in HPV-infected tissue (Klaes, 
Friedrich et al. 2001).
In normal tissue p16 prevents the phosphorylation of the Rb protein. The inhibition 
of Rb protein phosphorylation prevents entry in to the G1 phase of the cell cycle 
(Serrano, Hannon et al. 1993). A negative feedback loop through hypo- 
phosphorylated Rb then reduces p16 levels in order to allow for another around of 
proliferation to begin. During an HPV-16 infection the viral E7 oncogene degrades 
hypophosphorylated forms of the Rb protein and therefore p16 can accumulate in 
the cell (Li, Nichols et al. 1994). This suggests that p16 could be used as a marker 
of Rb protein degradation in the epithelium. It is important to mention that the 
reliability of p16 during diagnosis however has been entirely based on 
observational studies where the extent of p16 accumulation in the epithelial layers 
is shown to correlate with the grade of neoplastic severity. These studies have 
shown that in normal tissue, p16 is expressed at low levels and goes largely 
undetected. By comparison lesions with LSIL typically contain low levels of p16 in
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the first third of the epithelium, whereas in lesions with HSIL, p16 is highly diffuse 
in the middle or final-third of the epithelium.
We therefore wanted to see if p16 could be detected in HPV-16 raft cultures 
according to our previous grading. To evaluate this, sections of all six raft cultures 
were stained with an antibody against p16 and additionally all sections were 
stained with hematoxylin to identify the cellular nuclei. In HPV-negative NIKS 
epithelium we detected p16 in sporadic basal cells but could not detect p16 above 
the basal compartment (Figure 4.11). In LSIL-like raft cultures we detected p16 in 
a sporadic number of basal cells and in sporadic cells within the second and third 
layers. Strikingly we detected p16 throughout the majority of the epithelium in HSIL 
raft cultures but with varying degrees of uniformity. For example, p16 was highly 
diffuse throughout HSIL raft culture 1K. In HSIL raft culture 6K we detected p16 in 
dense pockets of cells, which extended throughout the top layers of the epithelium 
however the staining was not as diffuse as in raft culture 1K. In raft culture 6Q we 
detected p16 in only sporadic cells however these cells were located throughout 
the upper layers of the epithelium. It was curious that p16 could also be detected 
in the cytoplasm of HSIL-raft cultures, and not in LSIL raft cultures. Because p16 
can localize to both nucleus and cytoplasm this simply could be due to higher 
expression levels in these cells.
It was also surprising to see a sporadic distribution of p16 in the HSIL raft cultures 
as we expected its expression to mirror the diffuse staining of the E7 surrogate 
marker MCM-7. One explanation could be that Rb degradation does not always 
feature in the upper layers of the epithelium. The elevation of p16 however relies 
specifically on the degradation of Rb. Past studies have suggested that Rb 
degradation is mostly predominant in the basal layer where the degradation of
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other Rb related pocket proteins lead to E2F activation and MCM expression in the 
suprabasal layers.
We conclude that all three of our LSIL raft cultures (4K, 2K, 4Q) and two of our 
HSIL raft cultures (6K and 1K) have typical p16 staining patterns that resemble 
those of cervical lesions with LSIL and HSIL, respectively. Although p16 staining 
patterns in 6Q are not as typical of high-grade cervical lesions, viral gene 
expression patterns together with pathological features place this raft culture in our 
high-grade category. This will lead us to further investigate if perhaps Rb protein 
degradation is not as prominent in this HPV-16 cell line, which would suggest 
MCM-7 to be a better marker of E7 detection in this system and possibly overall in 
HPV induced lesions.
Tables 4.1 and 4.2 summarise the raft characteristics for LSIL-like and HSIL-like 
raft cultures.
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Figure 4.11 Detection of p16 in HPV-16 raft cultures with LSIL and HSIL phenotypes
HPV-negative NIKS raft cultures and HPV-16 raft cultures sections were stained with an antibody 
against p16 (brown). Hematoxylin was applied to identify cellular nuclei (blue). HPV-negative NIKS 
contain p16 in sporadic cells of the basal compartment (black arrows). In LSIL-like raft cultures 
p16-positive cells are sporadically located in the first and second layers. In HSIL-like raft cultures 
p16-positive cells are detected in most layers of the epithelium. Raft 1K contains highly diffuse p16 
whereas raft 6K contains dense pockets of p16-positive cells. Raft 6Q contains highly sporadic 
p16-positive cells throughout the epithelium (black arrow).
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Table 4.1 LSIL-like raft culture characteristics
HPV-16
Clone
(passage
number)
*2K
(4-6)
3K
(5)
*4K
(4-6)
*4Q
(4-6)
5K
(5)
9Q
(5)
13Q
(5)
MCM-7 + + ++ + ++ ++ ++ ++
E4 + + ++ +++ ++ ++ ++ ++
L1 + + ++ +++ ++ ++ ++ ++
Timing o f K10 
expression
N N N N N N N
Timing of 
filaggrin 
expression
N N N N N N N
Number of 
times 
rafted/observed
3 1 3 3 1 1 1
(See key under table 4.2)
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Table 4.2 HSIL-like raft culture characteristics
HPV-16 clone 
(passage 
number)
*1K
(4-6)
*6K
(8)
*6Q
(4-6)
MCM-7 +++ +++ +++
E4 + + +
L1 +
Timing of K10 D D D
expression
Timing of D D D
filaggrin
expression
Number of times 3 3 3
rafted/observed
Key for Tables 4.1 and 4.2
* = HPV-16 cell lines chosen for more in depth analysis 
MCM-7:
(+) = MCM-7 is expressed in a subset of cells within the first several layers 
(++) = MCM-7 is expressed in the majority of cells within the first several layers 
(+++) = MCM-7 is expressed in the majority of cells throughout the entire epithelium
E4:
(+) = E4 protein is expressed in a small number of cells in the uppermost layer 
(++) = E4 protein is expressed in the majority of cells in the uppermost layers 
(+++) = E4 protein is expressed in a small number of cells in the lower layers and in 
the majority of cell in the uppermost layers
L1: (-) = No L1 protein expression detected
(+) = L1 protein is rarely expressed in cells within the cornified layers 
(++) = L1 protein is expressed in a small number of cells within the granular and 
cornified layers
(+++) = L1 protein is expressed in a greater number of cells within the granular and 
cornified layers
N = Normal when compared to HPV negative NIKS raft culture 
D = Delay in raft epithelium when compared to HPV negative NIKS raft culture
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4.3 Discussion
In Chapter 3 we had shown that the NIKS HPV-16 raft culture system models a 
productive HPV-16 infection of the cervix. We have now shown in Chapter 4 that 
the NIKS HPV-16 raft culture system also models the wide spectrum of HPV 
induced LSIL and HSIL. We have based these findings on the identification of viral 
gene expression patterns (i.e. MCM-7, E4 and L1) and pathological features that 
have been previously identified in cervical lesions of LSIL and HSIL grades. The 
respective HPV-16 cell lines have been phenotypically labelled as either LSIL-like 
or HSIL-like. Past studies in the field which have utilised this raft system, have not 
previously reported on this phenotypic variation. To our knowledge this phenotypic 
variation has not yet been identified in other HPV episomal systems.
We have also shown that HPV-16 episomal cell lines can reproduce their LSIL-like 
or HSIL-like gene expression pattern in repeated raft culture experiments. In 
addition LSIL and HSIL phenotypes are biologically reproducible within the NIKS 
cell line system as two different transfections yielded LSIL and HSIL-like cell lines 
(i.e. cell lines distinguished by Q and K). As these phenotypes are reproducible in 
independent transfections, it is possible that this system can be further developed 
as laboratory model of episomal HPV induced neoplasia.
As our HPV-16 cell lines are all at a low passage numbers we can conclude that 
the HSIL-like phenotype (i.e. high MCM-7 persistence) is not a consequence of 
long-term culturing. Past studies have suggested that E7 expression increases or 
becomes deregulated in cell lines that have reached high passage numbers. 
However, high passage numbers also led to viral integration, which likely explains 
the increase in E7 expression (Alazawi, Pett et al. 2002).
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In our system, the phenotypic differences identified in early passage episomal cell 
lines, suggest that viral episomes potentially have different replication and/or 
transcription capacities following their early establishment in the host cell. This 
raises an important point more relevant to the time frame of neoplastic disease. 
Our results suggest that in real-life infection LSIL does not have to necessarily 
precede HSIL in the disease process. HSIL can therefore occur as an acute stage 
of infection. In personal communication with two pathologists (Rhona McVey, 
Manchester Royal Infirmary, Manchester, UK and Sue Ramachandra, Whittington 
Hospital; London, UK) it has been reported that many patients present with HSIL, 
at their first examination.
The phenotypic differences displayed in the NIKS HPV-16 raft culture system also 
show that E7 regulation can be highly diverse in the suprabasal compartment. 
Following immunohistochemical analysis, NIKS HPV-16 raft cultures presented 
with three patterns of MCM-7 expression that have been previously identified in 
mucosal lesions of LSIL or HSIL grades. Interestingly LSIL-like raft cultures 
presented with two distinct patterns of MCM-7 expression. One of these patterns 
being more typical of low-grade lesions associated with the low-risk type HPV-11 
(Middleton, Peh et al. 2003). In raft culture 4K MCM-7 positive cells were mostly 
absent in the basal layer and were detected in small numbers in the suprabasal 
layers.
There are several possible explanations as to why some low-and high-risk viruses 
yield different levels of MCM-7 expression in the upper layers. In the case of both 
low and high-risk HPVs, It has been suggested that the E7 protein is continuously
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driving S-phase re-entry in differentiating cells rather than preventing S-phase exit 
(Banerjee, Genovese et al. 2006) The ability of E7 to successfully drive cells into 
S-phase depends on several factors. S-phase entry is dependant on the ability of 
E7 to bind to and degrade hypophosphorylated Rb. In addition it has also been 
suggested that high levels of E7 are also needed to overcome the rise in the 
CDK2 and CDK4 inhibitors p21 and p27 (reviewed in (Doorbar 2006). p21 and 
p27 are likely elevated in the presence of E7, as a host defense mechanism, in 
order to prevent cellular replication in the differentiating layers.
It is established that E7 proteins of high-risk viruses have a higher affinity for Rb 
when compared to E7 proteins of low-risk risk viruses (Heck, Yee et al. 1992). This 
could explain why S-phase re-entry is less efficient in low-risk viruses. A second 
point is that low-risk viruses might have evolved to maintain steady levels of E7, 
which at times are not sufficient to overcome p21 and p27 levels induced by the 
cell. This has been suggested as a tactic of low-risk viruses, which is used to 
control proliferation (Banerjee, Genovese et al. 2006). This might further explain 
why low-risk viruses are less likely to cause high-grade disease and cancers.
Similar to what was described above for low-risk viruses it appears the virus in raft 
culture 4K is less efficient at inducing S-phase in differentiating cells. This raises 
the possibility that cell line 4K maintains a level of E7 expression that is not 
sufficient to consistently bypass p21 and p27 cell cycle inhibition or degrade Rb.
In contrast to this pattern, in LSIL raft cultures with pattern B, MCM-7 expression is 
more diffuse in the lower layers. This pattern is more typical of lesions induced by 
high-risk viruses such as HPV-16 (Middleton, Peh et al. 2003). This could indicate
149
Chapter 4 -  Results
that cell line 2K and 4Q contain sufficient levels of E7 to bypass CDK2 and CDK4 
cell cycle checkpoints and therefore S-phase induction is more consistent in the 
upper layers.
Although there appears to be differences in E7 regulation in the lower layers of 
both LSIL-like raft cultures, early gene expression is tightly regulated in the upper 
layers in the case of both levels of S-phase induction. This appears to be a 
fundamental feature of all HPV viruses where early gene expression ends in order 
to carry out the productive phase of the life cycle. As we observed, both LSIL-like 
MCM-7 patterns correlated with L1 capsid protein expression.
In HSIL raft cultures MCM-7 expression persisted throughout the majority of the 
epithelium. This MCM-7 pattern is more typically detected in lesions caused by 
high-risk viruses. MCM-7 persistence is likely due to a deregulation of E7 
expression from viral episomes, potentially leading to high levels of E7. These 
aspects will be discussed in more detail in Chapter 5.
LSIL and HSL gene expression patterns also show interesting features of early 
and late viral gene regulation. As shown earlier the end of MCM-7 compartment 
appears to identify when late gene expression beings. The order of gene 
expression is conserved however in both LSIL and HSIL lesions it appears that 
late gene expression is delayed relative to the levels of MCM-7 persistence. As 
observed with both cervical lesions and HSIL-like raft cultures, this delay in some 
cases leads to an incomplete life cycle. The switch between early to late gene 
expression is poorly understood. One possible explanation is that the delay in late 
gene expression could be due to splice factor regulation.
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The cellular splice factor SRp20 is necessary for early gene expression, but at the 
same time represses late gene expression, including that of L1 capsid expression 
(Jia, Liu et al. 2009). In cervical lesions SRp20 is confined to the less differentiated 
layers where early genes would be expressed. SRp20 levels are subsequently 
reduced in the differentiated layers above, which coincides with late gene 
expression (Jia, Liu et al. 2009).
We have shown that the late differentiation program is delayed in HSIL-like raft 
cultures. This might indicate that splice factors like SRp20 are present at high 
levels throughout the epithelium and are not reduced until late differentiation 
occurs.
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5.0 The analysis of monolayer LSIL-like and HSIL-like 
HPV-16 cell lines
5.1 Introduction
In Chapter 4 we have found that the viral gene expression patterns and 
pathological features of HSIL-like raft cultures were similar to that of high-grade 
cervical lesions. The fact that our HPV-16 raft model system can reflect these LSIL 
and HSIL phenotypes has given us the opportunity to ask new questions 
pertaining to the viral molecular basis of HPV-associated neoplasia.
The proposed viral mechanisms leading to HPV-induced neoplasia and HPV- 
related cancers have been heavily weighted on the E6 and E7 oncogenes as they 
have both been demonstrated to have transforming capabilities on the cell. Past 
studies have correlated the integration of E6 and E7 into a host chromosome with 
precancerous high-grade neoplasias and cancer (Klaes, Woerner et al. 1999) 
Separate studies have further shown that both E6 and E7 are more stably 
expressed following viral integration, presumably due the loss of viral regulatory 
elements during that process (Jeon and Lambert 1995). It has therefore been 
suggested that the deregulated and therefore persistent expression of E6 and E7 
from viral integrants is necessary for cancer development.
More recently however it has been shown that 85% of precancerous high-grade 
lesions and 15% of HPV related cancers contain only viral episomes (Klaes, 
Woerner et al. 1999; Hafner, Driesch et al. 2008). It was further shown in these
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high-grade lesions that E6 and E7 were only expressed from episomes. It is 
therefore possible that integration is likely to be more important for the final stages 
of cancer development and less important for the precancerous stages of 
neoplasia. This would therefore suggest that a deregulation of E6 and E7 
expression could also occur from intact viral episomes.
Several studies using E6 and E7 transgenic mouse models have shown that 
persistent E6 and E7 expression is important for the development of neoplasia and 
cancer, however this has not been shown in systems that express endogenous 
levels of E6 and E7 from a full intact HPV-16 genome (Brake and Lambert 2005; 
Shai, Brake et al. 2007).
Other interesting questions are how cellular growth, viral copy number 
maintenance levels and E6 and E7 expression levels of the basal layer determine 
subsequent viral gene expression patterns, and if these lead to either LSIL- or 
HSIL-phenotypes. In this Chapter we have tried to address these questions using 
monolayer episomal LSIL- and HSIL- HPV-16 cell lines. Early passage monolayer 
cultures were used for these experiments as they represent the pre-differentiated 
basal layer of raft cultures, where early viral events (e.g. viral replication and viral 
oncogene expression) are likely to begin. Using monolayer LSIL-like and HSIL-like 
cultures we investigated in these cells if early E6 and E7 oncogene expression 
and/or cellular growth characteristics correlate with the levels of E7 surrogate 
marker MCM-7 persistence observed earlier in LSIL- and HSIL- raft cultures. In 
addition to investigating early viral oncogene levels we investigated in these early 
passage HPV-16 cell lines if early E7 oncogene expression was solely from 
episomal forms of the genome or if integrated forms of the genome also produced
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a proportion of E7 transcripts. This would more fully address the hypothesis that 
early viral episomal establishment in the basal layer can lead to differences in viral 
oncogene expression levels thus potentially leading to more acute LSIL or HSIL 
phenotypes within the epithelium.
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5.2 Results
5.2.1 HSIL-like monolayer episomal HPV-16 cell lines are not sensitive to 
contact inhibition
In Chapter 4 we showed that in raft culture, cell lines with HSIL phenotype 
maintained proliferating cells throughout the majority of the epithelium, which 
coincided with a delay in cellular differentiation and late viral gene expression. By 
comparison such cells were only, detected in the first several layers of raft 
epithelium with LSIL phenotype, which coincided with a normal onset of cellular 
terminal differentiation and an earlier onset of late viral gene expression.
It is possible that the level of MCM-7 persistence in raft culture reflects a difference 
in the overall growth potential of LSIL- and HSIL-like cell lines. Therefore, we 
wanted to evaluate if HSIL-like cell lines have a higher growth potential than the 
LSIL-like cell lines. In order to compare the growth potentials of LSIL-like and 
HSIL-like cell lines, we seeded all six LSIL-like and HSIL-like cell lines at 1 x 105 
cells per well in 6-well plates. Each cell line was harvested and counted in 
triplicates over a seven-day period (Figure 5.1). During sub-confluent growth 
densities (days one to four) all six HPV-16 cell lines maintained a growth 
advantage over the HPV-negative NIKS (Figure 5.1 A), which was expected, as the 
viral oncogenes lead to higher levels of proliferation. At the end of the four-day 
period there were no differences between the total cell numbers between LSIL-like 
and HSIL-like cell lines (Figure 5.1B). This means that there is no significant 
difference in growth rate between the cell lines on the days one to four.
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However, as the levels of cell to cell contact increased at days four to five we 
observed differences in the growth rates between LSIL-like and HSIL-like cell lines 
(Figure 5.1 A).
The growth rate of all LSIL-like cell lines decreased following increased levels of 
cell to cell contact and reached growth saturation by day five. We also observed 
that the cells were completely confluent at day five. HPV-negative NIKS had a 
slower growth rate and reached growth saturation by day eight (data not shown). 
We also found that NIKS were also sensitive to contact inhibition at day eight and 
reached the same growth saturation cell number as LSIL-like cell lines.
In contrast to this a sharp increase in growth rate occurred for all HSIL-like cell 
lines as cell to cell contact increased (days four-five). All of the HSIL-like lines 
grew beyond the growth saturation point of HPV-negative NIKS and LSIL-like cell 
lines. When the HSIL cell lines reached growth saturation, their total cell numbers 
were approximately twice that of HPV negative NIKS and LSIL-like cell lines 
(Figure 5.1c). Two of the HSIL-like cell lines (1K and 6Q) reached saturation by 
day seven. However, we were unable to determine a saturation point for HSIL 
clone 6K at day seven, as its initial growth rate was slightly lower compared to the 
other HSIL clones 1K and 6Q. Additional experiments have shown that 6K and 6Q 
have similar growth saturation densities.
This data suggests that similar to HPV-negative NIKS, the LSIL-like cell lines can 
become contact inhibited when they reach 100% confluency. Normally, when 
keratinocytes reach maximum cell-to-cell contact cell proliferation is inhibited, and 
they default into their differentiation program. This is consistent with our LSIL-like
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raft cultures, where we found that these cell lines can default normally into their 
differentiation program as the cells move above the basal layer (Figure 4.8). In 
contrast to this, HSIL-like cell lines were not initially sensitive to contact inhibition. 
Their ability to grow beyond complete confluency could potentially explain the 
observed delays in the terminal differentiation program in HSIL-like raft cultures as 
well as their ability to maintain MCM-7 expression throughout the raft culture 
epithelium.
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Figure 5.1.Growth characteristics of LSIL and HSIL HPV -16 cell lines
(A) Monolayer cultures of LSIL and HSIL cell lines were counted in triplicate over seven days until 
reaching post-confluent cell densities (day seven). The mean total cell numbers from triplicate 
counts for each cell line were plotted against days of growth. The error bars represent the standard 
deviation of the triplicate counts. LSIL cell lines approach confluent densities (day four-five) and 
further growth beyond confluence is inhibited (day five). An increase in growth rate is observed in 
HSIL cell lines as the cells approach confluence (days four-five) where growth is maintained after 
reaching the growth saturation points of LSIL-like cell lines. (B-C) The bar graphs show the mean 
cell numbers for LSIL and HSIL HPV-16 cell lines at day four (sub-confluence) and day seven 
(post-confluence). The error bars represent the standard deviation of the triplicate counts.
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5.2.2 HPV-16 cell lines have sim ilar morphologies prior to cell-cell contact 
but have different morphologies following cell-cell contact
After our observation that HSIL-like clones could proliferate beyond the cell 
saturation numbers of LSIL-like clones, we wanted to exclude the possibility that 
this was due to inherent differences in the size and morphology of the HSIL-like 
cell lines. We therefore visualized the morphologies of LSIL-and HSIL-like cell 
lines at sub-confluent (day three) and post-confluent levels (day seven) by phase 
contrast microscopy. Figure 5.2 includes a typical representation of the LSIL and 
HSIL-like cell lines at sub-confluent and confluent levels of growth.
In sub-confluent cultures HPV negative NIKS, LSIL cell line 4Q, and HSIL cell line, 
6K, grew at similar densities and there were no remarkable differences in their 
sizes and morphologies. At post confluent levels, HSIL cell line 6K had a different 
morphology compared to NIKS and LSIL cell line 4K. This was evident by a more 
basal-like appearance and a high nuclear to cytoplasmic ratio in HSIL cell line 6K, 
which both indicated ongoing proliferation. In contrast, clusters of differentiating 
cells were apparent in LSIL cell line 4Q, where the nuclei looked degraded and 
less pronounced. These morphologies are typical of keratinocytes that have 
stopped proliferating.
We have therefore confirmed that HSIL-like cell lines did not grow to higher 
numbers at post confluent levels as a result of their inherent cell morphology. We 
further observed the onset of morphological differences between the LSIL and 
HSIL cell lines when they reach complete confluency.
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Lastly, we made a very important realization, which lends to the relationship 
between monolayer growth characteristics at complete confluency and raft culture 
phenotypes. We observed that the cell density at confluence rather than at sub­
confluence would likely be more similar to the cell density of the basal layer in raft 
cultures. This led us to consider that confluent monolayer cultures rather than sub­
confluent monolayer cultures more closely mimic the cell environment of tightly 
packed basal layer of raft culture epithelium. It is therefore possible that the growth 
characteristics at complete confluency more closely reflect the growth potential of 
cell lines in raft culture.
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Figure 5.2 Cell morphology of LSIL-like and HSIL-like cell lines at pre and post confluent 
densities
The HPV-16 monolayer cell lines were analyzed at 20x magnification by phase contrast at day 
three (sub-confluence) and day seven (post-confluence). The smaller boxes contain an expanded 
view of the uniformly sized, marked bordered areas. The cell size and morphology of HSIL, LSIL 
cell lines and NIKS are similar at sub-confluent cell densities. At post-confluent cell densities NIKS 
and LSIL cell lines display the typical morphology of keratinocytes that have undergone growth 
inhibition. Their cytoplasms are enlarged relative to the size of the nuclei. At day seven LSIL cell 
line 4Q also shows evidence of differentiation where the nuclei appear dissolved. At post-confluent 
densities the HSIL-like cell lines remain basal-like with high nuclear to cytoplasmic ratios. This 
morphology is typical of cells that are still proliferating
161
Chapter 5 -  Results
5.2.2.1 HSIL-like cell lines display mitotic activity at post-confluent 
growth densities
In order to further assess the mitotic activity of our HPV-16 episomal cell lines we 
stained confluent monolayer HPV-16 cell lines with H&E. The use of H&E allows 
for the visualization of nuclear and cytoplasmic morphologies and mitotic figures.
Mitotic figures are a snapshot of the chromosomal aggregations that occur during 
the different stages of mitosis. Mitotic figures of cells that are in metaphase display 
chromosomes that are aligned at the metaphase plate (Figure 5.3A). Mitotic 
figures of cells in anaphase show previously paired chromosomes, which have 
separated to opposite poles of the cell. Atypical mitotic figures can form during 
abnormal mitotic spindle formation. Atypical mitotic figures include tripolar mitoses, 
which are commonly found in malignant cells and are associated with HPV- 
induced neoplasias (Figure 5.3A),
In H&E stained, confluent monolayer cultures, mitotic figures were rarely detected 
in any LSIL- cell lines and HPV-negative NIKS (Figure 5.3b). We detected active 
mitosis in approximately 0.2% (1 out of 400) of the LSIL-like cells and HPV- 
negative NIKS. LSIL-like cell lines and HPV-negative NIKS also contained low 
nuclear to cytoplasm ratios, which as explained earlier are typical for keratinocytes 
that have stopped proliferating. In contrast, all HSIL-cell lines were morphologically 
basal-like, with high nuclear to cytoplasmic ratios. We detected the highest 
number of mitotic figures in confluent cultures of HSIL-cell line 6K, where 
approximately 7.5% (30 out of 400) of cells were in active mitosis. The other two 
HSIL cell lines, 1K and 6Q, were less mitotically active, with approximately 4% (16 
out of 400) and 3% (12 out of 400) mitotically active cells, respectively.
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Figure 5.3 Mitotic activity of LSiL-like and HSIL-like cell lines at post-confluent growth 
densities
(A) This cartoon shows two types of mitotic figures, which can be detected when cells are in 
metaphase and anaphase. Tripolar mitoses are an example of an atypical mitotic figure, which is 
commonly found in HPV-induced neoplasias. (B) Cells at post-confluent densities were stained 
with H&E to observe nuclear and cytoplasmic morphologies and mitotic figures. NIKS and LSIL cell 
lines contain low nuclear to cytoplasmic ratios, reflecting a typical morphology of keratinocytes that 
have stopped proliferating. Mitotic figures are also extremely rare in these cell lines. HSIL cell lines 
display typical morphologies of cells that are proliferating. This is evident by their basal-like 
appearance and their high nuclear to cytoplasmic ratios. Mitotic figures are present in all HSIL cell 
lines, indicated by the arrows, and include atypical mitoses (e.g. tri-polar mitoses).
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These numbers include also atypical mitotic figures, such a tripolar mitoses that 
we found in all three HSIL-like cell lines but not at all in LSIL-like cell lines or HPV- 
negative NIKS.
These results confirm our previous conclusion that HSIL cell lines remain 
mitotically active at fully confluent densities, whereas LSIL cell lines, just like HPV- 
negative NIKS, display the normal growth inhibitory characteristics of confluent 
keratinocytes.
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5.2.3 HPV-16 E7 oncogene expression levels increase in HSIL cell lines at 
confluence
We had previously established using two methods that HSIL-like cell lines 
continue to proliferate at fully confluent densities, whereas LSIL-like cell lines stop 
proliferating at this point. Since the E6 and E7 oncogenes have been shown to 
drive proliferation in HPV-infected cells we wanted to test if the were in part 
responsible for the observed growth characteristics.
The E6 and E7 oncogenes have established consequences on the host cell, which 
allow the cell to maintain a proliferative state and also bypass apoptotic pathways. 
The E6 and E7 oncogenes are also associated with the reduction in levels of 
several cellular proteins that regulate proliferation with respect to cell-cell contact. 
For example it has been shown that the adherin junction (AJ) protein, E-cadherin, 
is delocalized from cell membranes and reduced in the presence of the viral 
oncogene E7(Wilding, Vousden et al. 1996; Yuan, Ito et al. 2009). In HPV- 
negative cells E-cadherin binds to cellular membranes during cell-cell contact, 
where it helps to maintain cellular adhesion (reviewed in (Baida and Matter 2003). 
It has also been shown that E-cadherin can bind to other cellular proteins at the 
cell membranes, which are important for cell cycle regulation. For example it can 
bind to Beta-catenin and retain it outside of the nucleus. Because nuclear Beta- 
catenin can transactivate pro-proliferative genes such as Cyclin D, this function of 
E-cadherin is considered to be anti-proliferative. Accordingly, the loss of E- 
cadherin has been associated with HPV-related neoplasias and various cancers 
and is therefore regarded as a tumour suppressor gene (Vessey, Wilding et al. 
1995).
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To evaluate E7 expression levels in the monolayer NIKS HPV-16 system, we first 
wanted to see if the levels of E7 expression in monolayer remained constant at 
sub-confluent (day three), confluent (day five) and post-confluent (day seven) 
culture conditions. To evaluate E7 expression we harvested each clone during the 
monolayer growth assay at days three, five and seven and evaluated E7 
expression levels by western blot (Figure 5.4A). The bar graph reflects the relative 
change in band intensity compared to day three (Figure 5.4B). To compensate for 
unequal loading the E7 band intensities were also normalised against GAPDH 
band intensities.
We found that relative to day three, E7 band intensities increased between days 
three, five and seven in all HSIL-like cell lines. By comparison the E7 band 
intensities of LSIL-like cell lines either decreased or increased moderately 
between days three, five and seven. We therefore concluded that E7 gene 
expression increased more dramatically in confluent and post-confluent cultures of 
HSIL cell lines when compared to LSIL-like cell lines.
For each level of confluency we also wanted to compare the E7 expression levels 
between all HPV-16 cell lines. To do so we analysed the identical lysates of each 
cell line, side by side by western blot against E7 (Figure 5.4C). At sub-confluent 
levels of growth (day three) there was no correlation with E7 expression levels and 
the respective phenotypes. At confluent (day five) and post-confluent (day seven) 
levels of growth, all of the HSIL-like cell lines expressed higher levels of E7 when 
compared to LSIL-like cell lines.
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We concluded that E7 expression increased and persisted at higher levels in 
confluent HSIL-like cell lines compared to LSIL-like cell lines. The increased E7 
expression levels in confluent HSIL-like cultures correlated with their ability to 
proliferate beyond confluent cell densities. This might also be indicative of the level 
of E7 expression in the basal cells of HSIL-like HPV-16 raft cultures, which could 
explain their ability to remain in a proliferative state longer.
At this point we cannot explain why only HSIL-like cell lines have dramatically 
increased levels of E7 expression at complete confluency. It could be due to 
subtle differences in promoter activity or regulation acted upon by the host cell or 
differences in viral protein stability.
Interestingly, we also made the observation that E7 expression levels were 
considerably lower in LSIL cell line 4K when compared to the remaining five HPV- 
16 cell lines. Raft cultures of LSIL cell line 4K presented with a sporadic MCM-7 
compartment (Pattern A), which closely resembles the MCM-7 patterns found in 
LSIL lesions cause by low-risk viruses such as HPV-11. Apart from confirming that 
initial E7 expression is a good indicator of the later proliferative potential in raft 
culture this suggests that in the case of HPV-16, E7 oncogene regulation is 
extremely variable. This then can potentially lead to a wide range of possible LSIL- 
like and HSIL-like viral gene expression patterns.
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Figure 5.4. Relative changes in E7 expression levels over days three, five and seven in LSIL- 
like and HSIL-like cell lines.
(A) Each cell line was harvested at days three, five and seven to assess E7 expression levels by 
western blot. (B) The bar graph represents the changes in E7 band intensities within each 
individual cell line over days five and seven relative to day three. All E7 band intensities were 
normalised against the GAPDH band intensity for each individual cell line. (C) Western blots show 
side-by-side comparisons of E7 expression levels in LSIL and HSIL cell lines for days three, five 
and seven. Equal loading is shown by western blot against GAPDH.
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5.2.4 HPV-16 E6 oncogene expression levels increase in HSIL cell lines at 
confluence
We had previously shown that at confluent and post-confluent growth densities 
viral oncogene E7 expression levels were higher in HSIL cell lines compared to 
LSIL cell lines. Next we wanted to evaluate if E6 oncogene levels increase in a 
similar fashion when HSIL-like cell lines reach complete confluency.
The HPV oncogene E6 interacts with and degrades several AJ proteins, which 
include the PDZ domain proteins, hDIg, Scribble and ZO-1 (reviewed in (Thomas, 
Narayan et al. 2008). PDZ proteins also bind to cell membranes during cell-cell 
contact and modulate cell growth and cell polarity. It has been shown that the 
degradation of PDZ proteins is likely to be important for episomal maintenance 
during the viral life cycle (Lee and Laimins 2004). Further reduced levels of PDZ 
proteins have been associated with a loss in cell polarity and abnormal 
proliferation when cell-cell contact is achieved. PDZ proteins are commonly 
reduced in HPV-related neoplasias and various cancers (Nakagawa, Yano et al. 
2004).
To evaluate E6 expression in our HPV16 episomal cell lines we measured the E6 
expression levels from the identical lysates taken at days three, five and seven by 
western blot (Figure 5.5A). The bar graph contains the relative changes in band 
intensity that occurred in each HPV-16 cell line, from day three to days five and 
seven (Figure 5.5B).
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At confluent and post-confluent levels of growth, E6 band intensity decreased or 
remained similar to the band intensity at sub-confluency (day three). By 
comparison we detected a modest but marked increase in E6 band intensity in all 
HSIL-like cell lines at full confluency (day five) and post-confluency (day seven). 
When we directly compared E6 expression levels between each cell line at day 
three we found that there was no obvious correlation between E6 expression 
levels and the growth phenotype (Figure 5.5C). In contrast at complete confluency 
(day five) and post confluency (day seven), E6 expression levels were slightly 
higher in all HSIL cell lines compared to the LSIL cell lines.
From these observations we conclude that both E6 and E7 levels increased and 
persisted at higher levels in fully confluent cultures of HSIL cell lines when 
compared to LSIL cell lines.
However, overall we found that E6 levels did not rise proportionally to E7 levels 
and we did not detect the same relative differences in HSIL cell lines to LSIL cell 
lines. We expected to see proportional rises of the two oncogenes as they are 
transcribed from a single bicistronic message. Although this could be attributed 
partly to technical difficulties, this may also hint at differences in E6 and E7 
regulation. This could either happen at the RNA level by transcript processing 
and/or splicing. Alternatively this could point to differences in protein stability of E6 
and E7, which occur at complete confluency.
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Figure 5.5 Relative changes in E6 expression levels over days three, five and seven in LSIL- 
like and HSIL-like cell lines.
(A) Each cell line was harvested at days three, five and seven to assess E6 expression levels by 
western blot. (B) The bar graph represents the changes in E6 band intensities within each 
individual cell line over days five and seven relative to day three. All E6 band intensities were 
normalised against the GAPDH band intensity for each individual cell line. (C) Western blots show 
side-by-side comparisons of E6 expression levels in LSIL and HSIL cell lines for days three, five 
and seven. Equal loading is shown by western blot against GAPDH.
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5.2.5 The E7 oncogene is expressed from an episomal form of the HPV-16 
genome in LSIL-like and HSIL-like HPV-16 cell lines.
In previous studies E6 and E7 viral integrants versus intact 8kb episome have 
been detected in the majority of HPV-related cancers and also in a percentage of 
pre-cancerous HPV-induced high-grade lesions. It further has been shown that the 
stable expression of E6 and E7 following integration can lead to chromosomal 
abnormalities, which pushes the cells further through the transformation process.
More recently alternative molecular assays, such as Amplification of 
Papillomavirus Oncogene Transcript (APOT), have been used to distinguish if E7 
transcripts are produced from episomal versus integrated forms of the viral 
genome. Several studies using the APOT method have surprisingly found that the 
majority HPV-induced high-grade lesions contain E7 transcripts that are produced 
from only the episomal form of the virus. In one study the APOT method identified 
that in 85% of the lesions with HSIL, E7 transcripts were produced from only 
episomal forms of the virus (Klaes, Woerner et al. 1999). In contrast, in the 
majority of carcinomas in-situ they have found that E7 transcripts were produced 
predominantly from integrated viral genomes. Therefore it has recently become 
more accepted that the integration of E6 and E7 is likely to be a later event in the 
pathological process and more important for the final stages of cancer 
development.
We had previously shown by Southern blot that all of the HPV-16 cell lines 
contained predominantly episomal forms of the HPV-16 virus. We decided to use 
the APOT assay as a way to ask more specifically if oncogene E7 expression
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came from episomal or integrated forms of the virus. The APOT method 
specifically involves RT-PCR analysis of two primer sets, which are specific for the 
E7 ORF and the early viral poly (A) region, which lies downstream of E7. In this 
method, if E7 transcripts are created from a non-disrupted episomal form of the 
HPV-16 genome these primers will amplify a single 1.1 kb cDNA fragment. 
However, if E7 transcripts are created from multiple E7 integration sites within the 
cellular genome, a series of different size fragments is generated.
To conduct our APOT experiment we used RNA extracts from sub-confluent 
cultures of each HPV-16 cell line. The APOT procedure resulted in the generation 
of a single 1.1 kb band for all three LSIL and HSIL clones (Figure 5.6). By 
comparison multiple bands were generated from our positive integration control 
sample.
These results confirm that E7 transcripts are produced from episomal forms of the 
HPV-16 genome in both LSIL-like and HSIL-like cell lines. This further suggests 
that differences in E7 viral gene expression in high-grade lesions could arise from 
differences in episomal copy number availability or differences in early promoter 
regulation, rather than E6 and E7 integration. Future work will also address if E6 
and E7 transcript levels also correlate with E6 and E7 protein levels.
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Figure 5.6. APOT analysis of E7 transcripts from HPV-16 monolayer cell lines 
(in collaboration with Emilio Pagliarulo, NIMR, London, UK)
The agarose gel shows a single amplified 1.1 kb E7 PCR product in all LSIL and HSIL cell lines, 
which indicates that E7 transcripts have come from an intact episome. For the DNA marker (M) the 
size of two bands is shown. The integrated control (IN) contains several amplified bands, which 
represent E7 transcripts, which are produced from several E7 integration sites in the host genome. 
HPV-negative NIKS (N-) were used as a negative control. All tested HPV-16 cell lines show only 
the 1.1 kb amplification product indicative of episomal forms of the viral genome.
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5.2.6 LSIL-like cell lines are more likely to contain higher viral copy numbers 
per cell than HSIL-like cell lines
We had previously shown that E7 transcripts were produced from only episomal 
forms of the virus in both LSIL and HSIL-like HPV-16 cell lines. This led us to 
investigate if episomal copy numbers in LSIL-like and HSIL-like lines account for 
the differences in E6 and E7 protein expression at complete confluency. Past 
studies have correlated the development of HSIL with a high viral load. However 
the majority of these studies were assessing the viral DNA levels of cells taken 
from cytological smears. These cells were taken from the top of the lesion and 
therefore their copy numbers did not necessarily reflect the viral DNA replication 
levels from the basal layer. However, using our monolayer HPV-16 cell lines we 
were able to assess the viral DNA replication levels, which would more closely 
resemble those found in the basal layer, where E7 expression is initiated.
To evaluate the viral copy number per cell in monolayer HPV-16 cell lines we used 
Q-PCR methods on total genomic DNA. In order to detect HPV-16 DNA we used 
primers specific for the HPV-16 E4 ORF. In order to quantify the total number of 
cells in each reaction we used primers specific for cellular GAPDH. We isolated 
the total genomic DNA from each cell line on day four of the growth assay, 
because this time-point was likely to reflect downstream expression levels of E7 
protein one day later at complete confluency (day five). In order to be statistically 
accurate we harvested each cell line in triplicates and also each cell line was 
grown separately in two more independent cell cultures to test for biological 
reproducibility. The mean from these nine independent samples was calculated for 
each cell line.
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Due to the fact that we could not run all nine samples from every cell line on the 
same plate, we carried through one identical sample in each run. All of our copy 
number values were then normalised to this sample. The bar graph in Figure 5.7 
shows the means of all nine samples for each cell line. The error bar represents 
the standard deviation of the mean.
Surprisingly, the LSIL cell lines on average had higher HPV copy numbers per cell, 
when compared to HSIL-like cell lines. We did however find that HPV-16 copy 
numbers varied more in the LSIL-like cell lines. We therefore conducted an 
unpaired t-test on all LSIL-like and HSIL-like cell lines. When we conducted 
statistical test between individual cell lines we found that in most comparisons 
LSIL and HSIL cell lines had significantly different copy numbers. We also found 
that overall LSIL-like cell lines as a phenotypic group have significantly higher 
copy numbers when compared to the copy numbers of HSIL-cell lines. This 
suggests that cells that maintain high copy numbers are more likely to correlate 
with LSIL phenotypes.
One possible explanation for this is that high copy numbers might lead to more 
controlled and therefore lower levels of E7 expression, due to higher levels of the 
HPV-16 E2 protein. It is widely established that the E2 replication protein can bind 
to several sites within the HPV-16 LCR, which then can lead to the repression of 
the early promoter and early oncogene transcription. However it has also been 
shown that high E2 levels are needed to repress transcription (Steger and 
Corbach 1997). A lower copy number could therefore cause low E2 protein levels, 
which would possibly not be sufficient to repress E7 transcription.
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To test this hypothesis we attempted to evaluate E2 protein levels in all six 
monolayer HPV-16 cell lines. We were however unable to detect endogenous 
levels of E2 with the current available E2 antibodies.
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Figure 5.7 HPV-16 viral copy numbers
(A) Quantitative-PCR was used to detect the HPV-16 DNA copy numbers per cell in LSIL and HSIL 
cell lines. The bar graph shows the mean copy numbers/cell values for each cell line, from nine 
individual samples. The error bar represents (+/-) standard deviation of copy numbers values from 
the nine samples. (B) An unpaired T-test was conducted to show the significance of the measured 
differences of HPV-16 copy numbers between LSIL and HSIL cell lines. The table below contains 
the respective P-values. All values with p<0.05 were considered significant.
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5.2.7. Cellular p53 expression levels are more reduced in HSIL-like cell lines 
compared to LSIL-like cell lines when at post-confluent monolayer growth 
densities
So far we have shown that the levels of the E6 and E7 oncogenes correlate with 
the level of MCM-7 persistence in raft culture, validating the use of MCM-7 as E7 
surrogate marker. One possibility is that the level of MCM-7 persistence could be 
directly due to the reduced levels of the main E6 and E7 cellular binding partners 
Rb protein and p53. E7 can bind to Rb protein and induce its degradation. This is 
critical, because Rb protein allows the transcription factor E2F to remain in an 
active state, which then leads to the expression of MCM-7 and G1 to S-phase 
entry. Therefore it is conceivable, that E7 expression can lead to Rb protein 
degradation, activate E2F, which increases MCM-7 expression and cell 
proliferation. The activation of E2F however also causes increased expression of 
p16, which normally then antagonizes Rb protein function in cell cycle regulation. 
Rb however then degrades p16 in order to ensure the cell cycle can proceed 
again. In the case of Rb degradation p16 is not reduced and therefore 
accumulates in the cell. Accordingly, it has been shown in the case of HPV 
infection that Rb degradation is inversely related to p16 levels in the cell.
Another cellular protein marker that is changed after HPV infection is the tumour 
suppressor gene p53. As a result of continuous Rb protein degradation and MCM- 
7 induction by viral E7 it has been shown that cells will express high levels of p53. 
During cellular stress p53 can act as a G1 to S-phase checkpoint protein, which 
prevents the cell from proceeding through S-phase. In a separate pathway p53 
can also induce cellular apoptosis. To counteract these effector functions of p53 
during an infection, the virus has developed a way to degrade p53 by the action of
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the E6 oncogene. This happens through ubiquitination and proteasomal 
degradation of p53.
Because of the described biological relationships and due to the lack of good E6 
and E7 antibodies, Rb protein and p53 degradation have been used as markers 
for E7 and E6, respectively. However, it has never been shown before whether the 
levels of Rb protein and p53 degradation exactly correlate with E7 and E6 protein 
levels. To test this for the time in the context of the NIKS HPV-16 system we 
evaluated if the level of Rb protein and p53 degradation in each cell line correlates 
with their respective E6 and E7 levels. Also, we looked if this correlated with the 
level of MCM-7 persistence observed in their raft cultures.
In order to evaluate this, we used the identical lysates from cells harvested at day 
three, five and seven from our previous growth assays for Western blot against Rb 
protein, p16 and p53. At day three and five, Rb protein degradation did not 
correlate with E7 levels or the level of S-phase persistence in raft culture (Figure 
5.7). We did however find that as expected p16 was inversely related to Rb protein 
levels. At day seven Rb protein levels were decreased in all cell lines whereas 
there were no dramatic changes in p16 levels compared to day five. We further 
concluded that the level of Rb protein degradation did not correlate with the level 
of MCM-7 persistence.
When we evaluated p53 levels at day three and five, we found that they were were 
consistently lower in all HPV-16 cell lines compared to HPV-negative NIKS. 
However, there did not seem to be a correlation with their respective E6 levels.
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Interestingly, at day seven, p53 was reduced more in the HSIL- cell lines 
compared to the LSIL cell lines. Furthermore, this correlated nicely with elevated 
E7 and E6 levels at this time point.
In summary the data suggests that the increased levels of E6 and E7 by day 
seven allowed for the further reduction of both Rb protein and p53 in HSIL-like cell 
lines. As stated earlier it is unlikely that reduced Rb levels directly lead to higher 
levels of S-phase persistence or growth inhibition as we found it to be was 
degraded in both LSIL and HSIL cell lines. It is more remarkable that p53 levels 
are lower in post-confluent HSIL cell lines compared to LSIL cell lines.
It is unlikely that MCM-7 persistence in HSIL raft cultures is due to the loss of p53- 
related G1 phase CDK4 checkpoint pathways. As Rb levels are already degraded 
in all of the HPV-16 cell lines, the G1-S-phase transition would likely proceed, 
even in the presence of high p53 levels. However, it is possible that we have 
identified a new cellular marker that can be used to distinguish between LSIL and 
HSIL lesion.
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Figure 5.8. Expression of E6 and E7 binding partners in LSIL and HSIL cell lines
Rb, p53 and p16 protein expression levels in HPV-16 cell lines were assessed by western blot. 
Expression levels for each protein were assessed on days three (sub-confluence), five 
(confluence) and seven (post-confluence) of the previous growth assay. The respective E6 and E7 
protein expression levels at the same time points are shown below (identical with the data from 
figures 5.3 and 5.4).
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5.2.9 Beta-catenin activity is higher in HSIL-like cell lines
We had previously shown that HSIL-like cell lines continued to proliferate when 
cell-cell contact was established, whereas LSIL-like cell lines were sensitive to 
contact inhibition. The E6 and E7 oncogene levels also increased and persisted at 
higher levels in confluent HSIL-like cell lines compared to LSIL-like cell lines.
One explanation for this is that an increase in E6 and E7 levels at cell contact 
allowed HSIL-like cell lines to bypass contact inhibition pathways. As mentioned 
earlier, E7 and E6 oncogenes can reduce the levels of adherin junction proteins 
such as E-cadherin and Scribble, respectively. The reductions in these proteins 
lead to a loss in G1 to S-phase inhibition. One way that adherin junction proteins 
regulate S-phase at cell-cell contact is through their ability to sequester Beta- 
catenin from the nucleus (reviewed in Baida and Matter 2003). Additionally, Beta- 
catenin is also tightly regulated by the canonical Wnt pathway and by adherin 
junction proteins as a measure to control cell proliferation. When Beta-catenin is 
active, it binds to the T-cell factor/lymphoid enhancer (TCF/LEF) transcription 
factors in the nucleus, by use of a specific binding site on TCF/LEF complex 
(reviewed in (Huelsken and Behrens 2002). The newly formed Beta-catenin/TCF 
complex then transactivates the expression of several genes such as Cyclin D and 
c-Myc, which lead to proliferation. When cell-cell contact is established Beta- 
catenin is degraded or is sequestered to adherin junctions to prevent further 
proliferation.
Recent work has shown that Beta-catenin activity is higher in NIKS that 
overexpress the E6 and E7 oncogenes, when compared to HPV-negative NIKS
(personal communication with Kenneth Raj, NIMR, London, UK). We therefore
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wanted to evaluate if perhaps Beta-catenin activity was elevated more in HSIL-like 
cell lines which might lead to their ability to maintain proliferative capabilities at 
increasing cell densities.
To test this we transfected sub-confluent LSIL-like cell lines, HSIL-like cell lines 
and HPV-negative NIKS with the Topflash Photinus luciferase reporter plasmid. 
The Topflash plasmid contains the specific TCF/LEF binding site for Beta-catenin. 
The Renilla luciferase reporter plasmid (pRL) was co-transfected with the Topflash 
plasmid, as a transfection control. All transfections were carried out in duplicate. 
The cells were subsequently harvested at 72 hours post-transfection after 
reaching complete confluency. To assess the Beta-catenin activity we quantified 
the Photinus luminescent signal from the Topflash vector. The Photinus luciferase 
levels were then normalised to the luminescent signals from the Renilla plasmid 
alone. The bar graph in Figure 5.9 shows the standard deviation from duplicate 
transfections, for each cell line. All of the HPV-16 cell lines contain higher levels of 
beta-catenin activity compared to HPV-negative NIKS. In addition HSIL-like cell 
lines contain higher levels of Beta-catenin activity compared to LSIL-like cell lines.
As Beta-catenin activity is higher in all HPV-16 cell lines compared to HPV 
negative NIKS, we can first suggest that the virus might increase or sustain Beta- 
catenin activity as another means of maintaining cells in S-phase. It is possible 
that the increased levels of E6 and E7 oncogene in confluent HSIL-like cell lines 
leads to a further increase in the Beta catenin activity, thus allowing the cells to 
maintain proliferative capabilities. Furthermore it is possible that the level of Beta- 
catenin activity in HSIL-like cell lines leads to S-phase persistence in raft culture 
epithelium. Further work will be needed to determine if the increase in Beta-
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catenin activity is due to a reduction in specific adherin junction proteins. 
Furthermore we will have to establish if the increase in Beta-catenin activity is due 
to an increase in one or both of the HPV oncogenes in HSIL-like cell lines.
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Figure 5.9 Beta catenin-TCF transactivation in LSIL and HSIL cell lines
LSIL and HSIL cell lines and HPV negative NIKS were transfected in duplicate with the Topflash 
Photinus luciferase reporter vector, which contains the TCF transcription factor Beta-catenin 
binding site. All cell lines were co-transfected with a Renilla luciferase reporter plasmid (pRL), 
which was used as a transfection control. The level of Beta-catenin activity for each cell line was 
assessed by quantification of the luminescent signal from the Topflash Photinus reporter vector. 
The bar graph shows the fold increase of Photinus above the Renilla transfection control. The 
error bars represent the standard deviation of the duplicate transfections.
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5.3 Discussion
In Chapter 5 we have shown that LSIL-like cell lines differ from HSIL-like cell lines 
with respect to their growth characteristics and E6 and E7 oncogene levels. More 
specifically growth assay experiments have shown that HSIL-like cell lines have 
the ability to proliferate in confluent cultures whereas LSIL-like cell lines appear to 
be sensitive to contact inhibition. We have also observed that the E6 and E7 
protein levels of HSIL-like cell lines are elevated in confluent cultures compared to 
sub-confluent cultures. By comparison the E6 and E7 protein levels in LSIL-like 
cell lines decrease or moderately increase in confluent cultures. Overall, the E6 
and E7 protein levels are higher in confluent cultures of HSIL-like cell lines 
compared to LSIL-like cell lines.
Although we can not at present explain why E6 and E7 levels rise in confluent 
HSIL-like cell lines, we have made the observation that confluent cultures likely 
mimic the cell density of the basal layer in raft cultures, more so than sub­
confluent cultures. We can speculate that the growth potential and viral oncogene 
levels in confluent monolayer cultures are likely to be similar to that of the basal 
layer cells in raft culture epithelium. We can therefore raise the possibility that the 
high levels of E6 and E7 observed in “basal-like” confluent cultures are 
responsible for the level of MCM-7 persistence in HSIL-like raft cultures. Recent 
studies have shown that persistent E7 expression in mice is necessary for the 
development of HSIL, however there was no indication if the level of E7 protein 
contributed to this disease grade (Jabbar, Abrams et al. 2009).
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The coincidental rise in oncogene levels during confluency has been only a recent 
find with this system. Prior to culturing HPV-16 cell lines in six-well plates we were 
unable to consistently detect endogenous E6 and E7 levels. HPV-16 cell lines 
were originally grown in six-well plates to carry out growth assays. The detection 
of viral oncogenes by Western blot has been historically difficult within the HPV 
field, as it has been mostly claimed that endogenous levels of E6 and E7 are 
difficult to detect by these methods. In our case growing the cell lines in a tight 
confined space increased our chances of detecting E6 and E7 expression 
compared to growing the same cell lines in larger flasks. Using this method of 
growth has subsequently allowed us to make these correlations between growth 
density and oncogene levels.
We have also made an interesting correlation between E6 and E7 protein levels 
and the different LSIL-like MCM-7 patterns in raft culture. Raft culture 4K, which 
like low-risk HPV-11 lesions, contains a sporadic S-phase compartment. We also 
observed that E6 and E7 protein levels are dramatically lower in cell line 4K 
compared to the remaining LSIL-like cell lines. Raft culture 4Q and 2K by 
comparison contained moderate levels of E7, which correlated with a more diffuse 
MCM-7 compartment. We have now shown that low and moderate levels of E6 
and E7 expression from are more favorable for productive infection whereas high 
levels of E6 and E7 correlate with a highly persistent MCM-7 compartment and an 
incomplete life cycle. A next step forward will therefore be to knockdown the E6 
and E7 protein levels in HSIL-like cell lines. Ideally we would recover a more 
LSIL-like phenotype following the reduction of E6 and E7 in HSIL-like cell lines.
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Results in this chapter also suggest the possibility that the virus interferes with 
contact inhibition pathways such as those involving active beta-catenin. 
Preliminary data suggests that the virus allows beta-catenin to remain active at 
times of cell-cell contact. When in the nucleus beta-catenin forms a complex with 
the TCF/LEF transcription factors leading to the transactivation of cellular genes 
that are necessary for cells to proceed through S-phase (Huelsken and Behrens 
2002). Beta-catenin is degraded or is sequestered to the cell membranes at times 
of cell-cell contact. We have found that confluent LSIL-like and HSIL-like HPV-16 
cell lines have increased beta-catenin activity compared to HPV negative NIKS. It 
is possible that the virus keeps beta-catenin active in cell-cell contacted areas 
such as the basal layer, as another means to ensure that cell replication 
machinery is available in the suprabasal layers. As this would be a normal 
mechanism of the virus, high levels of E6 and E7 would possibly sustain this 
activity in the upper layers of the epithelium. Coincidently HSIL like cell lines all 
display higher levels of beta-catenin activity when compared to LSIL-like cell lines.
It is also possible that the increased beta-catenin activity is due to a reduction of 
PDZ proteins, such as hScrib and hDlg. In the absence of E6 these PDZ proteins 
normally control Beta-catenin activity via their interactions with the tumor 
suppressor gene APC.(Matsumine, Ogai et al. 1996; Takizawa, Nagasaka et al. 
2006) In cases of high E6 expression, high reductions of PDZ proteins could lead 
to an increase in active beta-catenin. In collaboration with Lawrence Banks and 
colleagues we have preliminary data that shows both hScrib and hDlg proteins are 
more reduced in HSIL-like raft cultures when compared to LSIL-like raft cultures. 
Future work will be aimed at investigating the role of these pathways in HPV 
inducedneoplasia.
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6.0 Final Discussion
In this thesis we have shown that the NIKS HPV-16 raft culture system can model 
a wider spectrum of HPV disease than we had previously envisioned. Surprisingly 
we have found that early passage HPV-16 episomal cell lines were heterogeneous 
in their ability to complete a HPV life cycle. After propagating these lines in 
organotypic raft cell culture we identified that a subset of raft cultures contained 
viral gene expression patterns that were reminiscent of low-grade HPV-16 induced 
cervical lesions (i.e.LSIL-like), where another subset contained viral gene 
expression patterns that were reminiscent of high-grade cervical lesions (i.e. HSIL- 
like) (Middleton, Peh et al. 2003). We have specifically based these findings 
through the identification of MCM-7 (E7 surrogate marker) and, HPV-16-E4 and 
HPV-16- L1 gene expression patterns. In addition, we have identified that LSIL-like 
raft cultures and HSIL-like raft cultures display pathological features that are 
similar to those found in cervical lesions of a similar pathological grade. This is the 
first report of LSIL-like and HSIL-like phenotypic variation in episomal HPV raft 
culture systems. We have therefore presented a novel laboratory model of HPV 
induced neoplasia. This has allowed us to ask new questions pertaining to the 
molecular basis of HPV induced neoplasia
The focuses of these questions were mainly towards the understanding of early 
events in the virus life cycle including viral copy number and E6 and E7 oncogene 
levels. Through this analysis we have found that viral copy number and E6 and E7 
protein levels vary between early passage monolayer episomal cell lines, which 
point to possible differences in early episomal establishment in the host cell. In 
addition we have found that the major difference in E6 and E7 protein level
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variation occur at high cell densities, a time when keratinocytes would normally 
stop proliferating, in order to default into the terminal differentiation program. We 
have found that E6 and E7 protein levels rise in confluent HSIL-like cell lines 
where E6 and E7 protein levels decrease or increase moderately in confluent 
cultures.
Interestingly the rise in E6 and E7 protein levels in HSIL-like cell lines at high cell 
density, also correlate with their ability to bypass density-dependent growth arrest. 
In contrast to this, as with HPV- negative NIKS, LSIL-like cells lines stop 
proliferating when cell-cell contact is achieved. We have further hypothesized that 
a lack of cell-cell sensing in the case of HSIL-like cell lines possibly allows these 
cells to persist in cycle in the raft epithelium, above the threshold of LSIL-like cell 
lines. Past work has not identified changes in oncogene levels at confluency or if 
lack of cell-cell sensing is important for increased cell-cycle persistence in the 
suprabasal layers
We have also made the observation that confluent cultures likely mimic the tightly 
packed basal layer environment more so than sub-confluent cultures. We 
therefore hypothesize that the basal oncogene level likely determines the level of 
cell cycle persistence in the suprabasal layers. Recent studies have suggested 
that persistent E6 and E7 expression is indeed important for the development of 
neoplasia however their studies did not evaluate if basal E6 and E7 levels lead to 
different LSIL or HSIL phenotypes (Brake and Lambert 2005; Jabbar, Abrams et 
al. 2009).
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More immediate future work will be to directly assess if the E6 and E7 oncogene 
levels are responsible for these phenotypes. This question can be directly 
addressed by using the shRNA knockdown technique. The successful knock down 
of E6 and E7 using shRNA has been previously achieved in cervical cancers lines 
(Gu, Putral et al. 2008). We can therefore select for HSIL-like clonal cell lines that 
display different levels of E6 and E7 knockdown efficiencies. HSIL-like cell lines 
with reduced levels of E6 and E7 will be propagated in organtotypic raft culture. 
Ideally we would want to show that a reduction of the E7 oncogenes leads to a 
reduction of the MCM-7 compartment and a regression to LSIL-like phenotype
The diversity of E7 regulation in HPV-16 raft cultures
Interestingly LSIL-like raft cultures contained two distinct MCM-7 expression 
patterns previously detected in mucosal HPV induced LSIL lesions, one being 
more typically associated with low-risk viruses such as HPV-11 (Middleton, Peh et 
al. 2003). Raft 4K, which displayed similar early gene expression patterns to that 
of HPV-11 lesions contained a sporadic MCM-7 compartment where MCM-7 was 
predominantly absent from the basal layer. We have found that this pattern 
correlates with the dramatically low E6 and E7 protein level that is produced by 
this particular HPV-16 cell line.
It has been previously suggested E7-mediated S-phase induction can be inhibited 
by anti-proliferative signals imposed by the cell. More specifically the (Cyclin E) 
cdk2/ (Cycllin D) cdk4 inhibitor p21 has been shown to rise in the presence of E7 
(Noya, Chien et al. 2001). In cases of low E7 it has been suggested that E7 forms 
a complex with p21 and Cyclin E, which leads to G1 arrest. However when E7 
levels are high it is has been suggested that E7 can inactivate p21 and which
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allows S-phase progression to proceed (reviewed in (Doorbar 2006). The low level 
of E7 expression in cell line 4K might therefore be less optimal for p21 inactivation 
leading to less efficient S-phase induction.
In the remaining two LSIL raft cultures 2K and 4Q, MCM-7 expression was more 
diffuse and was first identified in the basal layer. We have correlated this with 
higher E6 and E7 levels when compared to that of cell line 4K. We can speculate 
that the level of E7 is sufficient for inactivating p21 more consistently in the lower 
basal layers. In contrast to LSIL raft cultures MCM-7 positive cells were detected 
throughout majority of the epithelium in HSIL-like raft cultures. As stated earlier 
MCM-7 persistence is likely related to the dramatically higher levels of E7, which 
likely saturate any host cell defenses.
A further step in this evaluation could first entail identifying the p21 levels in LSIL- 
like and HSIL-like raft culture epithelium. In the case of raft culture 4K it is possible 
that we might identify that MCM-7 negative cells are positive for p21. This would 
indicate alternate regions in the epithelium where S-phase induction did not occur 
as a consequence to cell cycle inhibition. This mode of E7 cell cycle regulation 
appears to be favorable for the virus and might well serve to control host cell 
proliferation in order carry out a complete life cycle.
Through identifying these different MCM-7 patterns we can further suggest that the 
virus does not always adhere to a strict method of E7 gene regulation and S- 
phase induction. At present this model could be useful for identifying HPV-16 
intermediate LSIL-like phenotypes that will potentially not be identified in biopsy 
material due to the fact that low-grade lesions are biopsied less frequently. This
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could undoubtedly lead to further studies of early HPV-16 gene regulation. In 
addition to evaluating MCM-7 expression patterns, identifying a good E7 antibody 
for raft culture experiments would greatly strengthen these studies.
Beta-catenin and cell-cell sensing
Preliminary results also suggest that the virus sustains active beta-catenin, which 
likely also interferes with cell cycle inhibition. Active beta-catenin forms a complex 
with TCF/LEF transcription factors in the nucleus, which leads to the 
transactivation of cell cycle proteins such as Cyclin D (Huelsken and Behrens 
2002). At times of cell-cell contact Beta-catenin is degraded or is sequestered to 
the cell membranes in order to control proliferation. As we have found elevated 
levels of active beta-catenin in all LSIL and HSIL-like cell lines above that of HPV 
negative NIKS, we can hypothesize that in normal circumstances the virus 
interferes with Beta-catenin pathways as another means to persist in the cell cycle 
above the tightly packed basal layer. HSIL cell lines appear to activate Beta- 
catenin at higher levels, which might consequently lead to increased cell cycle 
persistence in the epithelium.
Recent work has shown that Beta-catenin activity is increased in E6 only NIKS cell 
lines when compared to E7 only NIKS cell lines and HPV negative NIKS. (In 
personal communication with Kenneth Raj, NIMR, London, UK). This might 
suggest then that both E6 and E7 are needed to extend the S-phase compartment 
above the basal layer however by different mechanisms.
Although we are not certain of a direct interaction with E6 and beta-catenin there 
are several possible scenarios that might explain a role of E6 in sustaining active
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beta-catenin. One scenario is related to a reduction of p53, which is directly 
mediated by E6. Past studies have shown that beta-catenin interacts with p53 via 
a negative feedback loop (Oren, Damalas et al. 2002). Mutations in p53 have been 
shown to result in abnormal beta-catenin accumulation (Cagatay and Ozturk 
2002). In the case of highly reduced levels of p53 as observed in HSIL-like cell 
lines, this might lead to abnormal levels of active beta-catenin.
We have also preliminary data also suggests that PDZ domain cellular proteins 
such as hDlg and hScrib are more reduced in HSIL-like raft cultures compared to 
LSIL-like raft cultures (data not shown). It is widely established that E6 degrades 
PDZ domain proteins, which is thought to be important for neoplastic development 
and carcinogenesis (Thomas, Narayan et al. 2008). The reduction of hScrib and 
hDlg could also potentially interfere with their binding of the tumor suppressor APC 
(Matsumine, Ogai et al. 1996; Takizawa, Nagasaka et al. 2006). APC functions to 
regulate beta-catenin activity in the cytoplasm in order to control proliferation. The 
high reduction of hScrib and hDlg proteins might therefore contribute to high Beta- 
catenin activity.
The further evalauation of the NIKS raft culture system as laboratory model 
of HPV-induced neoplasia
Through these studies we have also found that LSIL-like and HSIL-like 
phenotypes are biologically reproducible in the NIKS system. We have concluded 
this based on the fact that two different transfections yielded LSIL-like and HSIL- 
like phenotypes. This is in support of this system as a potential laboratory model of 
episomal HPV induced neoplasia. At present LSIL-like and HSIL-like phenotypes
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have not been identified in any other system that maintains viral episomes. 
However, this does not discount that these phenotypes do not exist in other 
keratinocyte cell line systems that maintain viral episomes.
At present the data in this thesis suggests that the oncogene levels are regulated 
differently from viral episomes and are responsible for the LSIL-like and HSIL-like 
phenotypes. This however does not rule out that a level of heterogeneity in the 
host cell line could also be contributing to these phenotypes in individual clonal cell 
lines. As mentioned earlier NIKS arose as a spontaneously immortalized cell line 
with a near diploid genome, and was also shown to be maintained as an isogenic 
cell line (Allen-Hoffmann, Schlosser et al. 2000). It will be necessary to verify that 
the parental NIKS are still homogeneous cell line and the cells did not acquire 
further genomic instability over time that might contribute to these phenotypes. We 
are currently karyotyping the NIKS and HPV-16 each cell lines to look for 
additional chromosomal rearrangement and base ploidy levels. Secondly it is 
possible that chromosomal rearrangement can lead to elevations or decreases in 
gene dosage. To evaluate this Array comparative genomic hybridization (aCGH) 
can be carried out on genomic DNA (gDNA). aCGH is a highly sensitive assay that 
identifies gene copy number changes within a specific chromosomal region 
(Strefford and Parker 2009).
Future work will be aimed at evaluating if this phenotypic variation also exists in 
primary cell lines. Past studies have shown that both cervical and foreskin 
keratinocytes can been successfully transfected with high-risk HPV genomes 
(Lace, Anson et al. 2009). Primary HPV-16 cell lines can be subsequently 
maintained for up to 30 passages. We have also recently harvested primary
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cervical cell lines from cervical biopsies, which could be used to establish a model 
of HPV-16 cervical disease.
196
References
References
Alazawi, W.,Pett, M.,Arch, B.,Scott, L.,Freeman, T.,Stanley, M. A. and Coleman, 
N. (2002). "Changes in cervical keratinocyte gene expression associated with 
integration of human papillomavirus 16". Cancer Res 62(23): 6959-65.
Allen-Hoffmann, B. L.,Schlosser, S. J.Jvarie, C. A.,Sattler, C. A.,Meisner, L. F. and 
O'connor, S. L. (2000). "Normal growth and differentiation in a spontaneously 
immortalized near-diploid human keratinocyte cell line, NIKS". J Invest Dermatol 
114(3): 444-55.
Androphy, E. J.,Lowy, D. R. and Schiller, J. T. (1987). "Bovine papillomavirus E2 
trans-activating gene product binds to specific sites in papillomavirus DNA". 
Nature 325(6099): 70-3.
Baker, C. C.,Phelps, W. C.,Lindgren, V.,Braun, M. J.,Gonda, M. A . and Howley, 
P. M. (1987). "Structural and transcriptional analysis of human papillomavirus type 
16 sequences in cervical carcinoma cell lines". J Virol 61(4): 962-71.
Baida, M. S. and Matter, K. (2003). "Epithelial cell adhesion and the regulation of 
gene expression". Trends Cell Biol 13(6): 310-8.
Balsitis, S.,Dick, F.,Dyson, N. and Lambert, P. F. (2006). "Critical roles for non- 
pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis". 
Cancer Res 66(19): 9393-400.
Balsitis, S. J.,Sage, J.,Duensing, S.,Munger, K.,Jacks, T. and Lambert, P. F.
(2003). "Recapitulation of the effects of the human papillomavirus type 16 E7 
oncogene on mouse epithelium by somatic Rb deletion and detection of pRb- 
independent effects of E7 in vivo". Mol Cell Biol 23(24): 9094-103.
Banerjee, N. S..Genovese, N. J.,Noya, F.,Chien, W. M.,Broker, T. R.andChow, L. 
T. (2006). "Conditionally activated E7 proteins of high-risk and low-risk human 
papillomaviruses induce S phase in postmitotic, differentiated human 
keratinocytes". J Virol 80(13): 6517-24.
Bedell, M. A.,Hudson, J. B.,Golub, T. R.,Turyk, M. E.,Hosken, M..Wilbanks, G. D. 
and Laimins, L. A. (1991). "Amplification of human papillomavirus genomes in vitro 
is dependent on epithelial differentiation". J Virol 65(5): 2254-60.
Berg, M. and Stenlund, A. (1997). "Functional interactions between papillomavirus 
E1 and E2 proteins". J Virol 71(5): 3853-63.
Bernard, H. U.,Chan, S. Y. and Delius, H. (1994). "Evolution of papillomaviruses". 
Curr Top Microbiol Immunol 186: 33-54.
Bernard, H. U.,Chan, S. Y.,Manos, M. M.,Ong, C. K.,Villa, L. L.,Delius, H.,Peyton, 
C. L.,Bauer, H. M. and Wheeler, C. M. (1994). "Identification and assessment of 
known and novel human papillomaviruses by polymerase chain reaction 
amplification, restriction fragment length polymorphisms, nucleotide sequence, 
and phylogenetic algorithms". J Infect Pis 170(5): 1077-85.
197
References
Bernard, H. U. (2005). "The clinical importance of the nomenclature, evolution and 
taxonomy of human papillomaviruses". J Clin Virol 32 Suppl 1: S1-6.
Black, A. R. and Azizkhan-Clifford, J. (1999). "Regulation of E2F: a family of 
transcription factors involved in proliferation control". Gene 237(2): 281-302.
Bosch, F. X. and De Sanjose, S. (2003). "Chapter 1: Human papillomavirus and 
cervical cancer-burden and assessment of causality". J Natl Cancer Inst 
Monoqr(31): 3-13.
Boyer, S. N.,Wazer, D. E. and Band, V. (1996). "E7 protein of human papilloma 
virus-16 induces degradation of retinoblastoma protein through the ubiquitin- 
proteasome pathway". Cancer Res 56(20): 4620-4.
Brake, T. and Lambert, P. F. (2005). "Estrogen contributes to the onset, 
persistence, and malignant progression of cervical cancer in a human 
papillomavirus-transgenic mouse model". Proc Natl Acad Sci U S A 102(7): 2490- 
5.
Branca, M.,Ciotti, M.,Santini, D.,Bonito, L. D.,Benedetto, A.,Giorgi, C.,Paba, 
P.,Favalli, C.,Costa, S.,Agarossi, A.,Alderisio, M. and Syrjanen, K. (2004). 
"Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is 
related to grade of the lesion but not to high-risk human papillomavirus, virus 
clearance, or prognosis in cervical cancer". Am J Clin Pathol 122(6): 902-11.
Brehm, A.,Nielsen, S. J.,Miska, E. A.,Mccance, D. J.,Reid, J. L.,Bannister, A. J. 
and Kouzarides, T. (1999). "The E7 oncoprotein associates with Mi2 and histone 
deacetylase activity to promote cell growth". EMBO J 18(9): 2449-58.
Bryan, J. T. and Brown, D. R. (2000). "Association of the human papillomavirus 
type 11 E1()E4 protein with cornified cell envelopes derived from infected genital 
epithelium". Virology 277(2): 262-9.
Buchkovich, K.,Duffy, L. A. and Harlow, E. (1989). "The retinoblastoma protein is 
phosphorylated during specific phases of the cell cycle". Cell 58(6): 1097-105.
Cagatay, T. and Ozturk, M. (2002). "P53 mutation as a source of aberrant beta- 
catenin accumulation in cancer cells". Oncogene 21(52): 7971-80.
Candi, E..Schmidt, R. and Melino, G. (2005). "The cornified envelope: a model of 
cell death in the skin". Nat Rev Mol Cell Biol 6(4): 328-40.
Chan, S. Y.,Bernard, H. U.,Ratterree, M.,Birkebak, T. A.,Faras, A. J. and Ostrow, 
R. S. (1997). "Genomic diversity and evolution of papillomaviruses in rhesus 
monkeys". J Virol 71(7): 4938-43.
Chen, X. S.,Garcea, R. L..Goldberg, l.,Casini, G. and Harrison, S. C. (2000). 
"Structure of small virus-like particles assembled from the L1 protein of human 
papillomavirus 16". Mol Cell 5(3): 557-67.
198
References
Cheng, S.,Schmidt-Grimminger, D. C.,Murant, T.,Broker, T. R. and Chow, L. T. 
(1995). "Differentiation-dependent up-regulation of the human papillomavirus E7 
gene reactivates cellular DNA replication in suprabasal differentiated 
keratinocytes". Genes Dev 9(19): 2335-49.
Chow, L. T.,Duffy, A. A.,Wang, H. K. and Broker, T. R. (2009). "A highly efficient 
system to produce infectious human papillomavirus: Elucidation of natural virus- 
host interactions". CeU_Cyde_8(9): 1319-23.
Cohen, J. (2005). "Public health. High hopes and dilemmas for a cervical cancer 
vaccine". Science 308(5722): 618-21.
Collins, A. S.,Nakahara, T.,Do, A. and Lambert, P. F. (2005). "Interactions with 
pocket proteins contribute to the role of human papillomavirus type 16 E7 in the 
papillomavirus life cycle". J Virol 79(23): 14769-80.
Cornelissen, M. T.,Smits, H. L.,Briet, M. A.,Van Den Tweel, J. G.,Struyk, A. P.,Van 
Der Noordaa, J. and Ter Schegget, J. (1990). "Uniformity of the splicing pattern of 
the E6/E7 transcripts in human papillomavirus type 16-transformed human 
fibroblasts, human cervical premalignant lesions and carcinomas". J Gen Virol 71 ( 
Pt 5): 1243-6.
Dale, B. A.,Salonen, J. and Jones, A. H. (1990). "New approaches and concepts 
in the study of differentiation of oral epithelia". Crit Rev Oral Biol Med 1(3): 167- 
90.
Davy, C. E.,Jackson, D. J.,Wang, Q.,Raj, K.,Masterson, P. J.,Fenner, N. 
F..Southern, S.,Cuthill, S..Millar, J. B. and Doorbar, J. (2002). "Identification of a 
G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16". 
J Virol 76(19): 9806-18.
Davy, C. E..Jackson, D. J.,Raj, K.,Peh, W. L..Southern, S. A.,Das, P.,Sorathia, 
R.,Laskey, P..Middleton, K.,Nakahara, T.,Wang, Q.,Masterson, P. J.,Lambert, P. 
F.,Cuthill, S..Millar, J. B. and Doorbar, J. (2005). "Human papillomavirus type 16 
E1 E4-induced G2 arrest is associated with cytoplasmic retention of active 
Cdk1/cyclin B1 complexes". J Virol 79(7): 3998-4011.
Day, P. M.,Baker, C. C.,Lowy, D. R. and Schiller, J. T. (2004). "Establishment of 
papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) 
expression". Proc Natl Acad Sci U S A 101(39): 14252-7.
De Geest, K.,Turyk, M. E.,Hosken, M. I..Hudson, J. B.,Laimins, L. A. and 
Wilbanks, G. D. (1993). "Growth and differentiation of human papillomavirus type 
31b positive human cervical cell lines". Gynecol Oncol 49(3): 303-10.
De Villiers, E. M.,Fauquet, C.,Broker, T. R.,Bernard, H. U. and Zur Hausen, H.
(2004). "Classification of papillomaviruses". Virology 324(1): 17-27.
/
199
References
Delvenne, P..Hubert, P..Jacobs, N.,Giannini, S. L.Havard, L.,Renard,
1..5aboulard, D. and Boniver, J. (2001). "The organotypic culture of HPV- 
transformed keratinocytes: an effective in vitro model for the development of new 
immunotherapeutic approaches for mucosal (pre)neoplastic lesions". Vaccine 
19(17-19): 2557-64.
Demers, G. W.,Halbert, C. L. and Galloway, D. A. (1994). "Elevated wild-type p53 
protein levels in human epithelial cell lines immortalized by the human 
papillomavirus type 16 E7 gene". Virology 198(1): 169-74.
Demeter, L. M.,Stoler, M. H.,Bonnez, W.,Corey, L.,Pappas, P.,Strussenberg, J. 
and Reichman, R. C. (1993). "Penile intraepithelial neoplasia: clinical presentation 
and an analysis of the physical state of human papillomavirus DNA". J Infect Pis 
168(1): 38-46.
Desaintes, C. and Demeret, C. (1996). "Control of papillomavirus DNA replication 
and transcription". Semin Cancer Biol 7(6): 339-47.
Doorbar, J.,Parton, A.,Hartley, K.,Banks, L..Crook, T.,Stanley, M. and Crawford, L. 
(1990). "Detection of novel splicing patterns in a HPV16-containing keratinocyte 
cell line". Virology 178(1): 254-62.
Doorbar, J.,Foo, C..Coleman, N.,Medcalf, L.,Hartley, 0.,Prospero, T.,Napthine,
5..5terling, J..Winter, G. and Griffin, H. (1997). "Characterization of events during 
the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4". 
Virology 238(1): 40-52.
Doorbar, J. (2006). "Molecular biology of human papillomavirus infection and 
cervical cancer". Clin Sci (Lond) 110(5): 525-41.
Duensing, S.,Duensing, A.,Flores, E. R.,Do, A.,Lambert, P. F. and Munger, K. 
(2001). "Centrosome abnormalities and genomic instability by episomal 
expression of human papillomavirus type 16 in raft cultures of human 
keratinocytes". J Virol 75(16): 7712-6.
Duensing, S. and Munger, K. (2003). "Human papillomavirus type 16 E7 
oncoprotein can induce abnormal centrosome duplication through a mechanism 
independent of inactivation of retinoblastoma protein family members". J Virol 
77(22): 12331-5.
Dyson, N.,Howley, P. M..Munger, K. and Harlow, E. (1989). "The human papilloma 
virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product". 
Science 243(4893): 934-7.
Eckert, R. L.,Crish, J. F. and Robinson, N. A. (1997). "The epidermal keratinocyte 
as a model for the study of gene regulation and cell differentiation". Physiol Rev 
77(2): 397-424.
Eichner, R.,Sun, T. T. and Aebi, U. (1986). "The role of keratin subfamilies and 
keratin pairs in the formation of human epidermal intermediate filaments". J Cell 
Biol 102(5): 1767-77.
200
References
Eichten, A.,Rud, D. S..Grace, M.,Piboonniyom, S. 0.,Zacny, V. and Munger, K.
(2004). "Molecular pathways executing the "trophic sentinel" response in HPV-16 
E7-expressing normal human diploid fibroblasts upon growth factor deprivation". 
Virology 319(1): 81-93.
Flores, E. R. and Lambert, P. F. (1997). "Evidence for a switch in the mode of 
human papillomavirus type 16 DNA replication during the viral life cycle". J Virol 
71(10): 7167-79.
Flores, E. R.,Allen-Hoffmann, B. L.,Lee, D. and Lambert, P. F. (2000). "The human 
papillomavirus type 16 E7 oncogene is required for the productive stage of the 
viral life cycle". J Virol 74(14): 6622-31.
Freeman, A.,Morris, L. S..Mills, A. D.,Stoeber, K.,Laskey, R. A.,Williams, G. H. and 
Coleman, N. (1999). "Minichromosome maintenance proteins as biological 
markers of dysplasia and malignancy". Clin Cancer Res 5(8): 2121-32.
Fuchs, E. (1990). "Epidermal differentiation: the bare essentials". J Cell Biol 111(6 
Pt 2): 2807-14.
Fujii, T.,Masumoto, N.,Saito, M.,Hirao, N.,Niimi, S.,Mukai, M.,Ono, A.,Hayashi,
S.,Kubushiro, K.,Sakai, E.,Tsukazaki, K. and Nozawa, S. (2005). "Comparison 
between in situ hybridization and real-time PCR technique as a means of detecting 
the integrated form of human papillomavirus 16 in cervical neoplasia". Diaqn Mol 
Pathol 14(2): 103-8.
Funk, J. 0.,Waga, S..Harry, J. B.,Espling, E..Stillman, B. and Galloway, D. A. 
(1997). "Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is 
blocked by interaction with the HPV-16 E7 oncoprotein". Genes Dev 11(16): 
2090-100.
Gallie, B. L. (1994). "Retinoblastoma gene mutations in human cancer". N Engl J 
Med 330(11): 786-7.
Gammoh, N.,Grm, H. S.,Massimi, P. and Banks, L. (2006). "Regulation of human 
papillomavirus type 16 E7 activity through direct protein interaction with the E2 
transcriptional activator". J Virol 80(4): 1787-97.
Gammoh, N.,Isaacson, E.,Tomaic, V.,Jackson, D. J.,Doorbar, J. and Banks, L. 
(2009). "Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2". Oncogene 
28(23): 2299-304.
Gissmann, L.,Pfister, H. and Zur Hausen, H. (1977). "Human papilloma viruses 
(HPV): characterization of four different isolates". Virology 76(2): 569-80.
Gissmann, L.,Wolnik, L.Jkenberg, H.,Koldovsky, U.,Schnurch, H. G. and Zur 
Hausen, H. (1983). "Human papillomavirus types 6 and 11 DNA sequences in 
genital and laryngeal papillomas and in some cervical cancers". Proc Natl Acad 
Sci U S A 80(2): 560-3.
201
References
Grassmann, K.,Rapp, B.,Maschek, H.,Petry, K. U. and Iftner, T. (1996). 
"Identification of a differentiation-inducible promoter in the E7 open reading frame 
of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line 
containing high copy numbers of episomal HPV-16 DNA". J Virol 70(4): 2339-49.
Gu, W.,Putral, L.andMcmillan, N. (2008). "siRNA and shRNA as anticancer agents 
in a cervical cancer model". Methods Mol Biol 442: 159-72.
Hafner, N.,Driesch, C.,Gajda, M.,Jansen, L.,Kirchmayr, R.,Runnebaum, I. B. and 
Durst, M. (2008). "Integration of the HPV16 genome does not invariably result in 
high levels of viral oncogene transcripts". Oncogene 27(11): 1610-7.
Harwood, C. A. and Proby, C. M. (2002). "Human papillomaviruses and non­
melanoma skin cancer". Curr Qpin Infect Pis 15(2): 101-14.
Heck, D. V.,Yee, C. L.,Howley, P. M. and Munger, K. (1992). "Efficiency of binding 
the retinoblastoma protein correlates with the transforming capacity of the E7 
oncoproteins of the human papillomaviruses". Proc Natl Acad Sci U S A 89(10): 
4442-6.
Helt, A. M.,Funk, J. O. and Galloway, D. A. (2002). "Inactivation of both the 
retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 
oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells". J 
Virol 76(20): 10559-68.
Hillemanns, P.andWang, X. (2006). "Integration of HPV-16 and HPV-18 DNA in 
vulvar intraepithelial neoplasia". Gynecol Oncol 100(2): 276-82.
Ho, L.,Chan, S. Y.,Burk, R. D.,Das, B. C.,Fujinaga, KJcenogle, J. P.,Kahn, 
T.,Kiviat, N.,Lancaster, W.,Mavromara-Nazos, P. and Et Al. (1993). "The genetic 
drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral 
spread and the movement of ancient human populations". J Virol 67(11): 6413- 
23.
Huelsken, J. and Behrens, J. (2002). "The Wnt signalling pathway". J Cell Sci 
115(Pt 21): 3977-8.
Hughes, F. J. and Romanos, M. A. (1993). "E1 protein of human papillomavirus is 
a DNA helicase/ATPase". Nucleic Acids Res 21(25): 5817-23.
Jabbar, S. F..Abrams, L.,Glick, A. and Lambert, P. F. (2009). "Persistence of high- 
grade cervical dysplasia and cervical cancer requires the continuous expression of 
the human papillomavirus type 16 E7 oncogene". Cancer Res 69(10): 4407-14.
Jeon, S. and Lambert, P. F. (1995). "Integration of human papillomavirus type 16 
DNA into the human genome leads to increased stability of E6 and E7 mRNAs: 
implications for cervical carcinogenesis". Proc Natl Acad Sci U S A 92(5): 1654-8.
Jia, R.,Liu, X.,Tao, M.,Kruhlak, M.,Guo, M..Meyers, C.,Baker, C. C. and Zheng, Z. 
M. (2009). "Control of the papillomavirus early-to-late switch by differentially 
expressed SRp20". J Virol 83(1): 167-80.
202
References
Klaes, R.,Woerner, S. M.,Ridder, R.,Wentzensen, N.,Duerst, M..Schneider, 
A.,Lotz, B.,Melsheimer, P. and Von Knebel Doeberitz, M. (1999). "Detection of 
high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of 
transcripts derived from integrated papillomavirus oncogenes". Cancer Res 
59(24): 6132-6.
Klaes, R.,Friedrich, T.,Spitkovsky, D.,Ridder, R.,Rudy, W.,Petry, U.,Dallenbach- 
Hellweg, G.,Schmidt, D. and Von Knebel Doeberitz, M. (2001). "Overexpression of 
p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the 
cervix uteri". Int J Cancer 92(2): 276-84.
Klingelhutz, A. J.,Foster, S. A. and Mcdougall, J. K. (1996). "Telomerase activation 
by the E6 gene product of human papillomavirus type 16". Nature 380(6569): 79- 
82.
Koutsky, L. A.,Holmes, K. K.,Critchlow, C. W.,Stevens, C. E.,Paavonen, 
J.,Beckmann, A. M.,Derouen, T. A.,Galloway, D. A.,Vernon, D. and Kiviat, N. B. 
(1992). "A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 
in relation to papillomavirus infection". N Engl J Med 327(18): 1272-8.
Kubota, Y.,Fujinami, K.,Uemura, H.,Dobashi, Y.,Miyamoto, HJwasaki, 
Y.,Kitamura, H. and Shuin, T. (1995). "Retinoblastoma gene mutations in primary 
human prostate cancer". Prostate 27(6): 314-20.
Lace, M. J.,Anson, J. R.,Klingelhutz, A. J.,Lee, J. H.,Bossier, A. D.,Haugen, T. H. 
and Turek, L. P. (2009). "Human Papillomavirus (HPV) Type -18 Induces 
Extended Growth in Primary Human Cervical, Tonsillar or Foreskin Keratinocytes 
More Effectively Than Other High-Risk Mucosal HPVs". J Virol.
Lace, M. J.,Yamakawa, Y.,Ushikai, M.,Anson, J. R.,Haugen, T. H. and Turek, L. P. 
(2009). "Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 
promoter, P97, in vivo and in vitro from a negative element overlapping the 
transcription-initiation site". J Gen Virol 90(Pt 10): 2402-12.
Lambert, P. F.,Ozbun, M. A.,Collins, A.,Holmgren, S.,Lee, D. and Nakahara, T.
(2005). "Using an immortalized cell line to study the HPV life cycle in organotypic 
"raft" cultures". Methods Mol Med 119: 141-55.
Lee, C. and Laimins, L. A. (2004). "Role of the PDZ domain-binding motif of the 
oncoprotein E6 in the pathogenesis of human papillomavirus type 31". J Virol 
78(22): 12366-77.
Li, Y.,Nichols, M. A.,Shay, J. W. and Xiong, Y. (1994). "Transcriptional repression 
of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma 
susceptibility gene product pRb". Cancer Res 54(23): 6078-82.
Longworth, M. S.,Wilson, R. and Laimins, L. A. (2005). "HPV31 E7 facilitates 
replication by activating E2F2 transcription through its interaction with HDACs". 
EMBO J 24(10): 1821-30.
Maiorano, D.,Lutzmann, M. and Mechali, M. (2006). "MCM proteins and DNA 
replication". Curr Qpin Cell Biol 18(2): 130-6.
203
References
Manabe, M. and O'guin, W. M. (1994). "Existence of trichohyalin-keratohyalin 
hybrid granules: co-localization of two major intermediate filament-associated 
proteins in non-follicular epithelia". Differentiation 58(1): 65-75.
Masterson, P. J..Stanley, M. A.,Lewis, A. P. and Romanos, M. A. (1998). "A C- 
terminal helicase domain of the human papillomavirus E1 protein binds E2 and the 
DNA polymerase alpha-primase p68 subunit". J Virol 72(9): 7407-19.
Matsumine, A.,Ogai, A.,Senda, T.,Okumura, N.,Satoh, K.,Baeg, G. H.,Kawahara, 
T.,Kobayashi, S.,Okada, M.,Toyoshima, K. and Akiyama, T. (1996). "Binding of 
APC to the human homolog of the Drosophila discs large tumor suppressor 
protein". Science 272(5264): 1020-3.
Mclaughlin-Drubin, M. E. and Munger, K. (2009). "The human papillomavirus E7 
oncoprotein". Virology 384(2): 335-44.
Meyers, C.,Bromberg-White, J. L.,Zhang, J.,Kaupas, M. E.,Bryan, J. T.,Lowe, R.
S. and Jansen, K. U. (2002). "Infectious virions produced from a human 
papillomavirus type 18/16 genomic DNA chimera". J Virol 76(10): 4723-33.
Middleton, K.,Peh, W.,Southern, S..Griffin, H.,Sotlar, K.,Nakahara, T.,EI-Sherif, 
A.,Morris, L.,Seth, R.,Hibma, M..Jenkins, D..Lambert, P..Coleman, N. and 
Doorbar, J. (2003). "Organization of human papillomavirus productive cycle during 
neoplastic progression provides a basis for selection of diagnostic markers". J 
Virol 77(19): 10186-201.
Milligan, S. G.,Veerapraditsin, T.,Ahamet, B.,Mole, S. and Graham, S. V. (2007). 
"Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 
cervical epithelial cells". Virology 360(1): 172-81.
Miyamoto, H.,Shuin, T.,Torigoe, S.Jwasaki, Y. and Kubota, Y. (1995). 
"Retinoblastoma gene mutations in primary human bladder cancer". Br J Cancer 
71(4): 831-5.
Modis, Y.,Trus, B. L. and Harrison, S. C. (2002). "Atomic model of the 
papillomavirus capsid". EMBO J 21(18): 4754-62.
Morin, P. J. (1999). "beta-catenin signaling and cancer". Bioessavs 21(12): 1021- 
30.
Morris, P. J.,Dent, C. L.,Ring, C. J. and Latchman, D. S. (1993). "The octamer 
binding site in the HPV16 regulatory region produces opposite effects on gene 
expression in cervical and non-cervical cells". Nucleic Acids Res 21(4): 1019-23.
Munger, K.,Werness, B. A.,Dyson, N.,Phelps, W. C.,Harlow, E. and Howley, P. M. 
(1989). "Complex formation of human papillomavirus E7 proteins with the 
retinoblastoma tumor suppressor gene product". EMBO J 8(13): 4099-105.
204
References
Munoz, N..Bosch, F. X.,De Sanjose, S.,Herrero, R.,Castellsague, X.,Shah, K. 
V.,Snijders, P. J. and Meijer, C. J. (2003). "Epidemiologic classification of human 
papillomavirus types associated with cervical cancer". N Enal J Med 348(6): 518- 
27.
Nagasaka, K.,Nakagawa, S.,Yano, T.,Takizawa, S.,Matsumoto, Y.,Tsuruga, 
T.,Nakagawa, K.,Minaguchi, T.,Oda, K.,Hiraike-Wada, 0.,Ooishi, H.,Yasugi, T. 
and Taketani, Y. (2006). "Human homolog of Drosophila tumor suppressor 
Scribble negatively regulates cell-cycle progression from G1 to S phase by 
localizing at the basolateral membrane in epithelial cells". Cancer Sci 97(11): 
1217-25.
Nakagawa, S.,Yano, T.,Nakagawa, K.,Takizawa, S..Suzuki, Y.,Yasugi, 
T.,Huibregtse, J. M. and Taketani, Y. (2004). "Analysis of the expression and 
localisation of a LAP protein, human scribble, in the normal and neoplastic 
epithelium of uterine cervix". Br J Cancer 90(1): 194-9.
Nakahara, T.,Peh, W. L.,Doorbar, J.,Lee, D. and Lambert, P. F. (2005). "Human 
papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the 
papillomavirus life cycle". J Virol 79(20): 13150-65.
Nelson, W. G. and Sun, T. T. (1983). "The 50- and 58-kdalton keratin classes as 
molecular markers for stratified squamous epithelia: cell culture studies". J Cell 
Biol 97(1): 244-51
Noya, F.,Chien, W. M.,Broker, T. R. and Chow, L. T. (2001). "p21cip1 Degradation 
in differentiated keratinocytes is abrogated by costabilization with cyclin E induced 
by human papillomavirus E7". J Virol 75(13): 6121-34
Oren, M.,Damalas, A.,Gottlieb, T.,Michael, D.,Taplick, J.,Leal, J. F.,Maya, 
R.,Moas, M.,Seger, R.,Taya, Y. and Ben-Ze'ev, A. (2002). "Regulation of p53: 
intricate loops and delicate balances". Biochem Pharmacol 64(5-6): 865-71.
Paramio, J. M..Casanova, M. L.,Segrelles, C.,Mittnacht, S.,Lane, E. B. and 
Jorcano, J. L. (1999). "Modulation of cell proliferation by cytokeratins K10 and 
K16". Mol Cell Biol 19(4): 3086-94.
Peh, W. L.,Middleton, K.,Christensen, N.,Nicholls, P.,Egawa, K.,Sotlar, 
K.,Brandsma, J.,Percival, A.,Lewis, J.,Liu, W. J. and Doorbar, J. (2002). "Life cycle 
heterogeneity in animal models of human papillomavirus-associated disease". J 
Virol 76(20): 10401-16.
Peh, W. L. and Doorbar, J. (2005). "Detection of papillomavirus proteins and DNA 
in paraffin-embedded tissue sections". Methods Mol Med 119: 49-59.
Pfister, H. (1992). "Human papillomaviruses and skin cancer". Semin Cancer Biol 
3(5): 263-71.
Pfister, H. (2003). "Chapter 8: Human papillomavirus and skin cancer". J Natl 
Cancer Inst Monoqr(31): 52-6.
205
References
Piccini, A.,Storey, A.,Romanos, M. and Banks, L. (1997). "Regulation of human 
papillomavirus type 16 DNA replication by E2, glucocorticoid hormone and 
epidermal growth factor". J Gen Virol 78 ( Pt 8): 1963-70.
Pirn, D.,Tomaic, V. and Banks, L. (2009). "The Hpv E6* Proteins from High-Risk, 
Mucosal Human Papillomaviruses Can Direct the Degradation of Cellular Proteins 
in the Absence of Full-Length E6 Protein". J Virol.
Plug-Demaggio, A. W. and Mcdougall, J. K. (2002). "The human papillomavirus 
type 16 E6 oncogene induces premature mitotic chromosome segregation". 
Oncogene 21(49): 7507-13.
Presland, R. B.,Kimball, J. R.,Kautsky, M. B.,Lewis, S. P.,Lo, C. Y. and Dale, B. A. 
(1997). "Evidence for specific proteolytic cleavage of the N-terminal domain of 
human profilaggrin during epidermal differentiation". J Invest Dermatol 108(2): 
170-8.
Pyeon, D.,Newton, M. A.,Lambert, P. F.,Den Boon, J. A.,Sengupta, S.,Marsit, C. 
J..Woodworth, C. D.,Connor, J. P..Haugen, T. H..Smith, E. M.,Kelsey, K. T.,Turek, 
L. P. and Ahlquist, P. (2007). "Fundamental differences in cell cycle deregulation 
in human papillomavirus-positive and human papillomavirus-negative head/neck 
and cervical cancers". Cancer Res 67(10): 4605-19.
Pyeon, D.,Pearce, S. M.,Lank, S. M..Ahlquist, P. and Lambert, P. F. (2009). 
"Establishment of human papillomavirus infection requires cell cycle progression". 
PLoS Pathoa 5(2): e1000318.
Rubin, M. A.,Kleter, B.,Zhou, M.,Ayala, G.,Cubilla, A. L.,Quint, W. G. and Pirog, E. 
C. (2001). "Detection and typing of human papillomavirus DNA in penile 
carcinoma: evidence for multiple independent pathways of penile carcinogenesis". 
Am J Pathol 159(4): 1211-8.
Scheffner, M.,Huibregtse, J. M.,Vierstra, R. D. and Howley, P. M. (1993). "The 
HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the 
ubiquitination of p53". Cell 75(3): 495-505.
Serrano, M.,Hannon, G. J. and Beach, D. (1993). "A new regulatory motif in cell- 
cycle control causing specific inhibition of cyclin D/CDK4". Nature 366(6456): 704- 
7.
Shai, A.,Brake, T.,Somoza, C. and Lambert, P. F. (2007). "The human 
papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical 
carcinogenesis through two independent activities". Cancer Res 67(4): 1626-35.
Smotkin, D. and Wettstein, F. O. (1986). "Transcription of human papillomavirus 
type 16 early genes in a cervical cancer and a cancer-derived cell line and 
identification of the E7 protein". Proc Natl Acad Sci U S A 83(13): 4680-4.
Sousa, R.,Dostatni, N. and Yaniv, M. (1990). "Control of papillomavirus gene 
expression". Biochim Biophvs Acta 1032(1): 19-37.
206
References
Stanley, M. (2008). "Immunobiology of HPV and HPV vaccines". Gynecol Oncol 
109(2 Suppl): S15-21.
Stanley, M. A.,Browne, H. M..Appleby, M. and Minson, A. C. (1989). "Properties of 
a non-tumorigenic human cervical keratinocyte cell line". Int J Cancer 43(4): 672-
6 .
Steger, G. and Corbach, S. (1997). "Dose-dependent regulation of the early 
promoter of human papillomavirus type 18 by the viral E2 protein". J Virol 71(1): 
50-8.
Strefford, J. C. and Parker, H. (2009). "Array-based comparative genomic 
hybridization as a tool for analyzing the leukemia genome". Methods Mol Biol 538: 
151-77.
Takizawa, S.,Nagasaka, K.,Nakagawa, S.,Yano, T.,Nakagawa, K.,Yasugi, 
T.,Takeuchi, T.,Kanda, T.,Huibregtse, J. M.,Akiyama, T. and Taketani, Y. (2006). 
"Human scribble, a novel tumor suppressor identified as a target of high-risk HPV 
E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli". 
Genes Cells 11(4): 453-64.
Tan, S. H.,Leong, L. E..Walker, P. A. and Bernard, H. U. (1994). "The human 
papillomavirus type 16 E2 transcription factor binds with low cooperativity to two 
flanking sites and represses the E6 promoter through displacement of Sp1 and 
TFIID". J Virol 68(10): 6411-20.
Thomas, M.,Narayan, N.,Pim, D.,Tomaic, V.,Massimi, P.,Nagasaka, K.,Kranjec, 
C..Gammoh, N. and Banks, L. (2008). "Human papillomaviruses, cervical cancer 
and cell polarity". Oncogene 27(55): 7018-30.
Thorland, E. C.,Myers, S. L.,Gostout, B. S. and Smith, D. I. (2003). "Common 
fragile sites are preferential targets for HPV16 integrations in cervical tumors". 
Oncogene 22(8): 1225-37.
Todaro, G. J. and Green, H. (1963). "Quantitative studies of the growth of mouse 
embryo cells in culture and their development into established lines". J Cell Biol 
17: 299-313.
Vessey, C. J..Wilding, J.,Folarin, N.,Hirano, S.,Takeichi, M.,Soutter, P..Stamp, G. 
W. and Pignatelli, M. (1995). "Altered expression and function of E-cadherin in 
cervical intraepithelial neoplasia and invasive squamous cell carcinoma". J Pathol 
176(2): 151-9.
Walboomers, J. M..Jacobs, M. V.,Manos, M. M.,Bosch, F. X.,Kummer, J. A.,Shah, 
K. V.,Snijders, P. J.,Peto, J.,Meijer, C. J. and Munoz, N. (1999). "Human 
papillomavirus is a necessary cause of invasive cervical cancer worldwide". J 
Pathol 189(1): 12-9.
Wilding, J.,Vousden, K. H.,Soutter, W. P.,Mccrea, P. D.,Del Buono, R. and 
Pignatelli, M. (1996). "E-cadherin transfection down-regulates the epidermal 
growth factor receptor and reverses the invasive phenotype of human papilloma 
virus-transfected keratinocytes". Cancer Res 56(22): 5285-92.
207
References
Williams, G. H.,Romanowski, P..Morris, L.,Madine, M.,Mills, A. D.,Stoeber, 
K.,Marr, J.,Laskey, R. A. and Coleman, N. (1998). "Improved cervical smear 
assessment using antibodies against proteins that regulate DNA replication". Proc 
Natl Acad Sci U S A 95(25): 14932-7.
Wilson, R. and Laimins, L. A. (2005). "Differentiation of HPV-containing cells using 
organotypic "raft" culture or methylcellulose". Methods Mol Med 119: 157-69.
Woodman, C. B..Collins, S..Winter, H..Bailey, A.,Ellis, J.,Prior, P..Yates, 
M.,Rollason, T. P. and Young, L. S. (2001). "Natural history of cervical human 
papillomavirus infection in young women: a longitudinal cohort study". Lancet 
357(9271): 1831-6.
You, J.,Croyle, J. L.,Nishimura, A.,Ozato, K. and Howley, P. M. (2004). 
"Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA 
to host mitotic chromosomes". Cell 117(3): 349-60.
Yuan, H.,lto, S.,Senga, T.,Hyodo, T.,Kiyono, T.,Kikkawa, F. and Hamaguchi, M. 
(2009). "Human papillomavirus type 16 oncoprotein E7 suppresses cadherin- 
mediated cell adhesion via ERK and AP-1 signaling". Int J Oncol 35(2): 309-14.
Zerfass-Thome, K.,Zwerschke, W.,Mannhardt, B.,Tindle, R.,Botz, J. W. and 
Jansen-Durr, P. (1996). "Inactivation of the cdk inhibitor p27KIP1 by the human 
papillomavirus type 16 E7 oncoprotein". Oncogene 13(11): 2323-30.
Zheng, Z. M. and Baker, C. C. (2006). "Papillomavirus genome structure, 
expression, and post-transcriptional regulation". Front Biosci 11: 2286-302.
Ziegert, C.,Wentzensen, N.,Vinokurova, S.,Kisseljov, F.,Einenkel, J.,Hoeckel, M. 
and Von Knebel Doeberitz, M. (2003). "A comprehensive analysis of HPV 
integration loci in anogenital lesions combining transcript and genome-based 
amplification techniques". Oncogene 22(25): 3977-84.
Zur Hausen, H. (1977). "Human papillomaviruses and their possible role in 
squamous cell carcinomas". Curr Top Microbiol Immunol 78: 1-30.
208
